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Abstract
Fragile X syndrome (FXS), caused by the silencing of the FMR1 gene, is the most common heritable form
of intellectual disability and autism. In both FXS and autism, the auditory cortex is of particular interest
because of its crucial role in language development, communication, and auditory processing, all of which
are hallmark deficits in patients. In the FXS animal model of the Fmr1 knockout (KO) mouse, numerous
auditory-related phenotypes have also been described related to abnormal auditory processing and an
impaired auditory cortex critical period. While such phenotypes are suggestive of altered excitatoryinhibitory balance in the auditory circuit, few studies have examined synaptic dysregulation in the auditory
cortex. Here, we investigate the postnatal maturation of ionotropic glutamate and GABA-mediated
synaptic transmission across key developmental ages in auditory forebrain maturation. We first
characterized wild-type mice, establishing clear developmental patterns in the naturally developing
auditory cortex. We subsequently identified a broad dysregulation of these maturational patterns in the
Fmr1 KO mice. Cellular and molecular expression studies of the developmental expression of ionotropic
receptor subunits in Chapter 2 revealed altered expression patterns that manifest before ear canal
opening, suggestive of dysregulation that manifests before auditory circuits are fully in sync with
environmental input. In Chapter 3, we examined the functional maturation of the L4 to L2/3 auditory
intracortical circuit, with Fmr1 KO mice revealing aberrant developmental patterns of basal synaptic
transmission excitability and synaptic plasticity. In Chapters 4 and 5, we directly investigate the functional
maturation of GABAergic and glutamatergic synapses in L2/3 pyramidal neurons in Fmr1 KO mice. Taken
together, our results suggest that the loss of FMRP causes an altered regulation and coordination of
inhibitory and excitatory synaptic maturation in the auditory cortex, which in part underlie the circuit
dysregulation that occurs during its critical period to ultimately elicit auditory-related phenotypes in FXS.
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ABSTRACT
EXCITATORY-INHIBITORY CIRCUIT DYSREGULATION DURING THE AUDITORY
CORTEX CRITICAL PERIOD IN THE FRAGILE X SYNDROME MOUSE MODEL
Yeri J. Song
Frances E. Jensen

Fragile X syndrome (FXS), caused by the silencing of the FMR1 gene, is the most common
heritable form of intellectual disability and autism. In both FXS and autism, the auditory
cortex is of particular interest because of its crucial role in language development,
communication, and auditory processing, all of which are hallmark deficits in patients. In
the FXS animal model of the Fmr1 knockout (KO) mouse, numerous auditory-related
phenotypes have also been described related to abnormal auditory processing and an
impaired auditory cortex critical period. While such phenotypes are suggestive of altered
excitatory-inhibitory balance in the auditory circuit, few studies have examined synaptic
dysregulation in the auditory cortex. Here, we investigate the postnatal maturation of
ionotropic

glutamate

and

GABA-mediated

synaptic

transmission

across

key

developmental ages in auditory forebrain maturation. We first characterized wild-type
mice, establishing clear developmental patterns in the naturally developing auditory
cortex. We subsequently identified a broad dysregulation of these maturational patterns
in the Fmr1 KO mice. Cellular and molecular expression studies of the developmental
expression of ionotropic receptor subunits in Chapter 2 revealed altered expression
patterns that manifest before ear canal opening, suggestive of dysregulation that
manifests before auditory circuits are fully in sync with environmental input. In Chapter 3,
we examined the functional maturation of the L4 to L2/3 auditory intracortical circuit, with
Fmr1 KO mice revealing aberrant developmental patterns of basal synaptic transmission
v

excitability and synaptic plasticity. In Chapters 4 and 5, we directly investigate the
functional maturation of GABAergic and glutamatergic synapses in L2/3 pyramidal
neurons in Fmr1 KO mice. Taken together, our results suggest that the loss of FMRP
causes an altered regulation and coordination of inhibitory and excitatory synaptic
maturation in the auditory cortex, which in part underlie the circuit dysregulation that
occurs during its critical period to ultimately elicit auditory-related phenotypes in FXS.
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CHAPTER 1:
INTRODUCTION

Overview
Neurodevelopmental disorders are multi-faceted conditions characterized by impaired
brain development and function, with symptom onset during early developmental periods
and a well-documented clinical association between intellectual disability, autism, and
epilepsy. About 33% of autistic children have intellectual disability (Maenner et al., 2020),
and up to 35% of autistic children suffer from seizures (Tuchman and Cuccaro, 2011; El
Achkar and Spence, 2015). Additionally, patients with severe intellectual disability are at
a higher risk for epilepsy (Tuchman, 2015), and about 40% of patients with early-life
seizures suffer from cognitive deficits or autism later in life (Ronen et al., 2007; Tuchman,
2015). Despite being multivariate and heterogeneous in cause, neurodevelopmental
disorders frequently share features of language development and communication
impairments, as well as auditory and other sensory processing deficits, making the
auditory cortex a brain region of interest.

Fragile X syndrome (FXS), the leading monogenic cause of intellectual disability, is one
such disorder where patients exhibit a clinical co-occurrence with autism and epilepsy,
and have impaired language and sensory-related impairments (Hersh et al., 2011;
Hagerman et al., 2017). In FXS, silencing of Fmr1 causes loss of expression of the Fragile
X mental retardation protein (FMRP), a regulator of synaptic activity-dependent translation
and modulator of excitatory-inhibitory (E-I) balance (Darnell et al., 2011; Tang et al., 2015).
Interestingly, FMRP expression and function is developmentally regulated and also found
to be altered in autism spectrum disorders and epilepsy (Bernard et al., 2013; Fernandez
1

et al., 2013; Folsom et al., 2015). Therefore, understanding the pathway in which FMRP
regulates proper synaptic maturation and circuit development in the brain, both broadly as
well as specifically within the auditory cortex, is important for elucidating mechanisms
related to impaired language development and auditory processing in FXS. Furthermore,
understanding shared mechanisms between intellectual disability, autism, and epilepsy
pathology can aid in the development of refined targeted treatments and therapeutics.

The remainder of this chapter will provide an overview of generalized features and
symptoms of FXS in patients, with a particular focus on auditory-related symptoms
(Section I), and review the recapitulation of the various phenotypes in the FXS animal
model, the Fmr1 knockout (KO) mouse (Section II). Auditory cortex maturation and critical
period regulation will be reviewed (Section III), with a particular focus on excitation and
inhibition their alterations in development and disease (Section IV), and then experimental
treatments that have been or are currently being explored for FXS will be presented
(Section V). Finally, the evolution of the FXS field will be discussed with consideration for
understanding pathomechanisms of the disorder and the open questions that remain, and
how the work presented herein can elucidate brain maturation patterns that underlie the
commonalities of neurodevelopmental disorders.

I. Fragile X Syndrome
Fragile X syndrome (FXS) is the leading monogenic form of intellectual disability and
autism caused by the absence or highly deficient levels of the Fragile X mental retardation
protein (FMRP) (Hersh et al., 2011; Hagerman et al., 2017). The mutation identified in
FXS is the hypermethylation of the CGG trinucleotide repeat expansion (>200) in the
promoter region of FMR1, located on the X chromosome (Xq27.3), causing its
2

transcriptional silencing and loss of FMRP expression. The estimated incidence of FXS is
1:5000 in males and 1:8000 in females (Hagerman et al., 2017), with the clinical severity
of FXS and intellectual disability highly correlated with the levels of FMRP due to the
mosaicism related to being an X-linked disorder (Kazdoba et al., 2014).

FXS patients exhibit a range of cognitive deficits related to learning, attention, and
memory. Patients often present with several stereotypical physical features including
prominent ears and long face, along with macro-orchidism in males. Symptoms of FXS
typically manifest during the 2nd year of life, where patients noticeably exhibit language
development delays, and further present with hyperactivity, anxiety, and sensory
hypersensitivity (Hagerman et al., 2017). Seizures occur in up to 16% of patients, with
typical onset within the first 5 years of life when communication and speech deficits
become more apparent (Nelson and Valakh, 2015; Hagerman et al., 2017). Behavioral
issues persist from childhood through adolescence, with patients often exhibiting
impulsivity, aggression, tantrums, anxiety, poor attention, and perseveration (Hersh et al.,
2011; Hagerman et al., 2017).

Across the various clinical features of FXS, there is a high incidence of symptoms that
specifically relate to auditory dysregulation, which are of particular interest given that many
of these phenotypes are shared across autism and epilepsy. As noted earlier, FXS
patients have communication abnormalities that begin with delayed language
development (Hoffmann et al., 2020). Children may not speak until 2-3 years of age, often
even having delayed use of prelinguistic communication (Finestack et al., 2009; Hersh et
al., 2011). FXS children have continued deficits in speech and literacy, with cognition
strongly correlated with language capabilities (Hoffmann et al., 2020). Specifically,
3

patients have poor expressive and receptive language, deficits in comprehension and
articulation, and limited use of vocabulary (Finestack et al., 2009; Rotschafer and Razak,
2014). Patients additionally exhibit further deficits in auditory processing (Rotschafer and
Razak, 2014), characterized using event-related potential (ERP) measures where the
activity of neuronal populations are analyzed in response to specific auditory stimuli and
tasks. In FXS, patients typically have abnormally large sensory ERPs to simple auditory
stimuli and abnormal habituation to repeated stimuli (Miller et al., 1999; Castren et al.,
2003; Frankland et al., 2004). Patients also perform poorly to auditory discrimination tasks
(Van der Molen et al., 2012), and EEG analysis within the auditory cortex also shows
decreased ability to synchronize neural network oscillations to patterns of chirps (Ethridge
et al., 2017). Such deficits in auditory processing and language and communication are
highly suggestive of altered auditory cortex development, function, and plasticity in FXS,
and provided a basis for the hypothesis included in this thesis.

II. FMRP and the Fmr1 KO mouse model
Molecular overview of FMRP
FMRP is most well-characterized for its role as a translational regulator, specifically acting
as a translational repressor by its association with polyribosomes. FMRP typically inhibits
ribosomal translocation and also stalls ribosome elongation on target mRNAs, thereby
blocking translation (Darnell et al., 2011; Darnell and Klann, 2013). The phosphorylation
status of FMRP determines whether FMRP is in its active repressive or inactive derepressed state. Specifically, phosphorylated FMRP, via the ribosomal S6 kinase (S6K),
is associated with stalled polyribosomes that blocks translational activity, whereas
dephosphorylation by protein phosphatase 2A (PP2A) causes the dissociation of FMRP
from polyribosomes to allow translation (Narayanan et al., 2007; Bassell and Warren,
4

2008) (Figure 1.1). FMRP is also capable of blocking translation at the level of initiation
by associating with translational machinery proteins (Bagni and Greenough, 2005; Bassell
and Warren, 2008).

FMRP & synaptic proteome. FMRP is ubiquitously expressed in all neurons and found
throughout all of its neuronal compartments. High levels of FMRP are found in both the
nucleus and cytoplasm with further localization in dendrites and spines, typically in
messenger ribonucleoprotein granules consisting of clusters of mRNAs, ribosomes,
FMRP, and other translational machinery (Bagni and Greenough, 2005). In the developing
mouse brain, over 800 mRNAs are found to be targets of FMRP, with a high enrichment
for pre- and postsynaptic proteins (Darnell et al., 2011; Darnell and Klann, 2013; Banerjee
et al., 2018). Direct presynaptic targets of FMRP include the mRNAs for scaffolding
proteins bassoon and piccolo, the neurexin family of cell surface adhesion molecules,
regulators of synaptic vesicle release, such as synapsins, synaptotagmins, and clathrinassociated adaptor complex, as well as voltage-gated calcium channels. FMRP targets
for postsynaptic mRNAs include subunits for NMDA receptors (NMDAR) including the
obligate NR1 subunit and developmentally regulated NR2A and NR2B, the group I
metabotropic glutamate receptor 5 (mGluR5), postsynaptic scaffolding proteins such as
PSD-95, SAPAP1-4, Shank1-3, and Homer1, and cell-adhesion proteins like neuroligins
1-3. Given the breadth and enrichment of FMRP-mRNA regulation of synaptic-related
proteins, it is evident that the loss of FMRP expression yields the manifestation of synaptic
dysfunction and impairments that likely results in impaired plasticity and cognition in FXS
and other neurodevelopmental disorders in which FMRP expression has been described
to be secondarily altered (Bernard et al., 2013; Fernandez et al., 2013; Folsom et al.,
2015).
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FMRP & interacting proteins. Separate from the translational regulation of synaptic
proteins, FMRP has also been found to directly bind and regulate the expression of mRNA
for transcription-related proteins (Korb et al., 2017). Specifically, FMRP targets the
mRNAs for several chromatin-associated proteins; thus, loss of FMRP expression can
yield epigenetic dysregulation and elicit aberrant gene expression. Additionally, FMRP
itself has been described to directly regulate chromatin, whereby it can directly function
as a chromatin-binding protein that functions in the DNA damage response (Alpatov et al.,
2014), while also associate with non-coding RNAs and microRNAs for chromatin
remodeling (Bagni and Greenough, 2005). Thus, FMRP has a far more extensive reach
beyond the large set of mRNAs it directly regulates, thereby indicating that examining
broader circuit development patterns, and consideration for whether changes are primary
or secondary to the initial genetic mutation will be important to understanding the impaired
neurodevelopment in FXS.

Recapitulation of FXS phenotypes in the Fmr1 KO model
Several mouse models have been developed for FXS, with the most extensively
characterized model being the Fmr1 knockout (KO) mouse (Kooy et al., 2017). The Fmr1
KO mouse was generated by the insertion of a neomycin resistance cassette into exon 5,
blocking the production of FMRP. While some variability does exist that is related to the
genetic background of the Fmr1 KO mice, there is indeed a recapitulation of some of the
core FXS symptoms in the KO mouse model. Consistent with post-mortem analysis of
FXS patients, Fmr1 KO mice exhibit an increased density of immature dendritic spines
(Kazdoba et al., 2014; Hagerman et al., 2017). Additionally, behavioral phenotypes of
Fmr1 KO mice include hyperactivity, mild deficits in spatial learning and working memory,
increased anxiety-related responses, and altered startle responses (Frankland et al.,
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2004; Kazdoba et al., 2014; Kooy et al., 2017), similar to the behavioral deficits present in
FXS patients.

While the learning and memory deficits are relatively mild in the animal model, Fmr1 KO
mice exhibit a strong, reproducible impairment in long-term depression (LTD), one of the
major cellular mechanisms underlying learning and memory (Lynch, 2004; Malenka and
Bear, 2004). Typically, mGluR-mediated LTD, a form of synaptic plasticity, is dependent
on dendritic protein synthesis that generates proteins necessary for the internalization of
AMPA receptors (AMPARs) to reduce synaptic strength. However, Fmr1 KO mice are
characterized to have enhanced mGluR-LTD with exaggerated LTD occurring
independent of activity-dependent protein synthesis, known as the mGluR theory of FXS
(Huber et al., 2002; Nosyreva and Huber, 2006). Plasticity deficits are prevalent in the
Fmr1 KO brain but are highly region-specific, with enhanced mGluR-LTD only observed
in the hippocampus and cerebellum, and variable forms of long-term potentiation (LTP)
deficits observed in regions of the cortex and other areas (Li et al., 2002; Larson et al.,
2005; Desai et al., 2006; Kim et al., 2013; Yang et al., 2014; Kooy et al., 2017).

Auditory-specific phenotypes in the Fmr1 KO model
Consistent with FXS patients, the Fmr1 KO mouse also exhibits many auditory-specific
phenotypes that mirrors much of the impairments and deficiencies in FXS. While Fmr1 KO
mice do not exhibit spontaneous seizures like patients, Fmr1 KO mice uniquely have a
high susceptibility to audiogenic seizures, where intense auditory stimulation (>100dB)
can induce seizures that quickly progress from wild-running to tonic-clonic seizures, often
causing death (Musumeci et al., 2000; Chen and Toth, 2001). The audiogenic seizures
are indicative of hyperexcitability within the auditory circuit, where loss of FMRP
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expression from glutamatergic neurons of the auditory brainstem, specifically the inferior
colliculus, is responsible for this robust seizure phenotype (Chen and Toth, 2001;
Gonzalez et al., 2019). At the level of the auditory brainstem, additional deficits have been
characterized in Fmr1 KO mice related to auditory processing. Specifically, Fmr1 KO mice
have increased acoustic startle response (Chen and Toth, 2001; Frankland et al., 2004)
and altered auditory brainstem responses to auditory stimulation, which are attributed to
the altered cell sizes, and distribution and firing of excitatory and inhibitory synapses in
the developing Fmr1 KO brainstem (Rotschafer et al., 2015; Garcia-Pino et al., 2017;
Rotschafer and Cramer, 2017; Lu, 2019; McCullagh et al., 2020).

Impairments are also prevalent in higher auditory processing centers, such as the auditory
cortex. Fmr1 KO mice have been found to have altered cortical responses to tones during
in vivo recordings of adult mice. Specifically, auditory cortex neurons have increased firing
to tones, broader frequency tuning, reduced spectrotemporal selectivity, and increased
variability in response latency (Rotschafer and Razak, 2013). Physiological differences
have also been observed in developing Fmr1 KO mice, where both in vivo single-unit
recordings and EEG analysis in the auditory cortex showed abnormalities both at baseline
and following sound-evoked responses (Wen et al., 2018; Wen et al., 2019). (Developing
Fmr1 KO mice further exhibit impairments in parvalbumin cell development and
perineuronal net formation, with reduced cell numbers and perineuronal net co-localization
during the second to third postnatal week of development before eventually normalizing
adults (Wen et al., 2018). Developmental plasticity is also impacted in the auditory cortex.
Fmr1 KO mice have failed stabilization of LTP, where there is a faster decay following
potentiation in cortical layer IV (Yang et al., 2014), and additionally KO mice have impaired
critical period plasticity in the primary auditory cortex, where Fmr1 KO mice fail to exhibit
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tonotopic frequency re-mapping following tone-rearing during early development (Kim et
al., 2013).

III. Critical periods of development
Altered critical periods in developing Fmr1 KO mice
Critical periods are postnatal developmental windows characterized by heightened
experience-dependent synaptogenesis and synaptic plasticity that establish stable neural
circuits. With regards to the sensory modalities, critical periods are thought to enlarge the
representation of behaviorally relevant sensory stimuli for optimal processing (Hensch,
2005). Much of the seminal work related to the mechanisms underlying the regulation of
sensory critical periods has focused on the visual cortex with ocular dominance and
monocular deprivation studies (Wiesel and Hubel, 1963; Shatz and Stryker, 1978), and
the somatosensory cortex with tactile representation (Woolsey and Van der Loos, 1970;
Petersen, 2007). While tonotopic mapping of sound frequencies during the auditory cortex
critical period has been studied within various mammals, relative to other sensory cortices,
there have been fewer studies examining mechanisms of auditory critical period regulation
until recently (Yun et al., 2006; de Villers-Sidani et al., 2007; Kalish et al., 2020).

Interestingly, Fmr1 KO mice have been characterized to have a variety of alterations in
critical periods for each of these sensory modalities. As described earlier, Fmr1 KO mice
have impaired plasticity during the primary auditory cortex critical period (Kim et al., 2013).
Within the visual cortex, monocular deprivation elicits substantial open-eye potentiation in
a shorter period of time in Fmr1 KO mice compared to WT, indicative of faster ocular
dominance plasticity responses (Dolen et al., 2007). Additionally, in the barrel cortex Fmr1
KO mice have a delayed critical period window, where the start of plasticity and its peak
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does not occur until a few days later compared to WT littermate mice (Harlow et al., 2010).
A delayed maturation of both AMPAR-NMDAR synapses and a GABA polarity switch has
been found to underlie the altered barrel cortex critical period (Harlow et al., 2010; He et
al., 2014; He et al., 2019), indicating that FMRP expression is crucial for the proper
development and progression of critical periods. In the auditory cortex, altered mGluRmediated signaling is suggested to contribute to the impaired plasticity (Kim et al., 2013;
Yang et al., 2014); however, a more detailed developmental examination of alterations
elicited by loss of FMRP expression in the auditory cortex has not been conducted.

Neuronal circuits and the regulation of critical periods by changes in E-I balance
The onset and closure of critical periods are regulated by the development and maturation
of excitatory-inhibitory (E-I) circuitry, with the expression of molecular “brakes” and
neuromodulatory factors, such as synaptic and structural proteins, epigenetic regulators,
and second messenger molecules, that limit the extent of plasticity (Hensch, 2005;
Takesian and Hensch, 2013). The maturation of inhibitory GABAergic signaling is
necessary for the triggering of critical periods, identified using transgenic mice that have
reduced GABAergic signaling and pharmacological manipulation using modulators of
GABAA receptors (GABAARs) (Hensch, 2005). Specifically, Gad65-knockout mice, which
have a deletion for the GABA synthetic enzyme that concentrates within axon terminals
and synaptic vesicles, fail to undergo a critical period in both the visual and auditory cortex.
GAD65 KO mice do not exhibit ocular dominance or tonotopic plasticity unless the visual
or auditory cortex is locally infused with diazepam to engage and enhance local inhibitory
circuits (Fagiolini and Hensch, 2000; Kalish et al., 2020). This diazepam-induced plasticity
in the GAD65 KO mice is capable of occurring at any age through adulthood, suggesting
that without proper GABA signaling GAD65 KO mice remain in a relatively immature pre10

critical period-like state. In wild-type mice local benzodiazepine infusions to the brain can
precociously induce critical periods prior to the typical window, but they are not capable of
inducing plasticity after the window, further indicating the necessary and sufficient role of
inhibitory GABAergic neurotransmission to regulate the onset of critical periods (Fagiolini
and Hensch, 2000; Fagiolini et al., 2004; Kalish et al., 2020). In addition to its induction
of critical periods, inhibitory signaling also ultimately limits the extent of plasticity, as
reducing intracortical inhibition in the adult visual or auditory cortex has been found to
promote ocular or tonotopic plasticity, respectively (Harauzov et al., 2010; CisnerosFranco et al., 2018).

Excitatory neurotransmission is also crucial for modulating plasticity during critical periods,
driving developmental synaptogenesis and synaptic plasticity (Hensch, 2005; Mao et al.,
2006; Oswald and Reyes, 2008; Harlow et al., 2010). The excitatory thalamocortical
projections from the thalamus to layer IV of the cortex are responsible for mediating
sensory input from the periphery. Its synaptic plasticity is most tightly confined to early
development before plasticity sequentially proceeds through the other cortical layers
consistent with intracortical processing (Jiang et al., 2007). The maturation of
thalamocortical synapses during the critical period involves the dynamic regulation of the
glutamate receptors, whereby the activity-dependent insertion of AMPARs into immature
NMDAR-only silent synapses governs thalamocortical synaptic strength and the capacity
for plasticity (Crair and Malenka, 1995; Isaac et al., 1997; Daw et al., 2007; Huang et al.,
2015). Precociously unsilencing or delaying silent synapse conversion can limit plasticity.
Hyperexcitability induced by early-life seizures has been found to prematurely unsilence
synapses via AMPAR insertion that disrupts auditory tonotopic critical period plasticity in
WT mice (Sun et al., 2018). Meanwhile, a persistence of silent synapses in the Fmr1 KO
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mice leads to a temporal delay in the plasticity window within the barrel cortex to delay its
critical period (Harlow et al., 2010). Thus, the dynamic modulation and maturation of
excitatory and inhibitory neurotransmission levels during development are important for
the regulation of critical periods and the capacity for plasticity.

IV. Excitatory-inhibitory balance in development and disease
E-I maturation in the auditory cortex
In addition to the role of developmental maturation of E-I neurotransmission in regulating
critical periods, achieving proper E-I balance is also necessary for optimal auditory
processing within the auditory cortex, such as sound encoding and plasticity. Consistent
with general brain maturation patterns, the relatively strong excitatory input early in
development within the auditory cortex is thought to determine the overall responsiveness
to sensory information and be permissive for mechanisms inducing long-term synaptic
plasticity (Froemke and Jones, 2011). This is observed within the rodent auditory cortex
where the development and sharpening of frequency tuning in excitatory neurons reaches
adult levels by the 2nd postnatal week, whereas frequency tuning in the inhibitory
population does not reach adult levels until the 3rd and 4th postnatal week of development
(Dorrn et al., 2010). The maturation and function of synaptic inhibition within the auditory
cortex is responsible for refining and increasing the specificity of auditory processing. The
sharpening of auditory frequency, increasing of signal-to-noise ratio for enhanced
discrimination, adaptation to stimuli, and precise temporal processing all require inhibitory
synaptic transmission within the auditory circuit (Wehr and Zador, 2003; Froemke and
Jones, 2011; Blackwell and Geffen, 2017).
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Developmental regulation of E- I neurotransmitter receptors
Excitatory and inhibitory neurotransmission can be modulated at multiple levels, but, at its
core, is fundamentally regulated by neurotransmitters and glutamatergic and GABAergic
receptors. The expression and function of the ionotropic AMPA, NMDA, and GABAA
receptors determine E-I levels. Individual subunits for each of these ionotropic receptors,
particularly during postnatal development when they are dynamically and differentially
expressed, further regulate the kinetics, permeability, and other biophysical properties to
additionally modulate neuronal excitability and plasticity (Rakhade and Jensen, 2009).

AMPA and NMDA receptors are ionotropic glutamate receptors that mediate excitatory
neurotransmission. As tetrameric structures, the assembly of the GluA1-4 subunits or
GluN1, GluN2A-D and GluN3A-B subunits determines the receptor properties for AMPAR
and NMDARs, respectively. AMPARs are distinct from NMDARs in that they are
predominantly impermeable to calcium due to the inclusion of the GluA2 subunit.
Compared to the other AMPAR subunits, GluA2 undergoes a distinct glutamine to arginine
post-transcriptional modification, whereby the positively charged arginine residue in the
ion channel blocks the passage of calcium ions (Isaac et al., 2007). However, at birth
GluA2 is expressed at relatively low levels at birth compared to the other subunits before
postnatally increasing in expression in the cortex and hippocampus (Monyer et al., 1991;
Kumar et al., 2002). The presence of GluA2-lacking AMPARs during neonatal
development renders AMPARs permeable to calcium, making neurons more excitable and
capable of activating intracellular calcium-dependent signaling pathways to facilitate a
period of heightened activity-dependent synaptic plasticity (Kumar et al., 2002; Isaac et
al., 2007; Rakhade and Jensen, 2009).
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Unlike AMPARs, all NMDARs are permeable to calcium and have a voltage-dependent
magnesium block, which confers coincidence-detecting properties of pre- and
postsynaptic activity (Lau and Zukin, 2007). NMDARs consist of the obligate GluN1
subunit and most commonly the GluN2 subunits, with GluN2B and GluN2A most robustly
expressed in the cortex and hippocampus (Lau and Zukin, 2007; Ewald and Cline, 2009).
GluN2B is more highly expressed at birth in the immature brain, with GluN2A increasing
postnatally to replace GluN2B as the dominant subunit (Monyer et al., 1994). These
subunits exhibit different deactivation kinetics, with GluN2B having slower decay times
compared to GluN2A-containing NMDARs (Cull-Candy et al., 2001), where their
differential developmental expression governs the degree of synaptic calcium influx,
postsynaptic density binding partners, and the directionality of plasticity, such as LTP or
LTD (Liu et al., 2004; Cho et al., 2009).

GABAARs are pentameric assemblies where synaptic receptors in the brain are commonly
assembled with two a-subunits, two b-subunits, and one g-subunit to mediate GABAergic
transmission and balance neuronal excitatory signaling. In particular, the developmental
regulation of the a-subunits determines GABA sensitivity and the kinetics of chloride ion
conductance (Okada et al., 2000; Bosman et al., 2005). In the cortex and hippocampus,
the expression of the a3-subunit is high at birth and is subsequently postnatally
downregulated while a1 is low and upregulated, with a3 associated with lower GABA
sensitivity and slower decay times relative to a1 (Laurie et al., 1992; Picton and Fisher,
2007; Galanopoulou, 2008a). Interestingly, GABAAR a1-mediated signaling is necessary
for the induction of critical periods within the visual cortex (Fagiolini et al., 2004), indicative
of the importance of developmental regulation of a1 expression. GABAergic maturation
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also entails the transition from depolarizing responses in the neonatal brain to the classical
hyperpolarizing GABA-mediated signaling that strengthens with postnatal age. The
relative expression of the developmentally regulated chloride transporters NKCC1 and
KCC2 establishes the chloride gradients to determine whether GABA elicits an excitatory
or inhibitory response, with NKCC1 and KCC2 acting as importers and exporters of
chloride ions, respectively (Ben-Ari, 2002; Dzhala et al., 2005; Rheims et al., 2008).

Dynamic E-I subunit regulation in the auditory cortex
Proper auditory processing and plasticity in the auditory cortex necessitates well-regulated
E-I function. These aforementioned ionotropic receptor subunits are also dynamically
regulated within the auditory cortex where their expression is highly sensitive to
environmental exposure and aging, and further associated with altered neuronal firing and
acoustic processing.

Early music exposure and rearing of rodents in enriched

environments increased the expression of the relatively more developmentally mature
subunits for AMPAR (GluA2), NMDAR (GluN2A), and GABAARs (a1) within the auditory
cortex, while sharpening frequency tuning of the neurons (Xu et al., 2007; Cai et al., 2010).
In contrast, adult rats that had early postnatal noise exposure to deteriorate frequency
representations in the auditory cortex exhibited decreased levels of the mature ionotropic
receptor subunits (Guo et al., 2012a). Similar patterns are observed with natural aging
where aged rodents exhibit a clear decrease in spectral sensitivity and dysregulated
plasticity that is associated with overall reduced GABAergic inhibition and altered asubunit expression, with decreased mature a1-subunit and increased a3-subunit
expression, making it more similar to the immature brain (Caspary et al., 2013; CisnerosFranco et al., 2018). Overall, while changes in relative AMPAR and GABAAR expression
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also occur to compensate for altered E-I levels in circumstances such as unilateral hearing
loss (Balaram et al., 2019), the auditory cortex indeed exhibits subunit-specific alterations
of ionotropic glutamate and GABAA receptors that relate to capabilities of auditory
processing and plasticity.

Alterations to E-I subunit expression in neurological disorders
Neurotransmitter receptor subunit alterations are also consistently observed in epilepsy
and neurodevelopmental disorders. Following seizures, GABAergic and glutamatergic
receptors exhibit changes in subunit expression (Talos et al., 2006a; Rakhade and
Jensen, 2009; Brooks-Kayal, 2011). Specifically, early-life hypoxia-induced seizures in
rodents increased the levels of GluA2-lacking calcium-permeable AMPARs and
prematurely diminished NMDAR-only silent synapses, yielding later-life hyperexcitability,
and plasticity and behavioral deficits (Rakhade et al., 2008; Zhou et al., 2011; LippmanBell et al., 2013). Chemoconvulsant-induced seizures in early-life cause increased
GABAAR expression selectively for the a1-subunit, while seizures as adults decreased its
expression, suggestive of age-dependent alterations from hyperexcitability (Brooks-Kayal,
2011). Various monogenic forms of autism spectrum disorders such as Tuberous
Sclerosis, CDKL5 deficiency disorder, Rett syndrome, and Dravet syndrome, further
exhibit altered neurotransmitter receptor subunit expression and function across various
brain regions (White et al., 2001; Braat and Kooy, 2015b; Li et al., 2016; Ruffolo et al.,
2018; Yennawar et al., 2019; Zhao and Yoshii, 2019). The altered subunit expression
profiles across the neurodevelopmental disorders are indicative of E-I imbalance in the
developing brain, elucidating mechanisms related to impaired neurological function.
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E-I imbalance in FXS
Evidence suggesting an E-I imbalance in the FXS brain with patients is supported by their
propensity to exhibit spontaneous seizures (Nelson and Valakh, 2015; Hagerman et al.,
2017), with hyperexcitability and impaired inhibition further confirmed from transcranial
magnetic stimulation and EEG studies of FXS patients (Knoth et al., 2014; Ethridge et al.,
2017; Morin-Parent et al., 2019). Consistent with this, the Fmr1 KO mouse model has also
been extensively described to exhibit neuronal and circuit hyperexcitability due to altered
intrinsic excitability, action potential properties, voltage-gated channels, neurotransmitter
receptors, and more (Goncalves et al., 2013; Contractor et al., 2015). However, changes
resulting from the loss of FMRP expression are not uniform and are rather specific to the
brain region and cell type (Contractor et al., 2015). For example, the enhanced mGluRmediated LTD and the associated AMPAR internalization are well-characterized in the
cerebellum and hippocampus, with the hippocampus even further exhibiting prolonged
epileptiform discharges in slice preparations (Huber et al., 2002; Bear et al., 2004; Chuang
et al., 2005; Nakamoto et al., 2007). However, such plasticity impairments or epileptiform
discharges are not observed in the cortex or other brain regions, with further differential
expression of mRNAs and proteins pertaining to excitatory neurotransmission such as
GluA1/2, synaptic scaffolding proteins, and CaMKIIa (Muddashetty et al., 2007; Schutt et
al., 2009). Region-specific impairments in GABAergic signaling are also observed in the
Fmr1 KO mouse, with varying degrees and directional changes of GABAAR subunit
expression and function, GABA neurotransmitter levels, and numbers of inhibitory cells
and synapses (Paluszkiewicz et al., 2011; Braat and Kooy, 2015a).

While E-I imbalance has been described in the Fmr1 KO auditory circuit that is likely
related to the auditory phenotypes in FXS patients, many of the studies to date have
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focused on the lower auditory circuit with characterization of the auditory brainstem
regions including the ventral cochlear nucleus, medial nucleus of the trapezoid body, and
lateral superior olive (Chen and Toth, 2001; Rotschafer et al., 2015; Garcia-Pino et al.,
2017; Rotschafer and Cramer, 2017). Fewer studies have examined auditory circuit and
E-I synaptic maturation at specific synaptic networks within the auditory cortex despite the
plasticity and processing deficits described in the Fmr1 KO mouse. Given the role of
glutamatergic and GABAergic neurotransmitter receptor maturation in both regulating
critical period plasticity and auditory processing, and the region-specific alterations caused
by global loss of FMRP expression, it is critical to evaluate E-I synaptic development in
the FXS auditory cortex to further elucidate mechanisms underlying the auditory
symptoms and identify new targets and therapeutics for the treatment of FXS.

V. Therapeutic strategies for the treatment of FXS
Limited success of past FXS clinical trials
Numerous clinical trials have been conducted over the past 20 years using compounds
from preclinical studies that had successfully reversed many of the behavioral,
physiological, and pathological phenotypes in the Fmr1 KO mouse. Based on the
aforementioned mGluR theory of FXS, antagonists and other negative modulators for
mGluR5 were extensively tested; however, double-blind controlled studies using fenobam
or mavoglurant showed no significant benefit of either compound in social behaviors
despite even stratifying patients based on the methylation status of the mutation to reduce
variability (Schaefer et al., 2015; Hagerman et al., 2017). Similarly, the GABAB agonist
arbaclofen, which also had much preclinical success, went to Phase III trials but failed to
improve the primary outcome measure of social avoidance and aberrant behaviors
(Schaefer et al., 2015; Berry-Kravis et al., 2018). Broad modulators of the GABAergic
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system have additionally been tested but have yielded limited success, including
ganaxolone, which is thought to target both synaptic and extrasynaptic GABAA receptors,
as well as metadoxine, which acts more presynaptically by targeting GABA transporters
(Hagerman et al., 2017).

Following the failed outcomes of these clinical trials, there has been much discussion
pertaining to considerations for subsequent clinical trials and therapeutic development.
Interestingly, while mGluR5 antagonists did not improve the primary behavioral outcome
measures, single dose studies of fenobam did significantly improve alterations in
sensorimotor gating in FXS patients, specifically prepulse inhibition deficits (Schaefer et
al., 2015). This suggests that the clinical outcome measures utilized for clinical studies
should be reconsidered to perhaps use measures that are more sensitive yet still feasible
for FXS patients, more specific to the physiological alterations occurring in the brain, and
less vulnerable to subjective scoring measures. Another consideration for future trials
includes the use of younger cohorts with smaller age ranges and possible stratification
based on the severity of the mutation. Given that FXS is a developmental disorder where
the goal is to improve intellectual disability, plasticity and behavior, the ability to make
changes and improvements in adults is likely limited, thus requiring a more refined
treatment window (Mullard, 2015).

Lastly, as new therapeutic agents are being explored, considerations must be made for
the target mechanism of action. Is the function of FMRP to be directly modulated? (Darnell
and Klann, 2013; Hagerman et al., 2017). Is the target a protein that is under the direct
translational regulation of FMRP? Or is the broad modulation of E-I imbalance during
discreet developmental time windows capable of eliciting beneficial outcomes.
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Nevertheless, the lack of success of clinical trials thus far indicates the need for more
detailed, region-specific evaluations of pathophysiological dysfunction in FXS.
Impairments in auditory processing, language development, and communication in FXS
necessitate a close examination of auditory cortex maturation and function. Such
assessments will enable the identification of new therapeutic targets along with,
biomarkers and dynamic windows of vulnerability, while further determining target
symptoms that can be malleable to correction in FXS patients.

VI. Open questions: E-I circuit maturation impairments in the FXS auditory cortex
Despite evidence suggesting perturbed E-I balance in the brains of FXS patients, as well
as the numerous auditory-related phenotypes experienced in both FXS and autism, there
is a limited understanding of auditory circuit maturation—particularly with the auditory
cortex—in neurodevelopmental disorders. There is an increasing need to evaluate E-I
maturation within more specific brain regions to decouple and improve the understanding
of mechanisms related to complex patient symptomology to ultimately reveal more
accurate biomarkers, targets and therapeutic paradigms for the treatment of Fragile X
syndrome. The current literature on critical periods of development, sensory system
maturation, and E-I abnormalities across FXS and other neurodevelopmental disorders,
suggest abnormalities related to the plasticity and intracortical connectivity in the
developing FXS auditory cortex. The work presented in the subsequent chapters of this
thesis provide the most complete description to date detailing excitatory-inhibitory synaptic
and circuit development during auditory cortex maturation in Fmr1 KO mice, a mouse
model of genetic intellectual disability.

20

The work presented in the subsequent chapters of this thesis provide the most complete
description to date of excitatory-inhibitory synaptic and circuit maturation of the auditory
cortex maturation in the Fmr1 KO mice, a mouse model of genetic intellectual disability.
In Chapter 2, we first examine the developmental expression patterns of ionotropic
glutamate and GABA receptors in the auditory cortex as they relate to key ages in auditory
circuit maturation. Chapter 3 evaluates physiological maturation in the developing
auditory cortex, examining intracortical L4-L2/3 circuit excitability and plasticity. We further
decouple functional alterations with a cell-type specific evaluation of GABAergic
maturation in the auditory cortex in Chapter 4, and highlight ongoing work glutamate
maturation in Chapter 5. Together, these characterizations offer a mechanism whereby
auditory cortex critical periods and auditory processing are impaired in the FXS mouse
model, and the implications related to FXS patients and therapeutic treatments.
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Figure 1.1: Phosphorylated FMRP blocks translational activity. The phosphorylation status of
FMRP determines whether FMRP is in its active repressive or inactive de-repressed state.
Phosphorylated FMRP, via the ribosomal S6 kinase (S6K), is associated with stalled polyribosomes
that blocks translational activity, whereas dephosphorylation by protein phosphatase 2A (PP2A)
causes the dissociation of FMRP from polyribosomes to allow translation. Early signaling cascade
mediated by mGluR signaling has different time course for activation of PP2A (fast) and mTOR
(slower). Adapted from Narayanan et al. (2007)
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DEVELOPMENTAL EXPRESSION OF IONOTROPIC RECEPTORS AND CHLORIDE
TRANSPORTERS IN THE AUDITORY CORTEX OF FMR1 KNOCK-OUT MICE
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Department of Neurology, Perelman School of Medicine
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ABSTRACT
In Fragile X syndrome (FXS), excitatory-inhibitory (E-I) imbalance in the developing brain
is thought to underlie many of the core neurological symptoms of this disorder. Despite
the myriad of auditory-related phenotypes in both patients and the Fmr1 knock-out (KO)
mice that relate to impaired auditory processing and plasticity, there have been limited
characterizations of E-I regulation specific to the developing auditory cortex. Here, we
examined the expression of ionotropic glutamate and GABA receptors, the fundamental
regulators of E-I neurotransmission, across key ages in auditory forebrain development,
specifically comparing subunits known to impart changes in developmental neuronal
excitability and plasticity during postnatal brain maturation. Consequently, in the naturally
developing WT auditory cortex, we found dynamic changes in receptor expression that
occur within finite 3-day intervals related to both ear canal opening and the auditory cortex
critical period window. Furthermore, in Fmr1 KO mice, we found dysregulated expression
of developmentally regulated subunits of AMPAR and GABAAR during the postnatal
maturation of the auditory cortex. These dynamic alterations in the expression of
ionotropic glutamate and GABA receptors are suggestive of altered receptor function and
E-I balance specifically in the auditory cortex that could be an underlying contributor to the
impaired auditory cortex critical period that has previously been characterized in Fmr1 KO
mice.
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INTRODUCTION
Fragile X syndrome (FXS) is the most common heritable form of intellectual disability and
autism, with patients exhibiting cognitive deficits, behavioral issues, sensory sensitivity,
and seizures (Kidd et al., 2014; Hagerman et al., 2017). While a myriad of abnormalities
has been described in the dysregulated neurodevelopment during FXS, neuronal and
circuit hyperexcitability is an underlying theme across characterizations in both FXS
human and Fmr1 knock-out (KO) animal model studies (Heard et al., 2014; Contractor et
al., 2015; Nelson and Valakh, 2015; Hagerman et al., 2017; Morin-Parent et al., 2019;
McCullagh et al., 2020).

The abundance of data suggesting excitatory-inhibitory (E-I) imbalance is thought to be
due to the role of Fragile X mental retardation protein (FMRP) as an RNA binding protein
that regulates an extensive number of mRNA transcripts, including hundreds of mRNAs
related to the synaptic proteome (Darnell et al., 2011). Accordingly, analyses of the Fmr1
KO mouse brain have characterized altered expression of receptors, transporters,
neurotransmitters, and ion channels, which include both those with and without direct
FMRP interactions to their respective mRNA transcripts (Li et al., 2002; Schutt et al., 2009;
Paluszkiewicz et al., 2011; Braat and Kooy, 2015a; McCullagh et al., 2020). However,
these expression studies have largely focused on the hippocampus, somatosensory
cortex, cerebellum, brainstem, and amygdala, and indicate region-specific alterations in
the aforementioned proteins due to the loss of FMRP.

FXS patients often exhibit auditory-specific deficits including impaired language
development and communication, and altered auditory processing. Despite the range of
auditory-related phenotypes also found in Fmr1 KO mice, including audiogenic seizure
25

susceptibility (Chen and Toth, 2001), altered auditory processing with enhanced auditory
cortex excitability (Yun et al., 2006; Rotschafer and Razak, 2013), and impaired tonotopic
and synaptic plasticity during the auditory cortex critical period (Kim et al., 2013; Yang et
al., 2014), there have been limited characterizations, to date, examining synaptic proteinrelated expression in the auditory cortex. Therefore, we sought to evaluate the
developmental expression profile of the auditory cortex, hypothesizing that the auditory
cortex of Fmr1 KO mice would exhibit underlying alterations in the expression of the
fundamental regulators of excitatory and inhibitory neurotransmission, ionotropic
glutamate and GABAA receptors, to contribute to the auditory-related phenotypes in FXS.

Ionotropic glutamate and GABAA synaptic receptors are dynamically expressed over the
course of development to impact neuronal excitability and plasticity. Individual receptor
subunits are further developmentally regulated where changes in the relative subunit
distribution influence the permeability, kinetics, and neurotransmitter binding sensitivity of
receptors (Laurie et al., 1992; Monyer et al., 1994; Isaac et al., 2007; Picton and Fisher,
2007; Ewald and Cline, 2009). The relatively high expression of AMPAR GluA1 subunit,
NMDAR GluN2B subunit, and GABAAR a3-subunit in the developing brain, particularly in
the cortex and hippocampus, generally skews the dynamics of the receptors towards
enhanced excitability, enabling rapid synaptogenesis and synaptic plasticity (Rakhade
and Jensen, 2009). As the expression of AMPAR GluA2, NMDAR GluN2A, and GABAAR
a1-subunits increase postnatally, neuronal excitability is more tightly controlled and is
associated with diminishing synaptic plasticity across development (Erisir and Harris,
2003; Fagiolini et al., 2004; Isaac et al., 2007).
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Alterations in relative ionotropic receptor subunit expression have been found across
neurodevelopmental disorders and epilepsy and are linked with neurobehavioral deficits,
E-I imbalance, and synaptic plasticity impairments. Recent studies have demonstrated
altered AMPAR and NMDAR subunit expression in rodent models of CDKL5 deficiency
disorder (Tang et al., 2019; Yennawar et al., 2019), while both glutamate and GABAAR
subunits have been identified to have impaired trafficking and expression in rodent seizure
models, Dravet syndrome, and tuberous sclerosis (White et al., 2001; Raol et al., 2006;
Rakhade and Jensen, 2009; Brooks-Kayal, 2011; Hernandez et al., 2019). In the rodent
auditory cortex, the expression of ionotropic receptor subunits is found to change based
on environment and aging, and is associated with auditory processing alterations (Cai et
al., 2010; Guo et al., 2012a; Caspary et al., 2013).

To identify underlying contributors to altered auditory function and excitability in Fmr1 KO
developing and adult mice, we investigated the developmental expression of ionotropic
glutamate and GABAA receptors, and the chloride transporters NKCC1 and KCC2 in the
auditory cortex of Fmr1 KO and WT mice during key ages of auditory forebrain
development. The following studies sought to achieve both 1) a comprehensive
examination of the natural WT developmental progression of E-I receptors and chloride
transporters in the auditory cortex, which, to date, no studies have extensively
characterized, and 2) identification of any alterations in the Fmr1 KO auditory cortex that
result in E-I imbalance and contribute to the impaired critical period plasticity. For any
differentially expressed receptor subunits between WT and KO mice, we further examined
whether differences manifested by transcriptional, translational, and/or trafficking
alterations given that the mRNAs of our receptors and transporters of interest included
both targets and non-targets of FMRP.
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METHODS
Animals
Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated
from the original breeders, whereby heterozygous female mice were later crossed with
male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT and KO male
littermate mice were used for all experiments to avoid the confounding effects of Xinactivation that would be present in heterozygous females. All procedures were
performed in accordance with the guidelines of the NIH and with the approval of the
Institution of Animal Care and Use Committee with the University of Pennsylvania. All
efforts were made to minimize animal suffering and numbers.

Auditory cortex isolation
To compare the developmental expression patterns of ionotropic glutamate and GABAA
receptor subunits, and chloride cotransporters in the auditory cortex, Fmr1 WT and KO
littermates were sacrificed at P9, P12, P15, P24, and P56. Brains were rapidly removed
from the skull and the auditory cortex was micro-dissected. Using a coronal brain matrix,
a 1.5-2.0 mm thick coronal brain slice containing the auditory cortex was extracted as
identified by stereotaxic coordinates and anatomical landmarks from Paxinos and Franklin
(2004) and the Allen Brain Atlas. The brain slice was then cut horizontally above the rhinal
fissure, whereby approximately 15° cuts were made bilaterally to isolate the auditory
cortex. Tissue was flash-frozen in chilled ethanol and stored at -80°C until
homogenization.
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For the analysis of membrane-bound protein expression by western blot, the auditory
cortex from 2 mice were pooled together for a single sample (n = total number of pooled
samples), as required for sufficient protein concentration for membrane preparations.
Samples for whole-cell/total measures of protein expression by western blot, or samples
for RT-qPCR were from individual mice.

Western blots
Both membrane and total whole-cell extraction was performed as previously described
(Talos et al., 2006a; Rakhade et al., 2012; Yennawar et al., 2019). Total protein amounts
were measured with a Bradford protein assay (Bio-Rad) and samples were then diluted to
obtain equal amounts of proteins in each sample (15 µg total) in lysis buffer and 4X
Laemmli Sample Buffer (Bio-Rad). Samples were separated by gel electrophoresis on
Criterion TGX 4-20% Tris-Glycine precast gels (Bio-Rad), and transferred to PVDF
membranes (Millipore Immobilon-FL). Primary antibodies used in this study are as follow:
GluA1 (1:1000, Abcam ab31232); GluA2 (1:1000, Millipore MAB397); NR2A (1:1000,
Sigma M264); NR2B (1:1000, Thermo MA1-2014); NR1 (1:750; Thermo OMA-04010);
GABAA a3 (1:1000, Sigma G4291); GABAA a1 (1:750, NeuroMab 75-136); NKCC1
(1:1000, Millipore AB3560P); KCC2 (1:1000, Millipore 07-432); b-actin (1:5000, Sigma
A5441). Secondary antibodies used were goat anti-rabbit IRDye 800CW (1:15,000; LICOR 926-32212) and goat anti-mouse IRDYE 680LT (1:20,000; LI-COR 926-68024). The
Odyssey Infrared Imaging System protocols were used for blots and quantification of
protein expression. b-actin was used for normalization of individual samples, and
normalized values were expressed as a percentage of mean age-matched WT samples
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for direct within-age evaluation, or mean P56 WT samples run on the same blot for
developmental comparisons.

Immunohistochemistry
Mice were anesthetized by intraperitoneal injection with pentobarbital and perfused with
4% paraformaldehyde in PBS and post-fixed for 2 hours. Brains were then cryoprotected
in 30% sucrose/PBS until saturated. Brains were embedded in OCT, frozen at -80°C,
cryosectioned to 30 µm thick sections collected in multi-well plates with 0.02% sodium
azide/PBS. After washing sections in PBS, antigen retrieval was performed by incubation
of sections in sodium citrate buffer, pH 6.0 for 30 min at 75°C. Sections were then
maintained in citrate buffer for 15 min at room temperature (RT), washed, and blocked in
10% normal goat serum/PBS. Primary antibody for the extracellular or topological domain
targeting GABAAa3 (1:500, alomone AGA-003) or GABAA a1 (1:500, Millipore 06-868)
was incubated overnight at 4°C in 1% goat serum/PBS. Sections were washed, incubated
in secondary antibody goat anti-rabbit 594 (1:1000, Invitrogen) for 1 hour at RT and
washed. Sections were permeabilized with 0.2% Triton/PBS for 5 min, washed, and reblocked in 10% goat serum/0.1% Triton/PBS for 1 hour at RT. Sections were incubated
with anti-VGAT (1:500, Synaptic Systems 131 004) and anti-MAP2 (1:500, abcam
ab5392) overnight at 4°C in 1% goat serum/0.1% Triton/PBS. Sections were washed,
incubated in secondary antibodies goat anti-chicken 488 and goat anti-guinea pig 647
(1:1000, Invitrogen) for 1 hour at RT. Sections were PBS washed, mounted on slides, and
cover slipped with Fluoromount.

Confocal Microscopy
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Images were acquired on a Leica SP5 confocal microscope. Using the hippocampus and
rhinal fissure as anatomical landmarks, the auditory was approximately localized using
both the 10X and 20X objectives. Upon localization, the objectives were switched to oil
immersion at 40X followed by 63X (NA = 1.4) with a digital zoom of 2. Gain, offset, and
laser intensity settings (Argon, HeNe 594, HeNe 633) were kept identical during imaging
sessions for P24, and a separate set of settings kept identical across P12 imaging. MAP2
immunostaining was used to approximate cortical layers based on cell body shape and
size. Imaging started in deep layers (L6) based on white matter, and then progressed out
to L2/3. From the same section, images were obtained at 1024x1024 pixels bilaterally
from both hemispheres (2 images taken from a given mouse), using a line average of 2
and z-step of 0.25µm where approximately 25-35 z-planes were obtained.

Imaging Process & Analysis
Image files were blinded and processed using FIJI. Five z-planes with the brightest
staining were selective from the entire z-plane stack for image processing. Noise was
reduced from each plane and channel using the despeckling function, followed by smooth
function. The 5 z-planes were then collapsed into a single image using the Sum Slices of
Z-project. Background was subtracted using a rolling ball algorithm (40 pixels for P12; 20
pixels for P24). Channels were auto-thresholded (Over/Under) and switched to an 8-bit
image. To avoid thresholding artifact, each channel was thresholded at multiple intervals
of the maximum threshold (95, 90 85, 80, and 75%). Using the Coloc2 plugin (Gao and
Heldt, 2016; Hernandez et al., 2019; Yennawar et al., 2019), we compared the integrated
intensity values for total fluorescent intensity, and Mander’s coefficient to quantify colocalization of VGAT with GABAAa3 or GABAAa1 (Manders et al., 1993). Calculations of
the coefficients were repeated at each of the additional thresholded intervals against the
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maximum threshold of the opposite channel to ensure any possible differences were not
due to thresholding artifacts.

RT-qPCR
The auditory cortex from P9, 12, 15 and 24 Fmr1 WT and KO mice were isolated, and
total RNA was extracted using RNeasy Mini Kit (Qiagen). First-strand cDNA was
synthesized using SuperScript III First-Strand Synthesis System (Invitrogen). qPCR was
performed using the TaqMan Gene Expression Assay (ThermoFisher) on an Eppendorf
EP Realplex system on 50ng of cDNA per sample. TaqMan probes for target genes are
as

follows:

Gria1:

Mm00433753_m1;

Gria2:

Mm00442822_m1;

Gabra1:

Mm00439046_m1; Gabra3: Mm01294271_m1. Reference/housekeeping genes used are
as follows: Actb: Mm00607939_s1; Gapdh: Mm99999915_g1; Hprt: Mm03024075_m1.

Measurements were made in triplicate and the expression of each gene was normalized
by subtracting the Ct for each reference gene from the target gene (DCt = Ct target gene
– Ct reference gene). The relative gene expression of KO compared to WT was
determined by first calculating the average DCt for WT samples, and then calculating DDCt
value for each sample relative to the average DCt for WT. Expression fold change for each
sample was calculated by 2(-DDCt).

Statistical Analysis
Statistical analysis was completed using Prism (GraphPad). Data was tested for normality
using the Shapiro-Wilk normality test. For within age comparisons, statistical significance
was assessed using a Student’s t test or Mann-Whitney test depending on normality of
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the data. For Western blots with developmental expression analysis, two-way ANOVA and
Sidak’s multiple comparisons tests were used to assess significance. Significance for all
analyses were determined by p < 0.05. Data are reported as mean ± SEM with p values
reported in Results.

RESULTS
We examined the developmental expression of AMPA, NMDA and GABAA receptors in
the auditory cortex across key ages in auditory forebrain development starting at P9, prior
to ear canal opening, P12 and P15, capturing the start and end of the mouse auditory CP
(Barkat et al., 2011), P24 and as adults at P56 (Figure 2.1A). We performed western blot
analysis to compare the expression of membrane-bound AMPAR subunits GluA1 and
GluA2, NMDAR subunits GluN1, GluN2A and GluN2B, and GABAAR a1 and a3 subunits
in Fmr1 KO mice compared to WT littermates. These specific subunits are dynamically
expressed across postnatal development to influence developmental plasticity, exhibit
altered expression in neurodevelopmental disorders and epilepsy, and are sensitive in
their expression with the auditory cortex to early environmental exposure (Rakhade and
Jensen, 2009; Cai et al., 2010; Guo et al., 2012a; Yennawar et al., 2019).

Fmr1 KO mice exhibit elevated AMPAR GluA2:GluA1 protein expression in the
auditory cortex, prior to ear canal opening
Although prior studies have examined the expression of ionotropic receptors in the
developing rodent auditory cortex (Laurie et al., 1992; Behuet et al., 2019), there are no
analyses to date of membrane-bound protein expression in mice, which can be more
reflective of physiological function. To evaluate the developmental expression pattern of
these subunits during the postnatal maturation of the auditory cortex, each of the
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aforementioned ages were normalized relative to P56 WT levels (Figure 2.1B-D).
Consistent with AMPAR evaluation in the overall cortex by Yennawar et al. (2019), the
most prominent developmental changes in GluA1 and GluA2 subunits were observed in
the auditory cortex within the 1st and 2nd postnatal week (2-way ANOVA, age, p < 0.0001).
At all ages of WT auditory cortex development, GluA1 expression exceeds its relative adult
levels, peaking at P15 before declining (Figure 2.1B). Compared to P9 GluA1 expression,
GluA2 expression is relatively lower at the same age but undergoes rapid increased
expression between P9 and P12 in WT mice, during the transition of ear canal opening
(Figure 2.1C). The ratio of GluA2:GluA1, indicative of the maturity of AMPARs and their
impermeability to calcium (Isaac et al., 2007), developmentally increases through the 4th
postnatal week in WT mice to reach adult levels (Figure 2.1G). When examining the
postnatal expression of the AMPAR subunits in the auditory cortex of Fmr1 KO mice, we
found altered regulation of GluA2:GluA1. Specifically, Fmr1 KO mice exhibited
significantly elevated GluA2:GluA1 expression before normalizing to WT levels (2-way
ANOVA, genotype: F(1, 108) = 5.099, p = 0.026; Sidak’s multiple comparisons test: P9 WT:
63.98 ± 3.17% vs. KO: 82.55 ± 6.28%, p = 0.038; P12 WT: 88.93 ± 2.38% vs. KO: 101.78
± 3.77%, p = 0.301) (Figure 2.1G).

We further compared relative Fmr1 KO protein expression to their age-matched WT
littermates to more directly carefully examine AMPAR protein alterations at each age.
While the levels of GluA1 in Fmr1 KO mice were unaltered compared to WT littermates at
all ages (Figure 2.1E-G), Fmr1 KO mice exhibit significant differences in membrane-bound
GluA2 expression selectively at early ages of auditory postnatal development. At P9, prior
to ear canal opening, Fmr1 KO mice have significantly increased GluA2 levels (WT: 100
± 5.27%, KO: 127.7 ± 8.9%, p = 0.0146) (Figure 2.1E). When evaluating the ratio of
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subunits GluA2:GluA1, Fmr1 KO mice have significantly increased GluA2:GluA1
expression in the auditory cortex at both P9 and P12 (P9, WT: 100 ± 4.75%, KO: 128.9 ±
9.14%, p = 0.011; P12, WT: 100 ± 2.68%, KO: 113 ± 3.92%, p = 0.015) (Figure 2.1E-F).
However, no differences in either subunit were observed at P15 or later ages (Figure 2G).

Levels of membrane-bound NMDAR subunits are largely unaltered in the auditory
cortex of Fmr1 KO mice.
We also assessed the developmental expression of GluN1, the obligate NMDAR subunit,
GluN2A and GluN2B to further analyze whether dysregulation of NMDAR expression
altered the trajectory of ionotropic glutamatergic receptor maturation (Figure 2.2). When
each of the ages were normalized relative to P56 WT levels, NMDAR subunits exhibited
the most dynamic developmental regulation within the first 2 postnatal weeks, similar to
membrane-bound AMPAR expression (Figure 2.2A-D). In WT development, GluN2A is
expressed at relatively low levels at birth, whereby it subsequently increases rapidly during
the 2nd postnatal week exceeding adult levels before declining after P15 (Figure 2-1A).
GluN2B and GluN1 expression are higher at P9 compared to GluN2A, but follow a similar
developmental trajectory (Figure 2.1B,D). Given the relatively low expression of GluN2A
at early postnatal ages, the ratio of GluN2B:GluN2A, indicative of NMDAR maturity,
exhibits a strong developmental downregulation during the 2nd postnatal week (Figure
2.1C). No genotype differences were observed for any of the subunit measures, where
developmental

expression

patterns

largely

mirrored

each

other

for

GluN2A,

GluN2B:GluN2A, and GluN1 (2-way ANOVA, age, p < 0.0001). While developmental
expression of GluN2B also had a significant effect of age (2-way ANOVA, age, F(4, 106) =
4, p = 0.0024), where peak expression occurred during the 2nd postnatal week, Fmr1 KO
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mice appear to have a shifted peak, where maximal GluN2B expression occurs at an
earlier age compared to WT mice (Figure 2.2B).

We did not observe any significant differences within the auditory cortex for NMDAR
expression in direct age-matched comparisons between Fmr1 WT and KO mice except at
P15 (Figure 2.2H). P15 Fmr1 KO mice had significantly decreased levels of membranebound GluN2A (WT: 100 ± 8.54%, KO: 74.96 ± 7.13%, p = 0.034) and GluN2B (WT: 100
± 4.56%, KO: 82.67 ± 5.58%, p = 0.029) compared to WT littermates. Given the
comparable reductions of both subunits, the ratio of GluN2B:GluN2A, indicative of the
maturity of NMDARs, was unchanged.

Fmr1 KO mice exhibit an altered regulation of GABAAR a-subunit expression during
auditory cortex maturation
We evaluated membrane-bound GABAA a-subunit developmental expression patterns
relative to P56 WT levels, where we again observed a significant effect of age across all
subunits (2-way ANOVA, age, p < 0.0001) (Figure 2.3A-C). Consistent with Laurie et al.
(1992), the most prominent developmental changes in a3 and a1-subunits were observed
in the auditory cortex around ear canal opening. Notably during WT auditory cortex
development, GABAAa3 peaked in expression at P12, soon after ear canal opening and
signals the start of the WT auditory CP (Barkat et al., 2011; Hackett et al., 2015), and
subsequently rapidly declined (Figure 2.3A). GABAAa1 increased most rapidly between
P9 and P12 in WT mice, peaking at P15, the end of the auditory CP, and maintaining adult
expression levels (Figure 2.3B). GABAAa1:a3 developmentally increases through the 4th
postnatal week in WT mice to reach adult levels (Figure 2.3C).
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Fmr1 KO mice exhibit altered a-subunit developmental patterns in the auditory cortex.
GABAAa3 was significantly different from WT development (2-way ANOVA, interaction:
F(4,109) = 2.897, p = 0.025; genotype: F(1,109) = 4.801, p = 0.031), where a3 does not peak
as highly in the KO auditory cortex (Sidak’s multiple comparisons: P12 WT 302.11 ±
14.18% vs. KO 255.48 ± 13.25%, p = 0.002) (Figure 2.2A). While there was no significant
genotype difference for GABAAa1 development, there appeared to be elevated a1
expression beyond adult levels at P15 and P24 in KO mice (Figure 2.3B). However, the
GABAAa1:a3 ratio during development is significantly different from Fmr1 KO mice (2-way
ANOVA, interaction: F(4,108) = 2.601, p = 0.04; genotype: F(1,108) = 2.899, p = 0.092) with
faster increases to adult WT levels earlier in development (Sidak’s multiple comparisons:
P24 WT 80.75 ± 4.53% vs. KO 95.25 ± 4.68%, p = 0.066) (Figure 2.3C).

Direct comparisons of Fmr1 KO mice to their age-matched WT littermates showed
significantly reduced GABAAa3 in Fmr1 KO mice at P12 (WT: 100 ± 4.48%, KO: 85.66 ±
3.62%, p = 0.021) (Figure 2.3E) Changes in a3-subunit expression may manifest even
earlier, where earliest trending decreases were observed at P9 (WT: 100 ± 3.58%, KO:
92.47 ± 1.63%, p = 0.069) (Figure 2.3D), days before the ear canal is open. No differences
in GABAAa3 were observed at later ages. However, we observed significantly increased
GABAAa1:a3 levels (WT: 100 ± 4.33%, KO: 119.7 ± 4.7%, p = 0.006) in Fmr1 KO mice at
P24, along with a trending increase in membrane-bound GABAAa1 at P24 (WT: 100 ±
5.44%, KO: 123.3 ± 9.85%, p = 0.069) (Figure 2.3G). Neither the GABAAa1 level nor the
ratio of GABAAa1:a3 subunits were different at the early ages. These collective differences
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in the a3 and a1 expression suggest a dynamic alteration in GABAAR developmental
expression in the auditory cortex of Fmr1 KO mice.

Expression of membrane-bound chloride transporters is unaltered in the auditory
cortex of Fmr1 KO mice.
Concurrent with subunit changes for GABAergic maturation is the transition from
depolarizing GABA signaling, when intracellular neuronal chloride concentrations are
high, to hyperpolarizing GABA, when intracellular chloride concentrations are low, which
is determined by the relative developmental expression of the chloride transporters
NKCC1 and KCC2 (Ben-Ari, 2002). In auditory cortex lysates, when each age was
normalized to P56 WT levels, a significant developmental expression pattern of the
NKCC1:KCC2 ratio consistent with general brain maturation was observed (2-way
ANOVA, age, F(4,104) = 51.04, p < 0.0001) (Figure 2.4F). NKCC1:KCC2 levels are relatively
high early in development and then decrease with age as KCC2 expression significantly
increases postnatally (Dzhala et al., 2005). Notably in the auditory cortex, NKCC1:KCC2
exhibits the strongest developmental downregulation between P9 and P12, during the
transition from a closed to an open ear canal. However, there were no differences in
membrane-bound NKCC1 or KCC2 levels in Fmr1 KO mice at any age compared to WT
littermates (Figure 2.4A-E).

Reduced fraction of GABAARa3 staining puncta in P12 Fmr1 KO auditory cortex
Given the significance of P12 as the start of the normal WT auditory CP, we wanted to
determine whether the differences we observed by western blot in membrane-bound
GABAARa3 levels were reflective of synaptic expression across the auditory cortex, or
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specific to a particular cortical layer. We performed immunohistochemistry of extracellulartargeting GABAAR a3 or GABAAR a1 staining to examine co-localization with the inhibitory
presynaptic

marker

vesicular

GABA

transporter

(VGAT).

We

quantified

the

immunoreactivity intensities of GABAAR a3, a1 and VGAT, and calculated the fraction of
VGAT puncta that colocalized with surface GABAAR a3 or a1 using the Mander’s
coefficient (Manders et al., 1993; Gao and Heldt, 2016; Yennawar et al., 2019). Compared
with WT mice, P12 Fmr1 KO mice had significantly reduced fluorescence intensity of
GABAARa3 across all of the cortical layers in the auditory cortex (2-way ANOVA,
genotype, F(1,

56)

= 7.516, p = 0.0082) (Figure 2.5B), indicating reduced expression

consistent with the differences observed by western blot (Figure 2.5B). Meanwhile, WT
and KO mice had similar levels of VGAT immunoreactivity (2-way ANOVA, genotype F(1,
56)

= 0.0066, p = 0.9357) (Figure 2.5C). Thus, when examining the fraction of VGAT+

inhibitory puncta co-localizing with GABAARa3, Fmr1 KO mice had significantly reduced
levels in the auditory cortex (2-way ANOVA, genotype, F(1, 56) = 8.005, p = 0.0065) (Figure
2.5D). Together with the western blot data, our expression data show that Fmr1 KO mice
have decreased synaptic a3-subunit-containing GABAARs in the auditory cortex at P12.

Altered transcriptional, translational and trafficking regulation of GABAAR asubunits in auditory cortex of Fmr1 KO mice
As a translational repressor FMRP does not directly bind the mRNAs for AMPARs or
GABAAR a-subunits; however, it does regulate the translation of mRNAs for hundreds of
synaptic proteins and epigenetic modifiers (Darnell et al., 2011; Korb et al., 2017). Thus,
we wanted to elucidate whether transcriptional, translational, and/or trafficking deficits
yield the altered membrane-bound expression of AMPAR and GABAAR subunits we
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observed in the auditory cortex of Fmr1 KO mice. To determine whether transcriptional
dysregulation occurs within the auditory cortex, we measured the relative transcript levels
of Gria1 and Gria2 (for GluA1 and GluA2, respectively), and Gabra3 and Gabra1 (for
GABAARa3 and GABAARa1, respectively) from auditory cortex lysates during
development by RT-qPCR (Figure 2.6). We found that while levels of Gria1 and Gria2
were not significantly different between Fmr1 WT and KO mice at any age, transcript levels
were significantly altered for Gabra3 and Gabra1 at select ages. Specifically, the relative
levels of Gabra3 is significantly reduced in KO mice at both P12 (WT: 1.005 ± 0.035, KO:
0.758 ± 0.074, p = 0.0096) and P24 (WT: 1.009 ± 0.049, KO: 0.876 ± 0.035, p = 0.039)
(Figure 2.6C). Additionally, Gabra1 levels are also significantly reduced in Fmr1 KO mice
at P24 (WT: 1.027 ± 0.089, KO: 0.730 ± 0.061, p = 0.012), with trends toward decreased
expression at P9 (WT: 1.018 ± 0.064, KO: 0.856 ± 0.059, p = 0.079) (Figure 2.6D).
Significant differences observed for Gabra3 and Gabra1 were further validated against
additional housekeeping genes. Notably, the altered transcriptional regulation for GABAAR
a3 and a1 occurs at P12 and P24, the key ages we observed differences in expression
for membrane-bound expression.

Given the mRNA level differences, we wanted to also evaluate translational regulation and
whether it additionally contributes to the altered regulation of AMPAR and GABAAR
subunit expression in the auditory cortex. We evaluated whole cell auditory cortex
homogenates by western blots specifically at P12 and P24 from Fmr1 KO and WT
littermates, where mRNA differences were observed (Figure 2.7). In contrast to the
membrane preparations described earlier, whole cell homogenates allow the
measurement of total protein expression. Consistent with the lack of transcriptional
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differences in Gria1 and Gria2, there were no alterations in total GluA1 or GluA2
expression in Fmr1 KO mice (Figure 2.7A). Interestingly, despite the decreased Gabra3
and Gabra1 mRNA levels at the P12 and P24 ages, no significant differences in total
expression for the individual subunits were observed, suggestive of elevated translational
regulation in the auditory cortex. However, when specifically evaluating the ratio of
GABAAR a1:a3, P12 KO mice exhibit significantly increased levels relative to WT
littermates (WT: 100 ± 6.95%, KO: 120.13 ± 4.44%, p = 0.023) (Figure 2.7B). Such
changes are reminiscent of the elevated GABAAR a1:a3 observed in membrane-bound
expression in P24 Fmr1 KO mice.

DISCUSSION
Auditory forebrain development is characterized by brief, unique epochs that influence the
maturation of the local auditory circuit – a state when the ear canal is distinctly closed or
open, regulating the transduction of auditory input, and a 3-day critical period window for
tonotopic mapping (Barkat et al., 2011). Given both the hyperexcitability described in the
Fmr1 KO brain along and the range of auditory deficit phenotypes in KO mice, we
executed a detailed characterization of developmental expression of ionotropic glutamate
and GABAA receptors and chloride transporters in the auditory cortex to investigate
possible alterations in excitatory-inhibitory imbalance in the Fmr1 KO mouse.

During normal WT auditory cortex development, we found ionotropic receptor subunits to
follow the broad patterns of cortical development, but report more detailed dynamic
changes occurring within 3-day intervals in the auditory cortex, specifically during the
transition of ear canal opening along with the onset and closure of the critical period. In
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Fmr1 KO mice, we observed dynamic changes in AMPAR and GABAAR subunits during
early auditory cortex development. GluA2 expression was elevated in P9 KO mice
compared to WT, with increased GluA2:GluA1 at P9 and P12. Concurrently, membranebound GABAAR a3-subunit was reduced at P9 and P12, which is further supported by
decreased GABAAR a3 synaptic puncta immunohistochemistry. GABAARs in P24 Fmr1
KO mice further exhibit elevated a1:a3 compared to WT littermates. The dysregulation of
AMPAR and GABAAR expression appear to be multi-factorial, with alterations suggested
at the transcriptional, translational, and trafficking levels.

Relative to the prior cortical and hippocampal characterizations of AMPAR and GABAAR
expression in Fmr1 KO mice, our expression profile of these subunits in the auditory cortex
exhibited several differences. AMPAR expression differences in the literature are highly
variable, with reports of both decreased and increased GluA1 expression in Fmr1 KO mice
(Li et al., 2002; Muddashetty et al., 2007; Schutt et al., 2009), and reduced GluA2 mRNA
with a higher proportion of GluA2-lacking AMPARs in FXS human induced pluripotent
stem cells (Achuta et al., 2018). GABAAR mRNA and protein expression tend to exhibit
either similar or reduced a-subunit levels across regions of the forebrain in Fmr1 KO mice
(D'Hulst et al., 2006; Adusei et al., 2010; Braat and Kooy, 2015a). Our differences
observed in the auditory cortex could be reflective of region-specific alterations that are
occurring in the FXS brain, as well as differences in sample preparation, given that we
specifically measured protein expression of isolated membrane fractions to reflect more
physiologically-relevant states. Nevertheless, our data interestingly highlight: 1)
differences in receptor expression occur early in occur early in the development of Fmr1
KO auditory cortex that later normalize as adults, consistent with the age-dependent
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alterations observed with the cortical synaptic proteome (Adusei et al., 2010; Tang et al.,
2015), and 2) patterns of relatively more mature subunit expression with elevated
GluA2:GluA1 and GABAAR a1:a3.

Early in brain development there is a higher proportion of NMDAR-only silent synapses,
which lack AMPARs and are correlated with the capacity for developmental plasticity
(Crair and Malenka, 1995; Hanse et al., 2013; Huang et al., 2015). Additionally, of the
AMPARs that are synaptically present, many tend to lack the GluA2 subunit, whereby the
presence of these calcium-permeable AMPARs is linked with increasing excitability and
activating calcium-dependent pathways to facilitate synaptogenesis and synaptic
maturation during early postnatal development (Kumar et al., 2002; Isaac et al., 2007).
The increased GluA2 and GluA2:GluA1 expression in the auditory cortex of P9 and P12
Fmr1 KO mice could be associated with the presence of fewer silent synapses and
decreased calcium entry, both of which could contribute to the occlusion of plasticity at the
start of the auditory critical period. Proper GABAergic maturation is also necessary for
modulating plasticity, as GABA-mediated signaling is required to induce the start of critical
periods, particularly by GABAAR a1 (Fagiolini et al., 2004; Kalish et al., 2020), but also
restrict plasticity in adults (Harauzov et al., 2010; Cisneros-Franco et al., 2018).
Interestingly, we observed decreased GABAAR a3 at P9 and P12, with increased GABAAR
a1:a3 at P24, which suggest altered a-subunit maturation that further influences the
induction and capacity for plasticity in conjunction with the AMPAR alterations.

Similar patterns of receptor subunit alterations have been found particularly in models of
early-life seizures where hyperexcitability is induced very early in postnatal development.
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Seizures in early life cause both an increased expression of the GABAAR a1 subunit and
the premature appearance of hyperpolarizing GABA in the hippocampus (Raol et al.,
2006; Galanopoulou, 2008b). However, seizures at older ages or as adults actually
caused the reverse pattern with elevated GABAAR a3 expression that mimic the more
immature brain (Brooks-Kayal, 2011). Furthermore, glutamatergic alterations have been
shown in prior work by our lab where early-life seizures caused a precocious unsilencing
of NMDAR-only silent synapses via AMPAR insertion in both hippocampal CA1 pyramidal
neurons and auditory thalamocortical cells to occlude synaptic and tonotopic plasticity,
respectively (Zhou et al., 2011; Sun et al., 2018). Interestingly, Fmr1 KO mice are known
to have circuit hyperexcitability that manifest at early ages (Contractor et al., 2015;
McCullagh et al., 2020), and in particular, are highly susceptible to audiogenic seizures,
indicative of heightened excitability within the auditory circuit that may drive our observed
alterations.

Given that FMRP does not directly regulate the mRNA transcripts for GluA1, GluA2 or the
GABAAR a-subunits, thus precluding the differences as a direct effect of loss of FMRP
expression, we wanted to further elucidate the level at which subunit dysregulation occurs.
No differences were observed with AMPAR mRNA transcripts, but there were relatively
reduced transcript levels of GABAAR a-subunit mRNAs in Fmr1 KO mice, notably at P12
and P24, ages when we observed significant membrane-bound protein expression
differences. The reduced Gabra1 and Gabra3 levels in the Fmr1 KO auditory cortex are
consistent with the reduced expression reported by D'Hulst et al. (2006). However,
translational upregulation appears to compensate for the reduced transcript levels, as total
protein levels from whole cell homogenates were unaltered for either GABAAR a1 or
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GABAAR a3, except for the significantly elevated GABAAR a1:a3 levels at P12, similar to
the elevated expression observed in membrane-bound expression at P24. The
unchanged total GABAAR protein expression compared to the differences in membranebound expression are also suggestive of altered receptor trafficking to the membrane.
Thus, there is altered regulation of the a-subunits of GABAARs at multiple levels, including
transcriptionally, translationally, and with receptor trafficking (Table 2.1), that is likely
compensatory or secondary in effect from the core changes elicited by loss of FMRP.

While we executed a comprehensive analysis of developmental expression of membranebound ionotropic glutamate and GABAA receptors in auditory cortex development of both
WT and Fmr1 KO mice, direct physiological measures must also be examined to
understand whether these differences yield functional differences in the developing
auditory circuit. These expression studies are limited by a lack of distinction across cortical
layers and cell types, including neuronal subtypes and non-neuronal glial cells. In addition,
we only focused on a small subset of receptor subunits, albeit those that are most
developmentally regulated and most prominent in the cortex, that could overlook possible
dysregulation in other subunits that may impact receptor assembly and function. In
subsequent chapters, we directly investigate functional differences in the auditory cortex
circuit using electrophysiology to examine cortical layer processing and cell-type specific
measures.

45

FIGURES

Figure 2.1: Fmr1 KO mice exhibit elevated AMPAR GluA2:GluA1 subunits in the auditory
cortex, prior to ear canal opening. (A) Timeline of approximate auditory postnatal maturation in
mice with the ages analyzed for experiments highlighted in yellow. (B-D) Western blot analysis of
membrane-bound expression of GluA1, GluA2, and GluA2:A1 in the auditory cortex, with all
timepoints normalized to P56 WT to analyze the developmental expression of the AMPAR subunits.
(D) Developmental expression of GluA2:A1 exhibits genotype effect with significantly decreased
expression for KO at P9. (E-G) AMPAR subunit expression normalized relative to age-matched WT
littermates. (E) GluA2 and GluA2:A1 expression is significantly increased in Fmr1 KO at P9, prior
to ear canal opening (n = 11 WT, 11 KO). (F) The expression of GluA2:A1 remains significantly
increased at P12 (n = 10, 11). (G) No differences in the AMPAR subunits are observed at P15 (n
= 10, 10), or the later ages of P24 (n = 12, 12) and P56 (n = 16, 15), not shown. (H) Representative
western blots of GluA1 and GluA2, with b-actin used as loading controls. (I) Schematic of
approximate auditory cortex dissections as described in Methods. * p < 0.05.
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Figure 2.2: NMDAR subunit expression is similar between Fmr1 WT and KO mice in the
auditory cortex over development. (A-D) Membrane-bound expression of GluN2A, GluN2B,
GluN2B:2A, and GluN1 western blot data plotted with all timepoints normalized to P56 WT to
analyze the developmental expression of NMDAR subunits in the auditory cortex. The
developmental expression of each subunit exhibits a significant effect of age but not genotype. (E)
Representative western blots of NMDAR subunits with b-actin used as loading controls. (F-H)
NMDAR subunits expressed relative to age-matched WT littermates. (F) No differences observed
between Fmr1 KO and WT at P12 (n = 10 WT, 11 KO). (G) P15 Fmr1 KO mice exhibit significantly
decreased levels of GluN2A and GluN2B compared to WT, but no differences are observed in
GluN2B:2A or GluN1 (n = 9, 9). (H) No differences in expression observed at P24 (n = 12, 12). No
differences were observed at either P9 (n = 11, 11) or P56 (n = 16, 15), data not shown. * p < 0.05.
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Figure 2.3: Fmr1 KO mice exhibit altered developmental regulation in expression of GABAAR
a1 and a3 subunits in the auditory cortex. (A-C) Western blot analysis of membrane-bound

expression of GABAAa3, GABAAa1, and GABAAR a1:a3 with all timepoints normalized to P56 WT
to analyze the developmental expression of the GABAA a-subunits in the auditory cortex. (A)
Developmental expression of GABAAa3 exhibits overall interaction between age and genotype with
a genotype effect, and significantly decreased expression for KO at P12. (C) Developmental
GABAAR a1:a3 expression exhibits an overall interaction between age and genotype. (D-G)
GABAAR a- subunits expressed relative to age-matched WT littermates. (D) Fmr1 KO exhibit a
trending decrease in GABAAa3 expression at P9 (n = 11 WT, 11 KO). (E) GABAAa3 is significantly
decreased at P12 (n = 10, 11). (F) No differences in expression observed at P15 (n = 10, 10). (G)
P24 Fmr1 KO exhibit a trending increase in GABAAa1 with significantly increased GABAAR a1:a3
expression (n = 12, 11). No differences observed at P56 (n = 18, 15), data not shown. (H)
Representative western blots of GABAAa3 and GABAAa1 with b-actin used as loading controls. * p
< 0.05, ** p < 0.01.
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Figure 2.4: The expression of chloride transporters is similar between Fmr1 WT and KO mice
in the auditory cortex across development. (A-C) Western blot analysis of membrane-bound
NKCC1, total KCC2 (both dimer and monomer levels), and NKCC1:KCC2 in the auditory cortex,
normalized relative to age-matched WT littermates. No differences were observed in the levels of
the individual transporters or the NKCC1:KCC2 ratio at the early developmental ages (P9: n = 11
WT, 10 KO; P12: n = 10, 11; P15: n = 9, 9). No differences observed at P24 (n = 11, 10) or P56 (n
= 18, 15), data not shown. (D-F) NKCC1, KCC2, and NKCC1:KCC2 data (same as above) plotted
with all timepoints normalized to P56 WT to analyze the developmental expression of chloride
transporters in the auditory cortex. The developmental expression of each transporter exhibits a
significant effect of age but not genotype. (G) Representative western blots of chloride transporters
with b-actin used as loading controls.
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Figure 2.5: Decreased co-localization of GABAAa3 and VGAT in auditory cortex of P12 Fmr1
KO mice. (A) Representative confocal micrographs of IHC of extracellular targeting GABAAa3 and
presynaptic VGAT in L2/3. (B-D) Quantification of results using Coloc2 plugin from FIJI (n = 8 WT,
8 KO). Total fluorescence intensity of (B) GABAAa3 and (C) VGAT immunoreactivity. (D) Mander’s
coefficient to calculate the fraction of VGAT immunoreactivity that co-localizes with a3. Two-way
ANOVA indicates a significant genotype effect in (B) and (D), however, there were no significant
differences in any particular cortical layer as analyzed by Sidak’s multiple comparisons test. No
difference in VGAT intensity. ** p < 0.01.
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Figure 2.6: Altered transcriptional regulation of GABAAR a-subunits in auditory cortex of
Fmr1 KO mice. Relative mRNA expression across ages by RT-qPCR for AMPAR and GABAAR asubunits. Levels were normalized to Gapdh and Actb (not shown), expressed relative to agematched WT littermates (n = 8-10 for each age and genotype). (A-B) No significant differences
were observed in the relative levels of Gria1 or Gria2 for AMPARs at any age. (C-D) Fmr1 KO mice
had significant differences in transcripts for GABAAR a-subunits in the auditory cortex. (C) Gabra3
is significantly decreased in both P12 and P24 Fmr1 KO mice. (D) Gabra1 is significant decreased
at in auditory cortex of P24 KO mice, with a trending decrease at P9. * p < 0.05, ** p < 0.01.
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Figure 2.7: Elevated whole cell levels of GABAAR a1:a3 in Fmr1 KO mice upon ear canal
opening. Total levels of AMPAR and GABAAR subunits measured from whole cell auditory cortex
lysates at P12 and P24. (A) No significant differences were observed in the GluA1, GluA2, or
GluA2:A1 in either P12 (n = 6 WT, 9 KO) or P24 (n = 6, 7). (B) Fmr1 KO mice exhibited significantly
increased total GABAAR a1:a3 levels at P12. No differences were observed at P24. (C)
Representative western blots with b-actin used as loading controls. * p < 0.05.
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P12

P24

mRNA

Total protein

Membrane-bound

a3

¯¯

---

¯

a1

---

---

---

a1:a3

n/a



---

a3

¯

---

---

a1

¯

---

 (trend)

a1:a3

n/a

---



Table 2.1: Fmr1 KO mice exhibit altered transcriptional, translational, and trafficking or
localization regulation of GABAAR a-subunits in the developing auditory cortex. Summary of
RT-qPCR and western blot results at P12 and P24 for the a3 and a1-subunits. A lack of differences
in total protein at either age despite the relative reduced mRNA transcript levels indicate increased
translational regulation. Differences in membrane-bound levels relative to unchanged whole-cell
levels indicate likely altered receptor trafficking in Fmr1 KO mice. Increases or decreases in relative
expression denoted with up and down arrows, respectively, with the number of arrows used to
denote level of statistical significance. “---” used to denote no discernible difference.
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CHAPTER 3:
ALTERED MATURATION OF L4-L2/3 CIRCUIT EXCTABILITY AND PLASTICITY IN
THE AUDITORY CORTEX OF FMR1 KNOCK-OUT MICE

Yeri J. Song, Frances E. Jensen
Department of Neurology, Perelman School of Medicine
University of Pennsylvania, Philadelphia, PA
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ABSTRACT
We previously identified altered developmental expression of glutamate and GABAAR
subunits during the postnatal maturation of the auditory cortex in Fmr1 KO mice,
suggestive of excitatory-inhibitory imbalance in this region. To understand whether the
altered expression of ionotropic receptors yields functional differences in the Fmr1 KO
auditory cortex that could contribute to the various FXS auditory-related phenotypes, we
examined the physiological maturation of L4 to L2/3 circuit, which is the crucial first stage
of intracortical sensory processing that refines tonotopic information and integrates input
from other regions for auditory processing. Using extracellular field recordings and wholecell patch-clamp electrophysiology in ex vivo brain slices, we evaluated the maturation of
basal synaptic transmission and long-term potentiation of L4-L2/3 synaptic connections to
evaluate excitability and synaptic plasticity in the developing auditory cortex. We report a
detailed sequence in the postnatal maturation of basal L4-L2/3 synaptic transmission and
plasticity in WT mice that is closely linked with the opening of the ear canal and auditory
critical period window. The auditory cortex of Fmr1 KO mice exhibits an aberrant
developmental regulation of L4-L2/3 circuit excitability and altered synaptic plasticity in
L2/3 pyramidal neurons that likely contribute to the impaired auditory cortex critical period
previously characterized in the Fragile X mouse model.
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INTRODUCTION
Our developmental expression data measuring membrane-associated ionotropic
glutamate and GABA receptors suggest dynamic alterations in the auditory cortex of Fmr1
KO mice indicative of excitatory-inhibitory (E-I) imbalance in early development (Chapter
2). Specifically, we observed a pattern of dysregulated postnatal maturation of AMPAR
GluA2 and GABAAR a-subunit expression in the Fmr1 KO auditory cortex. Given their
roles as the primary mediators of rapid E-I neurotransmission and regulators of
developmental plasticity, we sought to verify whether such changes manifested in
functional alterations within the auditory circuit of Fmr1 KO mice.

Fmr1 KO mice have an impaired auditory cortex critical period, as identified from in vivo
recordings following tone-rearing manipulations (Kim et al., 2013). Specifically, Fmr1 KO
mice are observed to have significantly diminished tonotopic plasticity in the auditory
cortex, in contrast to the barrel cortex which has a delayed onset of critical period plasticity
(Harlow et al., 2010). However, unlike Harlow et al. (2010), direct measurements of early
postnatal auditory cortex circuit development were not made by Kim et al. (2013) since
recordings were performed in 3-6-week-old mice after early developmental tone-rearing
manipulations. Additionally, in Fmr1 KO auditory cortex brain slice preparations, Yang et
al. (2014) identified failed stabilization of L3/4 long-term potentiation following white matter
stimulation. However, these studies are also limited in elucidating aberrant circuit
maturation given that the youngest age of evaluation was P16-20, when the auditory
tonotopic critical period is already over in normal developing mice (Barkat et al., 2011;
Yang et al., 2014). Therefore, we sought to 1) directly examine the postnatal
developmental maturation of circuit and synaptic plasticity in the auditory cortex,
particularly in relation to ear canal opening and the typical auditory critical period window,
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and 2) to identify possible physiological differences between Fmr1 KO and WT mice
related to our ionotropic receptor expression data findings.

We were specifically interested in the synaptic connections from L4 to L2/3 in the auditory
cortex (Figure 3.1), as this is the first stage of higher-level sensory processing within the
intracortical circuit (Merzenich et al., 1975; Kanold et al., 2014; Li et al., 2014; Javitt and
Sweet, 2015). The thalamus relays tonotopically organized projections to L4 of the cortex
(Barkat et al., 2011; Hackett et al., 2011), which subsequently sends feedforward
connections to L2/3. The neurons in L2/3 process tonotopic information from L4 and also
crucially integrate input from other brain regions before sending their own projections to
deeper layers and other cortical regions (Guo et al., 2012b; Meng et al., 2020). Synaptic
plasticity of the L4-L2/3 circuit has been more well-defined in other sensory areas like the
visual cortex (Jiang et al., 2007; Kim et al., 2013; Li et al., 2017), specific to the auditory
cortex have been limited. Much of the auditory plasticity studies have focused on the
postnatal maturation of thalamocortical synapses (Hogsden and Dringenberg, 2009; Chun
et al., 2013; Meng et al., 2014; Sun et al., 2018), with some more recent characterizations
of the development of L2/3 microcircuit in developing mice (Meng et al., 2020). Therefore,
we wanted to closely examine the sequence of intracortical maturation of the L4-L2/3
circuit of the auditory cortex in both Fmr1 KO and WT mice.

In this chapter, we first examine the excitability and short-term plasticity of the L4-L2/3
auditory cortex microcircuit using extracellular field recordings of brain slices, comparing
input-output curves for basal synaptic transmission and paired-pulse ratios across
development in WT and Fmr1 KO mice. We further evaluate synaptic plasticity in the
auditory cortex of these mice, specifically evaluating L2/3 pyramidal neurons using whole57

cell patch-clamp electrophysiology. Our studies highlight a clear developmental
progression in the excitability of basal synaptic transmission and synaptic plasticity of the
L4-L2/3 auditory cortex circuit that is linked with the opening of the ear canal and the
critical period window in WT mice, which is altered in developing Fmr1 KO mice. In
particular, we observe Fmr1 KO mice to have aberrant regulation of L4-L2/3 circuit
excitability and altered synaptic plasticity in L2/3 pyramidal neurons that likely contribute
to the impaired auditory cortex critical period previously characterized in the Fragile X
mouse model.

METHODS
Animals
Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated
from the original breeders, whereby heterozygous female mice were crossed with WT or
hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT
and KO male littermate mice were used for all experiments to avoid the confounding
effects of X-inactivation that would be present in heterozygous females. All procedures
were performed in accordance with the guidelines of the NIH and with the approval of the
Institution of Animal Care and Use Committee with the University of Pennsylvania. All
efforts were made to minimize animal suffering and numbers.

Brain slice preparation
Acute coronal brain slices for whole-cell electrophysiology were prepared from Fmr1 WT
and KO littermate mice at the following ages: P9-10, P12-13, P15-16, P21-25, and P4045. Animals were rapidly decapitated and brains were quickly removed and placed in
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chilled cutting solution containing the following (in mM): 220 sucrose, 3 KCl, 1.25
NaH2PO4, 0.5 CaCl2, 1 MgCl2, 26 NaHCO3, and 10 D-glucose, ~300 mOsm, pH 7.4,
bubbled with 95% O2/5% CO2 at 4°C. Coronal slices (350 µm) containing the auditory
cortex, identified by anatomical landmarks, were cut using a vibratome (Leica VT1000S)
in cutting solution. Slices were incubated in oxygenated ACSF containing the following (in
mM): 124 NaCl, 5 KCl, 2 CaCl2, 1.2 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, and 10 Dglucose, ~295 mOsm, and transferred to 32°C for 30 min. Then, slices were kept at room
temperature for at least 1 hour before recordings.

Extracellular recordings
Multi-electrode array (MEA) recording systems (MED64 System, Alpha Med Scientific)
were used to perform extracellular field potential recordings. The MEA probes have 64
planar electrodes, arranged in an 8x8 pattern with 150 µm interelectrode spacing (MEDP5155). Slices were transferred to the MEA recording chamber and perfused with ACSF
at 30-32°C with 3-8 ml/min flow rates. Higher perfusion rates were necessary for older
animals to improve O2 supply to brain slices and maintain viability (P9-16: ~3-4 ml/min;
P21-25: ~6 ml/min; P40-45: ~8 ml/min) (Hajos et al., 2009; Reinhard et al., 2014; Panuccio
et al., 2018). Slices were anchored with a harp and aligned so that the electrodes were
parallel with the cortical layers of the auditory cortex, as identified by anatomical
landmarks using the 4X objective of a Nikon Eclipse TE2000-5 microscope. Slices were
recovered in the recording chamber for 30 min with minimal stimulation (7-10 µA) every
1-1.5 min to monitor normalization of responses before beginning experiments.
Stimulations (0.2 ms pulse) were made in L4 with electrodes positioned approximately
400-450 µm from the pia, with field EPSP (fEPSP) response analysis made from the
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adjacent electrode positioned in L2/3. For each experiment, the main L4 stimulation
electrode was selected by identifying the stimulation and recording electrode pair that
elicited the smallest synaptic response when stimulated at 10 µA or 20 µA to maintain
consistent recording practices across all experiments.

Input-output (I-O) curves were generated by stimulating L4 at increasing intensities (5 µA
every 30s) until maximal synaptic response was reached, measured by the maximum
amplitude of the fEPSP response. Half-maximal stimulus intensities were approximated
by identifying the minimum intensity that elicited the half-maximal fEPSP amplitude
determined from I-O curves. Paired-pulse ratios were calculated by dividing the amplitude
of the second fEPSP by the first fEPSP when two successive stimuli of 500, 200, 100, 50,
25, 10 and 6 ms intervals were applied every 30 s at the half-maximal stimulus intensity.

Whole-cell electrophysiology
Whole-cell patch-clamp recordings were made in the auditory cortex, visualized with an
upright Zeiss Axioscop 2 FsPlus IR-DIC microscope. All recordings were made at room
temperature with ACSF perfused at a rate of ~2 ml/min. Glass electrodes were pulled (P87, Sutter Instruments) with a resistance of 2-5 MW and filled within internal solution
containing (in mM): 110 Cs methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl2, 0.5 EGTA, 10
HEPES, 4 ATP-Mg, 0.3 GTP, 7 phosphocreatine, creatine phosphokinase (17 units/ml), 1
QX-314, pH 7.3, 270-280 mOsm.

For single-cell LTP studies, eEPSC recordings were made from L2/3 pyramidal neurons
with stimulations evoked from L4. Pharmacological blockers for GABAARs were not used
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given that we wanted to examine overall synaptic plasticity of the L2/3 pyramidal neurons;
thus, eEPSCs were a mixed excitatory-inhibitory response. Stimulation intensities that
evoked 40-60% of the maximal eEPSC amplitude were used. Cells were held at -60 mV
for 5 min baseline recording (10 s intervals), followed by pairing where cells were held at
+30 mV with 5 tetani (0.1 ms pulses, 100 Hz for 500 ms, separated by 830 ms), and
monitored for 30 min post-pairing at -60 mV. Access resistance was monitored throughout
each experiment, with applied series resistance compensation of up to 75%, and
recordings discarded if access resistance was >25 MW or changed >20%. Data was
collected using Axopatch 200B amplifier and pClamp 10 software (Molecular Devices),
filtered at 2 kHz and digitized at 20 kHz using a Digidata 1440A analog to digital converter.
Analysis was performed offline using Clampfit 10.2 (Molecular Devices). eEPSC
amplitudes were measured, with normalization of eEPSCs to the average amplitude of the
baseline recording.

Experimental design and statistical analysis
For all experiments, the sample size and power were determined based on previously
published work in our laboratory and using StatMate software. Mice were excluded if their
weight was >2 SDs from the mean weight of age-matched mice.

Statistical analysis was completed using Prism 8 (GraphPad). A comparison of sigmoidal
curve fits was used for the analysis of input-output curves in MEA experiments, whereas
a 2-way ANOVA, with Sidak’s multiple comparisons test were used for paired-pulse ratio
analyses. Data were tested for normality using the Shapiro-Wilk normality test. For withinage genotype comparisons of LTP studies, statistical significance was assessed using 2way repeated measures ANOVA. The level of potentiation was also compared at a
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midpoint of the LTP recording, where the average eEPSC was calculated from a full
minute of recordings at 15 min post-pairing, with statistical significance between agematched genotypes assessed using a Student’s t test. For comparing changes in decay
of LTP, a comparison of slopes from linear regressions were performed from 6 to 30
minutes post-pairing values. Data are reported as mean ± SEM with p values reported in
Results. All n’s are reported in the figure legends or tables, or within figures themselves.

RESULTS
Accelerated

developmental

progression

of

evoked

excitatory

synaptic

transmission in the auditory intracortical circuit of Fmr1 KO mice
Given the differences in membrane-bound of AMPAR and GABAAR subunit expression in
the Fmr1 KO auditory cortex (Chapter 2), we further examined whether this manifests in
altered excitability within the developing auditory cortex circuit. Specifically, we assessed
possible dysregulation of excitability of L4 to L2/3 basal synaptic transmission, evaluating
input-output (I-O) curves at each age by plotting stimulation intensity to fEPSP amplitude
and comparing sigmoidal curve fits. We first examined the natural shifts in excitability
during postnatal development to elucidate intracortical circuit maturation of the auditory
cortex by overlaying all of the I-O curves across the ages for each genotype (Figure 3.2AB). In WT mice, we observed a clear progression of shifts in the I-O curves that correspond
with pre- and post-critical period (Figure 3.2A). Specifically, WT I-O curves at P9-10 and
P12-13 were largely the same (Tukey’s multiple comparisons: P9-10 vs. P12-13, p =
0.9998), but subsequently exhibited a significant leftward shift after P12-13, indicating
increased excitability within the circuit (Tukey’s: P12-13 vs. P15-16, p < 0.0001; P15-16
vs. P21-25, p = 0.5837) (Figure 3.2A). Lastly, a slight rightward shift occurred in the P4045 I-O curve (Tukey’s: P21-25 vs. P40-45, p = 0.0316), likely attributable to the slower
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GABAergic maturation that occurs in the postnatal brain (Rakhade and Jensen, 2009). In
contrast, the aforementioned developmental shifts occurred at earlier ages in Fmr1 KO
mice (Figure 3.2B). Fmr1 KO mice displayed a leftward shift in their P12-13 I-O curve
compared to P9-10 and thus, were already more excitable and similar to P15-16 (Tukey’s:
P9-10 vs. P12,13, p < 0.0001; P12-13 vs. P15-16, p = 0.9675). The typical rightward shift
in the I-O curve that yields a slight decreased excitability instead occurred at P21-25 in
Fmr1 KO mice, thus already being more similar to P40-45 (Tukey’s: P15-16 vs. P21-25, p
= 0.001; P21-25 vs. P40-45, p = 0.7375). These results suggest that Fmr1 KO mice have
accelerated developmental shifts in excitability in their intracortical L4 to L2/3 synaptic
transmission relative to the normal WT auditory CP, where developmental peaks appear
to occur earlier in Fmr1 KO mice.

We further compared I-O curves of Fmr1 KO mice directly to their age-matched WT
littermates to more closely examine differences in excitability at each age. First, we found
that Fmr1 KO mice exhibited dynamic differences in L4-L2/3 excitability across postnatal
auditory cortex development. While the I-O curves at P9-10 were significantly different
between genotypes (F(4, 274) = 4.913, p = 0.008), the gain appeared to have more of an
influence compared to the threshold where KO mice did not rise as quickly compared to
WT mice (Figure 3.2C-D). The major differences in excitability between WT and KO mice
occurred at P12-13 and P21-25, where Fmr1 KO were significantly more excitable at P1213 in their L4-L2/3 connectivity (F(4, 442) = 11.44, p < 0.0001) (Figure 3.2E). In contrast, at
P21-25, Fmr1 KO were significantly less excitable in their basal synaptic transmission
compared to WT (F(4, 329) = 15.15, p < 0.0001) (Figure 3.2G). No differences in excitability
were observed between genotypes at P15-16 and P40-45.

63

Altered L4-L2/3 presynaptic function in P12 Fmr1 KO mice
Given the genotype differences in excitability, we next evaluated whether there may be a
presynaptic component. Intracortical synapses are known to exhibit a mix of synaptic
facilitation and depression, with synaptic depression as the predominant form of shortterm synaptic plasticity in the L4 to L2/3 circuit in the visual cortex (Abbott et al., 1997;
Blitz et al., 2004). Therefore, we compared paired-pulse ratios (PPR) of fEPSPs, a
measure of short-term plasticity that is heavily due to presynaptic transmitter release
mechanisms, which distinguishes itself from postsynaptic mechanisms. PPRs are
calculated from the amplitudes of the second fEPSP to the first fEPSP following 2
consecutive stimuli from a range of interstimulus intervals (Figure 3.2). Consistent with
previous cortical reports, we broadly observed short-term depression (PPR < 1) in the L4L2/3 auditory synaptic circuit across most ages. However, PPR values generally increase
with postnatal age across most of the interstimulus intervals in both WT (2-way ANOVA,
interaction effect, F(24,550) = 10.63, p < 0.0001) and Fmr1 KO mice (interaction effect,
F(24,531) = 7.246, p < 0.0001), suggestive of an overall strengthening of presynaptic firing
capabilities with synaptic maturation across development.

Differences in PPR are observed between genotypes at P12-13 (2-way ANOVA,
genotype, F(1,300) = 7.007, p = 0.0085) (Figure 3.2B) and P40-45 (genotype, F(1,175) = 5.138,
p = 0.025) (Figure 3.2F). While no significant differences can be reported at any individual
interstimulus intervals following multiple comparisons, there is tendency towards more
depressed PPR values, particularly at the intervals of 500, 50 and 25 ms. These results
suggest possible alterations in presynaptic-related excitatory-inhibitory neurotransmission
within the L4-L2/3 auditory cortex circuit in Fmr1 KO mice.
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Fmr1 KO mice have an altered progression of synaptic plasticity in L2/3 pyramidal
neurons of the auditory cortex
Given the dynamic developmental alterations in L4-L2/3 basal synaptic transmission in
Fmr1 KO mice, along with differences in short-term plasticity particularly at P12, the start
of the normal auditory cortex critical period, we further evaluated whether Fmr1 KO mice
also exhibited alterations in long-term synaptic plasticity in the same L4-L2/3 circuit that
could contribute to the impaired auditory cortex critical period previously reported in Fmr1
KO mice (Kim et al., 2013). We analyzed long-term potentiation (LTP) in L2/3 pyramidal
neurons by examining the potentiation of evoked EPSCs (eEPSCs) using whole-cell
recordings and a pairing protocol to synchronize presynaptic L4 stimulation and
postsynaptic neuronal depolarization (+30 mV) (Figure 3.4). The eEPSCs in these LTP
studies were technically a mixed response, similar to fEPSPs, as GABAergic signaling
was not pharmacologically blocked to enable us to assess the capabilities of synaptic
plasticity in the presence of both excitatory and inhibitory signaling.

In WT mice, L2/3 pyramidal neurons of the auditory cortex exhibited age-dependent LTP
that is in sync with the sequence of postnatal maturation of the auditory circuit, specifically
ear canal opening and the start of the auditory tonotopic critical period (Barkat et al., 2015).
Notably, LTP was not induced in L2/3 pyramidal neurons at P9-10, while the ear canal is
still closed. A potentiated response was initially observed soon after pairing at P9-10, but
the eEPSC response subsequently decreased often resulting in a depressed eEPSC
amplitude (84.40 ± 11.87% compared to baseline, 15 min after pairing) (Figure 3.4C).
Starting at P12, which is soon after the ear canal opens and the start of the auditory cortex
critical period, LTP was induced in the L4-L2/3 synaptic circuit (128.29 ± 5.67%) (Figure
3.4D). LTP was still capable of being induced at the later ages, but there was a gradual
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decline in LTP magnitude with age (P15-16: 116.66 ± 4.36%; P21-26: 110.38 ± 5.89%).
The age-dependent regulation of synaptic plasticity in WT mice was also observed with
changes in the LTP decay slopes and spread of amplitude responses (Figure 3.4G). P910 mice had a sharp decline in decay (linear regression, slope: -1.43 ± 0.19) with high
variability in eEPSC response. The decay slope relatively attenuated at P12 (-0.39 ± 0.08),
and subsequently increased with age (P15-16: -0.47 ± 0.05; P21-25: -0.79 ± 0.07), with
notable decreases in variability across maturation. These results indicate that in the
auditory cortex, the synaptic plasticity of L4 inputs to L2/3 pyramidal neurons is timed to
maximize LTP for immediately after ear canal opening, which subsequently decreases in
its capacity with age.

We further compared the developmental regulation of L4-L2/3 synaptic plasticity in Fmr1
KO mice at the same ages. Similar to P9-10 WT mice, Fmr1 KO mice were also unable to
readily induce LTP. However, L2/3 pyramidal neurons in the KO tended to not have as
depressed eEPSC responses following pairing (93.44 ± 12.50% compared to baseline, 15
min after pairing) (Figure 3.4C). P12 Fmr1 KO mice were able to express LTP, but
exhibited greater variability in their eEPSC responses and their ability to sustain
potentiation compared to their age-matched WT littermates (KO: 109.35 ± 8.59%; WT:
128.29 ± 5.67%; t test, p = 0.075) (Figure 3.4D). The significant variability of eEPSCs were
also observed pre-pairing in the average baseline eEPSC responses, with P12 KO mice
exhibiting significantly increased variance in the raw amplitudes comparing to WT mice
(WT: 404.3 ± 14.42 pA; KO: 333.1 ± 67.51; comparison of variances: F(10,11) = 20.08, p <
0.0001) (Figure 3.5B). However, similar to WT mice, LTP was more reliably maintained
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at older ages in KO mice with reduced variability (P15-16: 123.16 ± 4.23%; P21-25: 109.50
± 4.32%).

We next evaluated the developmental progression of the decay slopes of LTP in Fmr1 KO
mice. Compared to the decay slopes of WT mice, KO mice exhibited a significantly altered
post-maturational sequence, where P9-10 KO mice do not have a steep decay slope like
WT mice (linear regression, -0.52 ± 0.17, p = 0.0004). Fmr1 KO mice had a stronger decay
at P12-13 compared to WT littermates (-0.75 ± 0.12, p = 0.0097), and also do not exhibit
the age-dependent increase in decay slope values (P15-16: -0.61 ± 0.07, p = 0.113; P2125: -0.12 ± 0.06, p < 0.0001). Our findings highlight that Fmr1 KO mice have an altered
regulation of L2/3 pyramidal neuron synaptic plasticity during the early postnatal
maturation of the auditory cortex.

DISCUSSION
Our electrophysiology data provides a detailed characterization of normal L4-L2/3
microcircuit maturation in developing WT mice, and further reveal significant functional
differences in L4-L2/3 synaptic signaling within the auditory cortex of Fmr1 KO mice during
early postnatal development. We found that the maturation of L4-L2/3 basal synaptic
transmission and synaptic plasticity is closely tuned with both ear canal opening and the
auditory cortex critical period for tonotopic plasticity. Furthermore, we found that Fmr1 KO
mice exhibit dynamic alterations in both the excitability and synaptic plasticity of the L4L2/3 circuit across auditory cortex development.
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We evaluated the L4-L2/3 circuit of the auditory cortex given its involvement in early-stage
cortical auditory processing and tonotopic plasticity (Barkat et al., 2011; Li et al., 2014;
Javitt and Sweet, 2015), and characterized a natural progression of excitability in WT
mice. The most dramatic I-O curve shift occurred at the end of the critical period (P15-16),
where excitability significantly increased. At P40-45, excitability decreased but I-O curves
remained more excitable overall compared to the P9-13 mice. These shifts are consistent
with the broad maturational patterns of excitability in the developing brain (Rakhade and
Jensen, 2009). Additionally, the I-O curve development shifts are also consistent with E-I
frequency tuning development in the rat auditory cortex, where excitatory response to
tonal frequency tuning matures to adult levels by P15, while inhibitory response tuning
develops around P25-30 (Dorrn et al., 2010). Recently, Meng et al. (2020) evaluated intraand interlaminal connectivity of L2/3 neurons in the developing mouse auditory cortex. A
transient hyperconnectivity of inputs from L4 were reported, comparable to the
developmental hyperexcitability we observed with our I-O curves. However, the reported
hyperconnectivity occurs at P12-16 (Meng et al., 2020), whereas we observed increased
excitability at P15-24 before decreasing in excitability at P40-45. This difference in the age
window of excitability and connectivity could be related to technical variations where 1) we
conducted field recordings with synaptic responses from neuronal populations across the
layers, whereas Meng et al. examined synaptic responses in individual L2/3 neurons
following laser-scanning photostimulation of caged glutamate; and 2) the ages were
grouped differently with P12-16 as a single group by Meng et al., whereas we more
granularly evaluated P12-13 and P15-16 separately. Such experimental design
differences could skew the characterization of timescales when examining synaptic
excitability and strength, given the dynamic synaptogenesis and synaptic maturation
rapidly occurring during early development.
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Nevertheless, our WT data highlight a clear developmental sequence in the maturation of
auditory cortex L4 to L2/3 basal synaptic transmission that is altered in Fmr1 KO mice.
Changes in excitability are dynamic across development, whereby KO mice are
significantly more excitable at P12 and less excitable at P24 compared to WT littermates.
Such physiological differences are consistent with the altered expression of membranebound AMPAR and GABAAR subunits described in Chapter 2, providing direct functional
evidence of E-I imbalance within the intracortical auditory circuit of Fmr1 KO mice that
could contribute to the auditory-related phenotypes characterized in the FXS mouse
model.

Paired-pulse measures in L2/3 from L4 stimulation resulted in synaptic depression,
consistent with other cortical studies (Abbott et al., 1997; Varela et al., 1997). Short-term
synaptic depression is largely believed to be related to depletion of a readily releasable
pool of vesicles or presynaptic calcium influx (Blitz et al., 2004). We found that at P12-13
Fmr1 KO mice had significantly different paired-pulse ratios, where values were more
depressed compared to WT. This suggests the presence of a presynaptic dysregulation
potentially related to presynaptic vesicle pools and calcium influx, which can alter the
firing, regulation and synaptic strength of L2/3 neurons to contribute to functional E-I
deficits (Varela et al., 1997).

Our eEPSC-LTP studies of L2/3 pyramidal neurons in the auditory cortex also reveal a
developmental sequence of L4-L2/3 synaptic plasticity that is dysregulated in Fmr1 KO
mice. Many of the previous developmental studies examining LTP in the auditory cortex
have largely focused on the thalamocortical synapses of L4 given their tonotopic
projections and their highly restrictive plasticity window, a common feature that is shared
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across other primary sensory cortices (Crair and Malenka, 1995; Isaac et al., 1997;
Feldman et al., 1999; Jiang et al., 2007; Chun et al., 2013; Sun et al., 2018). However,
few studies have directly evaluated age-dependent LTP of the L4-L2/3 circuit in the
auditory cortex, which is crucial for the processing of L4 tonotopic information (Guo et al.,
2012b; Meng et al., 2020). Our LTP data in WT mice indicate that the synaptic plasticity
of L2/3 pyramidal neurons from L4 synaptic input is closely timed with the opening of the
ear canal and the start of the auditory cortex critical period. LTP was not capable of being
induced in P9-10 WT mice, but was robustly induced starting P12, followed by an agedependent decline in its magnitude. These findings differ from plasticity studies in the
visual cortex, where LTP is capable of being induced in L2/3 by as early as P8 in mice
(Jiang et al., 2007; Li et al., 2017). Interestingly, our results closely correlate with Meng et
al. (2020) where peak synaptic strength from L4 connections occur at P12-16 in the
auditory cortex, suggesting region-specific variations that are closely tied to the maturation
of the overall auditory system.

Fmr1 KO mice exhibit aberrant maturational patterns in the developmental progression of
LTP in the auditory cortex compared to WT mice. While LTP was also capable of being
induced starting at P12 in Fmr1 KO mice, there were several notable deviating features.
Specifically, P9-10 KO neurons did not have as depressed of responses following pairing
relative to WT mice, and P12-13 KO neurons have more variability in their synaptic
responses and their ability to sustain potentiation. Such alterations are more pronounced
when examining the decay slopes of LTP, where the clear developmental pattern
observed in WT mice is visibly altered in the postnatal progression of Fmr1 KO mice. Thus,
our findings highlight abnormal patterns of LTP during early postnatal ages that could
influence the regulation and capacity for synaptic plasticity in the Fmr1 KO auditory cortex.
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Prior studies that identified impaired L4 plasticity in the auditory cortex of Fmr1 KO mice
found that altered mGluR-mediated signaling contributed to the deficits (Kim et al., 2013;
Yang et al., 2014). However, our differences in developmental LTP could also be related
to the differences in the maturation of L4-L2/3 basal synaptic transmission we described
earlier, along with potential functional maturational differences of ionotropic glutamatergic
and GABAergic signaling. For example, alterations in the Fmr1 KO barrel cortex critical
period are linked to maturational differences for GABAAR reversal potentials and NMDARsilent synapses, which are well-known modulators of developmental plasticity (Feldman
et al., 1999; Hensch, 2005; Galanopoulou, 2008a; Harlow et al., 2010; He et al., 2014; He
et al., 2019). Such properties and their potential dysregulation have not been evaluated in
the auditory cortex to date. Therefore, in subsequent chapters, we directly investigate
specific features of GABAergic and glutamatergic functional maturation using
electrophysiology to examine their influence on altered E-I balance and auditory circuit
function in Fmr1 KO mice.
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FIGURES

Figure 3.1: Intracortical circuit of the auditory cortex. (A) Schematic of mouse brain showing
tonotopic projections from the thalamus. Adapted from Kehayas and Holtmaat (2017). (B)
Intracortical circuitry within the auditory cortex. Thalamic inputs (medial geniculate body, MGB) to
L4, which subsequently sends feedforward projections to L2/3. Neurons in L2/3 also receive input
from other brain regions, and further send projections to both deep cortical layers (L5 and L6) as
well as other brain regions. Not all circuit connections are shown.
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Figure 3.2: Fmr1 KO mice exhibit dynamic changes in excitability in L4 to L2/3 basal synaptic
transmission during auditory cortex development. I-O curves of stimulation intensity to fEPSP
amplitude, normalized to maximum amplitude and fit with sigmoidal curves. (A-B) Overlay of I-O
curves for WT and KO mice to evaluate developmental shifts in excitability. (C) Stimulation
intensities for half-maximal response from curve fits in (A) and (B). Different shaded colors in the
table indicate significantly different curves within each genotype. Fmr1 KO mice appear to have
accelerated shifts in developmental excitability. (D-H) Top: representative fEPSP traces in L2/3
extracellular recordings from L4. Bottom: comparison of I-O curves at each age between WT and
Fmr1 KO mice. (E) Fmr1 KO mice are significantly more excitable at P12-13 and (G) significantly
less excitable at P21-24. (I) Representative DIC image of coronal slice with MEA overlaid on the
auditory cortex for extracellular recordings. Scale bar: 600 µm. *** p < 0.001, **** p < 0.0001.
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Figure 3.3: Altered presynaptic regulation of L4-L2/3 auditory cortex circuit in P12 Fmr1 KO
mice. (A-F) Paired-pulse ratios (PPR) from MEA fEPSP recordings across developmental ages to
measure differences in short-term plasticity driven by presynaptic mechanisms. L4-L2/3 largely
have short-term depression (PPR < 1). Fmr1 KO mice exhibit a significant difference in PPRs at
P12-13 (B) and P40-45 (F), with a trend towards more depressed PPR values particularly at 25,
50, and 500 ms. (C) Representative fEPSP traces at P12-13 of interstimulus intervals of 25 and 50
ms. The number of slices and mice analyzed for each age and genotype are reported in Figure 3.1.
* p < 0.05, ** p < 0.01.
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Figure 3.4: Fmr1 KO mice exhibit an altered progression of L4-L2/3 synaptic plasticity during
auditory cortex maturation. (A-B) Representative eEPSC traces from L2/3 pyramidal neurons
with averaged recordings from baseline (pre-pairing) and averaged recordings from 15 min postpairing from the auditory cortex of (A) WT and (B) Fmr1 KO mice across development. (C-F) Time
course of normalized eEPSC amplitude change in LTP experiments. (C) P9-10 mice fail to exhibit
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LTP in the L4-L2/3 circuit. (D-F) LTP is capable of being induced from P12-25. (G-H) Overlay of
the averaged decay data (6-30 min post-pairing) by genotype. In WT mice, LTP does not occur
until P12, whereby enhancement is attenuated with age. Fmr1 KO mice exhibit an altered pattern
of synaptic plasticity with increased variability. P9-10: n = 9 slices, 7 WT mice & 10 slices/7 KO
mice; P12-13: n = 12 slices/7 WT mice & 11 slices/7 KO mice; P15-16: n = 11 slices/8 WT mice &
10 slices/6 KO mice; P21-25: n = 10 slices/7 WT mice & 9 slices/7 KO mice.
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Figure 3.5: Fmr1 KO mice exhibit significantly greater variability in the average baseline
eEPSC response at P12. (A-D) The average eEPSC amplitude was calculated for each cell from
the baseline recordings of eEPSC-LTP experiments in Figure 3.4. While no difference was
observed in the overall amplitudes of eEPSCs in L2/3 pyramidal neurons for L4 stimulation across
the developmental ages, (B) P12 KO mice exhibited significantly increased variability in the size of
the synaptic response.
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ABSTRACT
Fragile X syndrome (FXS) is the leading monogenic form of intellectual disability and
autism, with patients exhibiting numerous auditory-related phenotypes during their
developmental period, including communication, language development, and auditory
processing deficits. Despite studies describing an excitatory-inhibitory imbalance in the
auditory circuit and an impaired auditory cortex critical period in FXS, evaluation of
inhibitory synaptic transmission in the auditory circuit in FXS models remain limited. Thus,
given the critical roles of GABAergic signaling in the regulation of critical periods, network
excitability, and auditory processing, we investigated the functional maturation of GABAA
receptor (GABAAR)-mediated inhibitory synaptic transmission in the auditory cortex. We
characterized normal GABAAR intracortical circuit development patterns in wild-type mice,
and further identified their dysregulation in developing Fmr1 knock-out (KO) mice. Using
extracellular field recordings in ex vivo brain slices, we identified an enhanced agedependent GABAAR antagonist sensitivity that contributes to the altered excitability of L4L2/3 basal synaptic transmission in Fmr1 KO mice. In addition, L2/3 pyramidal neuron
patch-clamp recordings from Fmr1 KO mice identified further GABAergic dysregulation
with enhanced GABAAR a1-specific pharmacological sensitivity, altered GABAAR reversal
potentials maturation, and impaired presynaptic GABA regulation. Together, our results
suggest alterations in the maturation of GABAAR signaling in the auditory cortex of Fmr1
KO mice that involve both postsynaptic and presynaptic mechanisms, which could
underlie features of E-I imbalance and disrupted plasticity that subsequently contributes
to the auditory phenotypes of FXS.
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INTRODUCTION
Fragile X syndrome (FXS) patients have deficits in auditory processing (Van der Molen et
al., 2012; Rotschafer and Razak, 2014), communication, and language development
(Finestack et al., 2009; Hersh et al., 2011), as well as hypersensitivity to sensory stimuli
(Miller et al., 1999), making the auditory cortex a region of particular interest. Fmr1 KO
mice also exhibit auditory phenotypes, including susceptibility to audiogenic seizures
(Chen and Toth, 2001), altered auditory processing (Yun et al., 2006; Rotschafer and
Razak, 2013), delayed parvalbumin cell development in early auditory cortex development
(Wen et al., 2018), and impaired tonotopic and synaptic plasticity during the auditory
cortex critical period (Kim et al., 2013; Yang et al., 2014). However, despite these
extensive phenotypes suggestive of excitatory-inhibitory (E-I) imbalance, studies directly
examining the maturation of synaptic transmission in the auditory cortex of Fmr1 KO mice
are limited.

In Chapter 2, we described altered developmental expression of AMPAR and GABAAR
subunits in the Fmr1 KO auditory cortex, and in Chapter 3, we presented synaptic
excitability and plasticity differences within L4-L2/3 of the auditory cortex. Given the broad
E-I deficits in this auditory intracortical circuit, we sought to investigate whether Fmr1 KO
mice more specifically experience dysregulation of GABAergic maturation in the auditory
cortex. The postnatal maturation of GABAergic signaling is crucial for regulating
excitability in the brain, where the developing brain uniquely transitions from depolarizing
excitatory to hyperpolarizing inhibitory GABAA receptor-mediated signaling to achieve E-I
balance (Galanopoulou, 2008a; Rheims et al., 2008; Rakhade and Jensen, 2009).
Inhibitory GABA action is also critical in inducing and ultimately restricting experiencedependent plasticity in sensory cortices, where signaling mediated by GABAAR a180

containing circuits were specifically found to be necessary for inducing visual cortex
plasticity (Fagiolini and Hensch, 2000; Fagiolini et al., 2004; Jang et al., 2009; Kalish et
al., 2020). Similarly, in the auditory cortex, the maturation of synaptic inhibitory properties
coincides with critical periods that can be further modulated by environmental exposure,
and is further necessary for features of proper auditory processing (Wehr and Zador, 2003;
de Villers-Sidani et al., 2007; Dorrn et al., 2010; Barkat et al., 2011; Sanes and Kotak,
2011; Takesian et al., 2012; Mowery et al., 2016; Blackwell and Geffen, 2017; Kalish et
al., 2020).

In this chapter, we investigated the functional maturation of L4-L2/3 inhibitory synaptic
transmission across key ages in auditory forebrain development in WT and Fmr1 KO mice
using electrophysiology. We established maturational patterns of the GABA inhibitory
circuit in the auditory cortex of WT mice that were dysregulated by the loss of FMRP in
Fmr1 KO mice. L2/3 neurons of Fmr1 KO mice exhibited enhanced developmental
sensitivity to pharmacological GABAAR modulators. Furthermore, L2/3 pyramidal neurons
show altered maturation of GABAAR reversal potentials and voltage-dependent
conductance, with additional impairments related to L4 presynaptic GABA release
mechanisms. Taken together, our findings provide direct evidence for altered presynaptic
and postsynaptic GABAergic regulation in the developing Fmr1 KO auditory cortex that
contribute to the impaired E-I circuit and plasticity maturation in the auditory forebrain that
likely underlie the various auditory-related deficits in FXS.

METHODS
Animals
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Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated
from the original breeders, whereby heterozygous female mice were later crossed with
WT or hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched
WT and KO male littermate mice were used for all experiments to avoid the confounding
effects of X-inactivation that would be present in heterozygous females. All procedures
were performed in accordance with the guidelines of the NIH and with the approval of the
Institution of Animal Care and Use Committee with the University of Pennsylvania. All
efforts were made to minimize animal suffering and numbers.

Brain slice preparation
Acute

coronal brain

slices

for extracellular,

whole-cell,

and

perforated-patch

electrophysiology were prepared from Fmr1 WT and KO littermate mice at the following
ages: P9-10, P12-13, P15-16, P21-25, and P40-45. Animals were rapidly decapitated and
brains were quickly removed and placed into a chilled cutting solution containing the
following (in mM): 220 sucrose, 3 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 1 MgCl2, 26 NaHCO3,
and 10 D-glucose, ~300 mOsm, pH 7.4, bubbled with 95% O2/5% CO2 at 4°C. Coronal
slices (350 µm) containing the auditory cortex, identified by anatomical landmarks, were
cut using a vibratome (Leica VT1000S) in cutting solution. Slices were incubated in
oxygenated ACSF containing the following (in mM): 124 NaCl, 5 KCl, 2 CaCl2, 1.2 MgSO4,
1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose, ~295-300 mOsm, and transferred to 32°C
for 30 min. Then, slices were kept at room temperature for at least 1 hour before
recordings.
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Extracellular recordings
Multi-electrode array (MEA) recording systems (MED64 System, Alpha Med Scientific)
were used to perform extracellular field potential recordings. The MEA probes have 64
planar electrodes, arranged in an 8x8 pattern with 150 µm interelectrode spacing (MEDP5155). Slices were transferred to the MEA recording chamber and perfused with ACSF
at 30-32°C with 3-8 ml/min flow rates. Higher perfusion rates were necessary for older
animals to improve O2 supply to brain slices and maintain viability (P9-16: ~3-4 ml/min;
P21-25: ~6 ml/min; P40-45: ~8 ml/min) (Hajos et al., 2009; Reinhard et al., 2014; Panuccio
et al., 2018). Slices were anchored with a harp and aligned so that the electrodes were
parallel with the cortical layers of the auditory cortex, as identified by anatomical
landmarks using the 4X objective of a Nikon Eclipse TE2000-5 microscope. Slices were
recovered in the recording chamber for 30 min with minimal stimulation (7-10 µA) every
1-1.5 min to monitor normalization of responses before beginning experiments.
Stimulations (0.2 ms pulse) were made in L4 with electrodes positioned approximately
400-450 µm from the pia, with field EPSP (fEPSP) response analysis made from the
adjacent electrode positioned in L2/3. For each experiment, the main L4 stimulation
electrode was selected by identifying the stimulation and recording electrode pair that
elicited the smallest synaptic response when stimulated at 10 µA or 20 µA to maintain
consistent recording practices across all experiments.

Input-output (I-O) curves were generated by stimulating L4 at increasing intensities (5 µA
every 30s) until maximal synaptic response was reached, measured by the maximum
amplitude of the fEPSP response. Half-maximal stimulus intensities were approximated
by identifying the minimum intensity that elicited the half-maximal fEPSP amplitude
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determined from I-O curves. Paired-pulse ratios were calculated by dividing the amplitude
of the second fEPSP by the first fEPSP when two successive stimuli of 500, 200, 100, 50,
25, 10 and 6 ms intervals were applied every 30 s at the half-maximal stimulus intensity.
For experiments analyzing sensitivity to picrotoxin (PTX, Sigma P1675), slices were
incubated in ACSF with 5 µM PTX for 30 min after initial baseline I-O and paired pulse
recordings, before resuming recordings (Jang et al., 2009). In PTX experiments the first
peak was measured, as the synaptic response often showed multiple peaks. All data
collection and analysis were performed in Mobius (MED64).

Whole-cell electrophysiology
Whole-cell patch-clamp recordings were made from L2/3 pyramidal neurons in the
auditory cortex, visualized with an upright Zeiss Axioscop 2 FsPlus IR-DIC microscope.
Recordings were made at room temperature with ACSF perfused at a rate of ~2 ml/min.
Glass electrodes were pulled (P-87, Sutter Instruments) with a resistance of 2-4 MW and
filled with internal solution containing (in mM): 135 CsCl, 10 EGTA, 10 HEPES, 5 ATPMg, 5 QX-314 (pH 7.3, 290-295 mOsm) (Zhou et al., 2013). To isolate sIPSCs, cells were
voltage-clamped at a holding potential of -60 mV and recorded for 10-15 min in the
presence of 20 µM NBQX (Tocris) and 50 µM D-AP5 (Abcam). In experiments examining
sensitivity to a selective a1-subunit GABAAR agonist, we recorded 10 min of traces
following 6 min of zolpidem (100 nM, Sigma). mIPSCs were additionally recorded in the
presence of 1 µM tetrodotoxin (TTX, Tocris). Paired-pulse ratios of evoked IPSCs were
calculated from an average of 5 sweeps following L4 stimulation using interstimulus
intervals of 400, 200, 90, 70, 50 and 20 ms. Access resistance was monitored throughout
each experiment, with applied series resistance compensation of 65%, and recordings
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discarded if access resistance was >25 MW or changed >20%. Data was collected using
Axopatch 200B amplifier and pCLAMP 10 software (Molecular Devices), filtered at 2 kHz
and digitized at 20 kHz using a Digidata 1440A analog to digital converter.
Analysis was performed offline using Clampfit 10.2 (Molecular Devices). Each trace was
first low-pass filtered at 1 kHz (Gaussian). The s/mIPSC events were detected
automatically with a threshold of 5-6 pA (2 times the root mean square of the noise),
depending on the noise level (Rakhade et al., 2008; Zhou et al., 2011; Sun et al., 2013),
and were visually confirmed. The weighted decay time constant (tdw) was calculated by
first fitting a double-exponential function on the average s/mIPSC trace for each neuron
that excluded multiple overlapping sIPSC events: f(t) = Afaste-t / τfast + Aslowe-t / tslow and then
using the fit values in the following equation: tdw = [(Afast × tfast) + (Aslow × tslow)] / (Afast +
Aslow) (Vislay et al., 2013; Zhou et al., 2013).

Perforated patch electrophysiology. EGABA was measured using perforated patch
recordings. Gramicidin (Sigma-Aldrich Inc.) was dissolved in methanol to 10 mg/ml, and
diluted in the internal pipette solution to a final concentration of 150 µg/ml (Ostroumov et
al., 2016). The membrane integrity within pipette tips was confirmed by the presence of
the sodium currents of recorded neurons (not being blocked by the QX-314 inside of the
electrodes). Evoked IPSCs (eIPSCs) in L2/3 pyramidal neurons were recorded at holding
potentials between -100 mV and 0 mV, with stimulation at the border of L3 and L4,
increasing in 10 mV steps with access resistance continuously monitored. All recordings
were performed in the presence of NBQX and D-AP5. Given that during early postnatal
ages L2/3 pyramidal neurons have a high input resistance that exhibit an age-dependent
decrease (P9-10: 523.9 ± 20.56 MW; P12-13: 503.5 ± 36.01 MW; P15-16: 350.5 ± 27.51
85

MW; P21-25: 216.6 ± 14.65 MW), it was necessary to correct the holding potential values
for I-V plots (Rheims et al., 2008). The following formula was used:
𝑉 ∗ = 𝑉$%&' × *

𝑅,
/ (1 + % 𝑐ℎ𝑎𝑛𝑔𝑒 𝑅9: )
𝑅, + 𝑅.

where Vhold is the command membrane holding potential; Rm is the average membrane
resistance during P9-10 perforated-patch recordings; Ra is the average access resistance
during P9-10 recordings; and % change in Rin is the percent change in input resistance
for a given age from P9-10’s Rin for proper age-dependent corrections. Reversal potentials
were estimated from the intersection of current-voltage plots, where the amplitudes of the
eIPSCs were plotted against the modified voltage holding potentials (V*).

Western blot analysis
Fmr1 WT and KO littermates were sacrificed at P24. Brains were rapidly removed from
the skull and the auditory cortex was micro-dissected. Using a coronal brain matrix, a 1.52.0 mm thick coronal brain slice containing the auditory cortex was extracted as identified
by stereotaxic coordinates and anatomical landmarks from Paxinos and Franklin (2004)
and the Allen Brain Atlas. The brain slice was then cut horizontally above the rhinal fissure,
whereby approximately 15° cuts were made bilaterally to isolate the auditory cortex.
Tissue was flash-frozen in chilled ethanol and stored at -80°C until homogenization.

Total whole-cell extraction was performed as previously described (Talos et al., 2006b;
Rakhade et al., 2012; Yennawar et al., 2019). Total protein amounts were measured with
a Bradford protein assay (Bio-Rad) and samples were then diluted to obtain equal
amounts of proteins in each sample (15 µg total) in lysis buffer and 4X Laemmli Sample
Buffer (Bio-Rad). Samples were separated by gel electrophoresis on Criterion TGX 4-20%
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Tris-Glycine precast gels (Bio-Rad), and transferred to PVDF membranes (Millipore
Immobilon-FL). Primary antibodies used in this study are as follow: NKCC1 (1:1000,
Millipore AB3560P); KCC2 (1:1000, Millipore 07-432); KCC2 pS940 (1:2000, Novus
NBP2-29513); b-actin (1:5000, Sigma A5441). Secondary antibodies used were goat antirabbit IRDye 800CW (1:15,000; LI-COR 926-32212) and goat anti-mouse IRDYE 680LT
(1:20,000; LI-COR 926-68024). The Odyssey Infrared Imaging System protocols were
used for blots and quantification of protein expression. b-actin was used for normalization
of individual samples, and normalized values were expressed as a percentage of mean
age-matched WT samples.

Experimental Design and Statistical analysis
For all experiments, the sample size and power were determined based on previously
published work in our laboratory and using StatMate software. Mice were excluded if their
weight was >2 SDs from the mean weight of age-matched mice.

Statistical analysis was completed using Prism 8 (GraphPad). Data were tested for
normality using the Shapiro-Wilk normality test. For within-age comparisons, statistical
significance was assessed using a Student’s t test or Mann-Whitney test depending on
normality of the data. For developmental expression analysis, two-way ANOVA and
Sidak’s multiple comparisons tests with adjusted p values were used to assess
significance. A comparison of sigmoidal curve fits was used for the analysis of input-output
curves in MEA experiments, whereas a 2-way ANOVA with Sidak’s multiple comparisons
test were used for paired-pulse ratio analyses. Changes in amplitude and tdw following
zolpidem were analyzed using paired t test or Wilcoxon matched-pairs signed rank
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depending on the normality of the data. Data are reported as mean ± SEM with p values
reported in Results. All n’s are reported in the figure legends or tables, or within figures
themselves.

RESULTS
Fmr1 KO mice have an enhanced age-dependent sensitivity to picrotoxin
In Chapter 3, we reported alterations in the excitability of evoked basal synaptic
transmission of the L4-L2/3 circuit in the Fmr1 KO auditory cortex. Specifically, KO mice
exhibited significantly increased excitability at P12-13, and decreased excitability at P2125 compared to their age-matched WT littermates. Given that GABAARs affect network
excitability and are crucial regulators of critical periods, we wanted to assess whether
altered GABAergic signaling contributed to these I-O curve differences in WT and Fmr1
KO mice. In a subset of slices, we measured I-O curves following incubation with a
subthreshold concentration (5 µM) of the GABAAR antagonist picrotoxin (PTX), which did
not cause epileptiform discharge (Jang et al., 2009; Stebbings et al., 2016). By analyzing
the shifts of the I-O curves to PTX, we identified the GABAA signaling component,
examining the evolution and strength of inhibition over auditory cortex development, and
identifying potential differences in pharmacological sensitivity within the L4-L2/3 auditory
cortex circuit reflective of GABAAR expression differences (Figure 4.1).

In the auditory cortex of WT mice, PTX did not alter the I-O curves either P9-10 or P12-13
(Figure 4.1A-B). However, at P15-16 in WT mice, PTX exposure resulted in a paradoxical
significant decrease in fEPSP amplitudes, manifested by suppressed I-O curves
compared to the ACSF baseline (F(4,163) = 3.803, p = 0.0055) (Figure 4.1C). Although this
was not the typical response we anticipated to a GABAAR antagonist, which normally
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increases excitatory tone, this was indicative of the presence of depolarizing GABAA
prevalent in early brain development. This depolarizing response progresses towards a
typical mature GABAAR antagonist response with age. At P21-25, I-O curves for WT mice
were not suppressed and rather had no major changes after PTX (F(4,161) = 0.7609, p =
0.5522) (Figure 4.1D); however, at P40-45, PTX increased the fEPSP amplitudes of the IO curves, indicating the action of hyperpolarizing GABA (F(4,231) = 5.088, p = 0.0006)
(Figure 4.2E).

Fmr1 KO mice also showed a similar progression from depolarizing to hyperpolarizing
PTX-induced I-O curve changes across development, although there were several notable
differences from WT mice. Unlike the lack of change in WT mice at P12-13, Fmr1 KO mice
exhibited diminished excitability in response to PTX with significantly suppressed I-O
curves compared to ACSF baseline (F(4,164) = 4.162, p = 0.0031) (Fig 4.1G). This was the
same age where we saw increased L4-L2/3 excitability in KO mice, suggesting that
depolarizing GABA may contribute to the enhanced excitability in Fmr1 KO mice (Figure
4.1B). By P15-16, KO mice did not have any significant I-O changes to PTX (F(4,198) =
1.603, p = 0.175) (Figure 4.1H), which was an age in the WT that showed PTX-induced
suppression of I-O curves. Furthermore, Fmr1 KO mice displayed PTX-induced
hyperexcitability starting at P21-25 where I-O curves shifted to significantly increased
fEPSP responses to PTX (P21-25: F(4,220) = 4.771, p = 0.001; P40-45: F(4,240) = 7.039, p <
0.0001) (Figure 4.1I-J), suggesting the presence of hyperpolarizing GABA in the circuit at
an earlier age than WT.

Notably, the ages at which Fmr1 KO mice exhibit significantly different PTX-induced I-O
curves compared to WT littermates, are those ages in which we observed the overall
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excitability differences between genotypes (Figure 4.1), suggesting that altered
GABAergic signaling heavily contributes to the P12-13 hyperexcitability and the P21-25
decreased excitability. Additionally, when examining the pattern of PTX-induced I-O curve
shifts across development, we found that both the depolarizing and hyperpolarizing
GABAAR signaling response occurred at earlier stages in the Fmr1 KO mice compared to
WT (i.e., P12 KO looks like P15 WT; P21 KO looks like P40 WT). Consistent with the
faster developmental L4-L2/3 basal synaptic transmission, Fmr1 KO mice also undergo
an overall pattern of accelerated age-dependent pharmacological sensitivity to a GABAAR
antagonist at the network level within the auditory cortex.

Maturation of cortical inhibitory synapses in Fmr1 KO pyramidal neurons
With the altered regulation of L4-L2/3 GABAergic maturation and expression of GABAAR
a-subunits in the Fmr1 KO mice auditory cortex, we next asked whether the development
of inhibitory synaptic function in the auditory cortex was specifically altered in L2/3
pyramidal neurons of Fmr1 KO mice. We performed whole-cell patch-clamp recordings
from ex vivo slice preparations across four developmental age groups, measuring sIPSC
properties using a high-chloride internal solution and measuring inward currents while
pyramidal cells were voltage-clamped at -60 mV in the presence of ionotropic glutamate
receptor antagonists (Figure 4.2; Table 4.1). Consistent with the overall progression of
sIPSC properties across development in the rodent cortex (Bosman et al., 2005; Takesian
et al., 2012), WT mice exhibited both a clear age-dependent increase in the frequency of
sIPSCs, and decrease in the weighted decay t, indicative of faster decay kinetics (Figure
4.2C-D). The sIPSC amplitudes were unchanged across WT development (Figure 4.2B).
Fmr1 KO mice exhibited similar developmental maturational patterns of sIPSCs, where
amplitudes and weighted decay t measures were largely unchanged when compared to
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their age-matched WT littermates. While the sIPSC frequencies across development in
Fmr1 KO mice were largely comparable to WT, Fmr1 KO mice did exhibit a trending
increase (p = 0.063) for the frequency at the P12-13 age (Figure 4.2C; Table 4.1),
suggestive of possible alterations during ear canal opening related to the developmental
progression of sIPSC maturation in Fmr1 KO mice.

Fmr1 KO mice exhibit enhanced sensitivity to GABAAR a1-specific agonist
The decay kinetics of IPSCs are highly dependent on the subunit composition of
GABAARs. The a2- and a3-subunits that are highly expressed at birth mediate relatively
long-lasting currents, while the a1-subunit, strongly upregulated postnatally to become the
predominant a-subunit, mediates faster, more mature IPSCs (Bosman et al., 2005;
Pangratz-Fuehrer et al., 2016). In addition to measuring the weighted decay t of sIPSCs
(Figure 4.2D) to functionally assess the relative contribution of a1 and a3 subunits, we
can also examine pharmacological sensitivity using subunit-specific agonists.

In a subset of the L2/3 pyramidal neurons from Figure 4.2, we analyzed changes in both
sIPSC amplitude and weighted decay t in response to zolpidem, a positive modulator of
a1-containing GABAARs (Sanna et al., 2002; Baur and Sigel, 2007), across auditory cortex
development (Figure 4.3; Table 4.2). At P9-10, zolpidem did not cause any significant
changes to the amplitude of sIPSCs in either WT or Fmr1 KO mice as expected, although,
it significantly increased the decay kinetics in both groups (Figure 4.3C-D). At P12-13 the
start of the normal auditory critical period, zolpidem continued to not elicit amplitude
changes in WT neurons; however, it did significantly increase sIPSC amplitudes in Fmr1
KO pyramidal neurons (Table 4.2). Additionally, while zolpidem significantly increased
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decay t for both genotypes at P12-13, KO mice exhibited a slightly more enhanced
sensitivity (WT: p = 0.0133; KO: p = 0.0074). By P15-16, WT mice exhibited significantly
increased amplitudes to zolpidem that persisted to P21-25. Fmr1 KO mice also had
significant increases in amplitude at P15-16 but failed to show a significant amplitude
enhancement to zolpidem at P21-25. However, neurons were still very responsive to
zolpidem at both P15-16 and P21-25 with significantly stronger decay t enhancements,
consistent with the expected age-dependent increase in sensitivity. Overall, our whole-cell
patch-clamp data suggests that while the maturation of sIPSC properties in L2/3 pyramidal
cells of the auditory cortex in Fmr1 KO mice was largely similar to that of natural WT
development, there exist some alterations where Fmr1 KO mice have enhanced zolpidem
sensitivity. This is consistent with our expression data where we observed both decreased
membrane-bound GABAAR a3-subunit and elevated total whole-cell GABAAR a1:a3
expression at P12 (Chapter 2), suggestive of altered a-subunit regulation in the Fmr1 KO
auditory cortex.

Altered developmental voltage-dependent eIPSC conductance in Fmr1 KO mice
Since Fmr1 KO mice have a delayed developmental switch in GABAAR polarity in the
somatosensory cortex (He et al., 2014), and our MEA studies indicate an altered agedependent sensitivity to PTX, we wanted to further evaluate whether the Fmr1 KO auditory
cortex exhibits altered EGABA maturation. We performed gramicidin-perforated patch
recordings from L2/3 pyramidal neurons to measure EGABA across development (Figure
4.4). Consistent with other rodent developmental GABA maturation studies in cortical
neurons (Rheims et al., 2008), the auditory cortex of WT mice also exhibits an agedependent transition of EGABA from depolarizing to hyperpolarizing values (P9-10: -53.68
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± 1.39 mV; P12-13: -52.58 ± 2.40 mV; P15-16: -66.04 ± 3.09 mV; P21-25: -75.07 ± 3.4914
mV) (Figure 4.4C). Notably, the largest EGABA change occurred between P12 and P15,
which is between ear canal opening with the start of the auditory critical period and its
closure (Tukey’s multiple comparisons: P12-13 vs. P15-16, p = 0.006; P15-16 vs. P21-25,
p = 0.1774). Fmr1 KO mice also exhibit similar maturational changes in the auditory cortex,
with no significant differences between WT and KO at any age (P9-10: -49.85 ± 2.47 mV;
P12-13: -56.29 ± 1.68 mV; P15-16: -71.64 ± 1.46 mV; P21-25: -79.85 ± 2.64 mV) (Figure
4.4C). KO mice also have the largest EGABA change between P12 and P15 (Tukey’s: P1213 vs. P15-16, p = 0.0004; P15-16 vs. P21-25, p = 0.2965). Interestingly, when we
excluded the P9-10 group to specifically examine EGABA for ages after ear canal opening,
where the auditory circuit is more robustly modulated by the mediation of auditory input,
there was a significant difference between Fmr1 KO and WT mice, where KO mice tended
to have more hyperpolarized EGABA values (2-way ANOVA, genotype effect, F(1,83) = 5.0, p
= 0.0276). These data suggest that Fmr1 KO mice exhibit alterations of larger inhibition
after the critical period onset, which may contribute to the critical period dysplasticity in the
auditory cortex.

The I-V plots were further normalized and averaged for each of the age groups for
developmental age-group comparisons to assess altered patterns of the relative eIPSC
magnitudes in Fmr1 KO compared to WT mice across development (Figure 4.4D-G). The
I-V plots for WT mice indicated a clear and statistically significant developmental
progression in the rectification pattern of the I-V curves. In P9-10 WT mice, there was a
strong outward rectification of the GABAAR current beginning around -40mV, consistent
with the voltage-dependent activation and modulation of GABAARs (Figure 4.4D) (Pavlov
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et al., 2009; O'Toole and Jenkins, 2012). At P12-13, the outward rectification became
significantly diminished at the depolarizing holding potentials (Figure 4.4E), which
subsequently transitioned into an inward rectification at the later P15-16 and P21-25 ages
in WT mice (Figure 4.4D-F). In contrast, Fmr1 KO P9-10 mice did not have a strong
outward rectification like the age-matched WT mice (segmented linear regression, F(3,297)
= 14.70, p < 0.0001). Rather, the I-V curve is already inwardly rectifying and similar to that
of P12-13. The later KO ages continued to become more inwardly rectifying with age like
the WT mice, although at P15-16, KO mice were not as strongly inwardly rectifying
compared to WT (F(3,283) = 11.96, p < 0.0001). However, the rectification patterns were
comparable to WT at P21-25 (F(3,312) = 0.9949, p = 0.3955). The perforated-patch clamp
experiments collectively suggest that auditory cortex L2/3 pyramidal neurons of Fmr1 KO
mice undergo dysregulated developmental transitions in their rectification of evoked
GABAAR currents prior to ear canal opening, and also have a tendency towards more
hyperpolarized GABAAR reversal potentials during postnatal development compared to
WT mice.

Increased phosphorylation of KCC2 in Fmr1 KO auditory cortex at P24
Given the more hyperpolarized GABAAR reversal potentials in Fmr1 KO mice, we wanted
to identify potential mechanisms contributing to these alterations. While the membranebound expression of the chloride transporters NKCC1 and KCC2 were unaltered in the
developing auditory cortex of Fmr1 KO mice (Chapter 2), post-translational modifications
of KCC2 can further impact the regulation of chloride transporters and thus EGABA. Notably,
the phosphorylation of KCC2 at serine 940 (S940) stabilizes KCC2 at the cell surface by
reducing internalization and enhances its activity (Lee et al., 2007; Medina et al., 2014).
Given the more hyperpolarized EGABA values in L2/3 pyramidal neurons of Fmr1 KO mice
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following ear canal opening, we measured the levels of pS940 KCC2 at P24, a
developmental age where mice express more adult-like levels of the chloride transporters
(Figure 2.4E), and KO mice exhibit enhanced sensitivity to picrotoxin (Figure 4.1I).
Western blot analysis of whole-cell lysates of the auditory cortex revealed unaltered
expression of NKCC1:KCC1 (WT: 100 ± 10.01%, KO: 101.1 ± 10.8%, p = 0.94), consistent
with the membrane-bound preparations (Figure 4.5B). However, we found that Fmr1 KO
mice had significantly elevated levels of pS940 KCC2 (WT: 100 ± 13.4%; KO: 138.8 ±
12.9%, p = 0.035), whereas total KCC2 levels were unchanged (WT: 100 ± 12%; KO:
132.5 ± 16.4%, p = 0.148). Our findings suggest that the phosphorylation of KCC2 at S940
is elevated in the auditory cortex of P24 Fmr1 KO mice, which in turn could increase
membrane stability and function to enhance inhibitory GABA signaling.

P12 Fmr1 KO mice exhibit impaired inhibitory presynaptic regulation of L2/3
pyramidal neurons
Much of our data reveal alterations in GABAergic postsynaptic maturation in L2/3
pyramidal neurons of the Fmr1 KO auditory cortex. While some of these changes appear
to be consistent with differences in postsynaptic GABAA a-subunit or chloride transporter
expression, there may also be a presynaptic component. To further characterize
dysregulation of GABA-mediated signaling in Fmr1 KO animals, we additionally examined
L2/3 pyramidal neuron mIPSCs and paired-pulse ratios (PPR) of eIPSC to identify
possible presynaptic contributions. We specifically examined the P12 auditory cortex
given the increasing trend in sIPSC frequency observed in Fmr1 KO mice (Figure 4.2C).
mIPSCs were measured in the presence TTX to block action potentials (Figure 4.6A-D).
The median amplitudes of mIPSCs were similar between Fmr1 WT and KO mice (WT:
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19.43 ± 1.102 pA, KO: 19.11 ± 0.7328 pA, p = 0.8138), as were the weighted decay t (WT:
14.54 ± 0.6811 ms, KO: 15.14 ± 0.7443, p = 0.5562) (Figure 4.6B, D). Unlike the trending
increase of sIPSC frequency in Fmr1 KO mice, there was no difference in mIPSC
frequency (WT: 1.080 ± 0.1712 Hz, KO: 1.065 ± 0.1225 Hz, p = 0.6768) (Figure 4.6C),
which suggests that presynaptic- or network activity-driven action potential events likely
contribute to the trending sIPSC frequency difference (Malkin et al., 2014).

sIPSC and mIPSCs of L2/3 pyramidal neurons include synaptic events mediated by both
local L2/3 and interlaminar L4 input; therefore, we sought to more specifically evaluate
whether there were L4 inhibitory presynaptic deficits. We compared the paired pulse ratios
(PPR) of eIPSCs in L2/3 pyramidal neurons from stimulation evoked in L4 with a range of
interstimulus intervals (Figure 4.6E-F). Both P12-13 WT and KO mice generally exhibit
paired-pulse depression (PPR < 1), but Fmr1 KO mice have significantly more depressed
responses compared to WT littermates (2-way ANOVA, genotype effect, F(1,198) = 6, p =
0.012) (Figure 4.6F). Notably, the intervals at which more depressed responses were
observed in Fmr1 KO mice are at 400, 50, and 20 ms, similar to the intervals where more
enhanced paired-pulse depression were observed in our Chapter 3 fEPSP paired-pulse
measures (Figure 3.3B). Our findings suggest that the L4-L2/3 circuit maturation in Fmr1
KO mice are further impacted by impairments in L4 inhibitory presynaptic mechanisms.

DISCUSSION
FXS patients exhibit language development, communication, and auditory processing
deficits suggestive of altered auditory cortex development and function, which require
circuit modification during critical periods that is dependent on inhibitory maturation (Sanes
96

and Kotak, 2011; Miyakawa et al., 2019; Kalish et al., 2020). Fmr1 KO mice have disrupted
auditory plasticity, processing and excitability (Kim et al., 2013; Rotschafer and Razak,
2014; McCullagh et al., 2020); however, dysregulation related to GABAergic signaling
maturation in the auditory cortex has not been carefully examined. Here, we characterized
auditory intracortical maturation of inhibitory transmission during the critical period in both
WT and Fmr1 KO mice, identifying circuit and synaptic GABAA transmission patterns. In
KO mice, we uncovered changes in auditory cortex L4-L2/3 excitability mediated by
GABAergic alterations that are accompanied by dysregulation of presynaptic and
postsynaptic

inhibitory

synaptic

maturation

in

L2/3

pyramidal

neurons,

and

pharmacological sensitivity differences. The impairments are dynamic across the duration
of auditory cortex development, with some deficits first manifesting prior to ear canal
opening, and others distinctly occurring at the start of the typical WT auditory critical period
window or later juvenile ages.

Inhibitory GABAergic tone both induces and restricts developmental critical period
plasticity (Fagiolini et al., 2004; Harauzov et al., 2010). In Chapter 3 we evaluated auditory
cortex L4-L2/3 basal synaptic transmission, given its involvement in early-stage cortical
auditory processing and tonotopic plasticity (Barkat et al., 2011) and characterized Fmr1
KO mice to have dynamic changes in excitability, where L4-L2/3 was significantly more
excitable at P12-13 and less excitable at P21-25. Here, we identified that these excitability
changes are likely in part attributable to developmental differences GABA signaling. In
response to subthreshold concentrations of PTX, Fmr1 KO mice exhibited enhanced
developmental transitions from depolarizing to hyperpolarizing responses to PTX that
were consistent with the L4-L2/3 excitability deficits in basal synaptic transmission. Such
alterations could be related to the hyperexcitability present in the Fmr1 KO brain
97

(Contractor et al., 2015), which may potentially drive an accelerated switch from
depolarizing to hyperpolarizing GABA as occurs in hippocampal CA1 neurons following
early-life seizures (Galanopoulou, 2008b; Brooks-Kayal, 2011).

We further analyzed GABA-mediated inhibitory maturation of L2/3 pyramidal neurons,
given their crucial role in integrating both L4 tonotopic information and input derived from
other brain regions (Guo et al., 2012a; Meng et al., 2020). Notably, we observed
differences at P12, the start of the WT critical period soon after ear canal opening. Fmr1
KO L2/3 pyramidal neurons exhibited a trending increase in sIPSC frequency; however,
mIPSC frequency were not different, suggesting that action potentials from increased
spontaneous network activity contributed to the frequency difference. Despite the
increased network activity, there are still defects related to inhibitory regulation of
excitatory neurons that are consistent with the impaired inhibitory control of L2/3 neurons
in the barrel cortex of Fmr1 KO mice (Paluszkiewicz et al., 2011). We found P12 Fmr1 KO
mice to have significantly enhanced eIPSC paired-pulse depression in L2/3 pyramidal
neurons in the auditory cortex compared to WT mice, suggestive of altered presynaptic
mechanisms related to GABA vesicles or calcium influx that impairs inhibitory regulation
(Wilcox and Dichter, 1994; Cea-Del Rio and Huntsman, 2014). Given that fast-spiking
inhibitory interneurons distinctly display short-term depression to repetitive stimulation
(Beierlein et al., 2003), it is likely that our observed deficits are related to the impaired
development of parvalbumin cell numbers and perineuronal nets in the developing
auditory cortex of Fmr1 KO mice (Wen et al., 2018).

While parvalbumin cell numbers are reduced in the developing Fmr1 KO auditory cortex
(Wen et al., 2018), as is GABAAR a3-subunit protein surface expression at P12 (Figures
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2.3 and 2.5), compensatory inhibitory synaptic development likely occurs given that sIPSC
and mIPSC properties in L2/3 pyramidal neurons were largely similar to WT. This lack of
s/mIPSC properties could be related to adaptive mechanisms from homeostatic feedback
during circuit development and/or compensatory GABAAR subunit incorporation to
maintain GABAergic signaling (Bosman et al., 2005; Kralic et al., 2006; Mullins et al.,
2016). Indeed, despite similar s/mIPSC amplitudes, we found L2/3 pyramidal neurons of
Fmr1 KO mice to exhibit enhanced sensitivity to the a1-specific agonist zolpidem,
suggesting that the incorporation of the a1-subunit may be increased in a subset of
synaptic GABAARs in the auditory cortex of KO mice, thereby causing enhanced zolpidem
sensitivity but no difference in decay t measures. Interestingly, in the basolateral
amygdala, Fmr1 KO mice exhibit dynamic alterations in sIPSC properties and diminished
zolpidem sensitivity across development (Vislay et al., 2013), indicating KO mice exhibit
regional differences in inhibitory neurotransmission development that may be intricately
influenced by local cell types and circuitry.

Altered GABA maturation of L2/3 pyramidal neurons was observed related to the transition
from depolarizing to hyperpolarizing GABA-mediated signaling (Ben-Ari, 2002). Although
multiple cortical regions have been examined (Rheims et al., 2008; He et al., 2014), few
characterizations of this transition are specific to the mouse auditory cortex, especially in
the L4-L2/3 synaptic network. We analyzed EGABA of L2/3 pyramidal neurons and found
KO mice had more hyperpolarized EGABA when examining ages with open ear canals.
Interestingly, while we did not find differences in the overall levels of NKCC1 or KCC2 in
the auditory cortex (Figure 2.4), we observed elevated phosphorylated S940-KCC2 levels
in P24 KO mice. Phosphorylation of this residue both stabilizes KCC2 at the membrane
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and increases its activity (Lee et al., 2007; Medina et al., 2014), which could enhance the
extrusion of chloride ions resulting in more hyperpolarizing EGABA and stronger inhibitory
action and sensitivity, consistent with the enhanced hyperpolarizing action of PTX in P2125 Fmr1 KO mice compared to age-matched WTs (Figure 4.1D, I). While the expression
of KCC2 positively regulates the expression of GABAAR a1-subunit (Succol et al., 2012),
the potential effects of KCC2 phosphorylation on GABAAR a-subunit expression is
currently not known. Our results contrast the maturation of Fmr1 KO L4 stellate cells of
the barrel cortex, which exhibit a delayed GABA polarity switch (He et al., 2014); however,
the robustness of this phenotype is questionable as EGABA was similar when measured by
Domanski et al. (2019).

Our eIPSC I-V plots identified a WT developmental progression previously unreported in
the auditory cortex. L2/3 pyramidal neuron eIPSCs transitioned from outward to inwardly
rectifying with age, similar to the developmental regulation of GABA currents in rat intrinsic
cardiac ganglion neurons, which may be related to additional chloride current-related
mechanisms for controlling neuronal excitability (Fischer et al., 2005). Chloride channels
and various GABAAR subunits can influence rectification (Verdoorn et al., 1990; Smith et
al., 1995; Jensen et al., 2002; Pavlov et al., 2009), with the a3-subunit also capable of
eliciting I-V changes. Development RNA-editing of a3 that renders more a1-like properties
switches I-V plots from an outwardly rectifying to a linear curve (Rula et al., 2008; Nimmich
et al., 2009). Meanwhile, Fmr1 KO mice lacked the outward rectification and instead
revealed inward rectifications that resembled older developmental ages, which is
consistent with the a-subunit regulation that we observe across our data. Such rectification
differences related to voltage-dependent conductance can make pyramidal neurons more
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excitable and generate action potentials (Pavlov et al., 2009) to further dysregulate
GABAergic inhibition.

We evaluated GABAergic transmission on L2/3 pyramidal neurons, but a comprehensive
understanding of inhibitory dysregulation in FXS auditory cortex development
necessitates examining different cell types and cortical layers (Kalish et al., 2020). Fmr1
KO L4 barrel cortex has deficits in excitatory drive onto inhibitory neurons (Gibson et al.,
2008). Thus, evaluating both local inhibitory input and excitatory projections on inhibitory
interneurons would further reveal auditory cortex GABA impairments. Additionally,
Goswami et al. (2019) showed local L2/3 auditory cortex hyperexcitability in P19-23 Fmr1
KO mice, attributing this to increased intrinsic excitability but did not directly measure.
Given our observations of decreased L4-L2/3 excitability in P21-25 KO mice,
characterizing intrinsic properties could establish whether L2/3 hyperexcitability is
compensatory for decreased synaptic excitability at earlier intracortical stages.

Overall, critical period plasticity and GABAergic maturation require the appropriate timing,
transition, kinetics and magnitude of both depolarizing and hyperpolarizing GABA across
development (Ben-Ari, 2002; Succol et al., 2012; He et al., 2014; Deidda et al., 2015).
Thus, when collectively examining the developmental regulation of GABAergic signaling
in Fmr1 KO mice, we identified alterations to both presynaptic and postsynaptic GABAA
mechanisms, as well as chloride transporter dynamics. Our findings clearly indicate that
the maturation of GABA-mediated synaptic transmission is altered in the developing
auditory cortex, which likely underlie part of the E-I circuit imbalance and the manifestation
of auditory-related deficits in Fmr1 KO mice.
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FIGURES

Figure 4.1: The auditory cortex of Fmr1 KO mice exhibits an accelerated age-dependent shift
in their sensitivity to picrotoxin (PTX). I-O curves from MEA field recordings were analyzed in
the presence of 5 µM. (A-E) Top: representative traces from Fmr1 WT mice at 40 µA stimulation.
Bottom: I-O curves before and after PTX, normalized to the maximum amplitude in ACSF and fit
with sigmoidal curves. (C) Fmr1 P15-16 WT mice exhibit decreased fEPSP amplitudes following
PTX, likely due to the presence of depolarizing GABAA. (E) Fmr1 WT exhibit significantly increased
fEPSP amplitudes to PTX at P40-45, indicating PTX’s blockade of inhibitory hyperpolarizing
GABAA. (F-J) Representative traces and I-O curves from Fmr1 KO mice. (G) Fmr1 KO mice exhibit
significantly decreased responses to PTX at P12-13 but not at (H) P15-16. (I-J) At both P21-25 and
P40-45, Fmr1 KO mice exhibit significantly increased amplitudes to PTX. The number of slices and
mice analyzed for each age and genotype are indicated in each graph. ** p < 0.01, *** p < 0.001,
**** p < 0.0001.
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Figure 4.2: Increasing trend for sIPSC frequency in P12-13 Fmr1 KO mice. (A) Representative
traces of sIPSCs recorded across development from L2/3 pyramidal neurons in the auditory cortex.
(B) Amplitudes of sIPSCs are unaltered in Fmr1 KO mice at any age. (C) P12 KO mice exhibit a
trend towards increased sIPSC frequency. (D) No differences in the weighted decay t (tdw) were
observed between WT and KO mice at any age. Developmental maturation of inhibitory
transmission is observed with increasing tdw times across ages. All values are summarized in Table
4.1. * p < 0.05.
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Figure 4.3: Fmr1 P12 KO mice exhibit enhanced sensitivity to zolpidem (ZOLP). (A-B)
Representative traces of averaged sIPSCs from L2/3 pyramidal neurons before and after 100 nM
zolpidem. (C) The effects of ZOLP on sIPSC amplitude across ages. No effects observed at P910, but significantly increased amplitude following ZOLP observed in Fmr1 KO mice starting at P1213. (D) The τdw of averaged sIPSCs significantly increases with ZOLP across all ages for both WT
and KO mice. The average values are summarized in Table 2. * p < 0.05, ** p < 0.01, *** p < 0.001,
**** p < 0.0001.
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Figure 4.4: Fmr1 KO mice exhibit altered voltage-dependent eIPSC conductance in L2/3
pyramidal neurons during auditory cortex development. (A-B) Representative example of (A)
GABAAR I-V plot and (B) traces of eIPSC gramicidin-perforated patch recordings from P9 WT and
KO mice. EGABA is estimated from linear fit from I-V plot. (C) Group data of EGABA from I-V plots
across all Fmr1 WT and KO mice and ages. (D-G) Averaged GABAA I-V plots across ages for WT
and KO mice to evaluate developmental regulation of GABAAR responses. Currents for each cell
were normalized to the eIPSC peak amplitude of the first holding potential. P9-10: n = 13 cells/5
WT mice and 15 cells/6 KO mice. P12-13: n = 15 cells/5 WT mice and 17 cells/6 KO mice. P15-16:
n = 13 cells/5 WT mice and 14 cells/6 KO mice. P21-25: n = 16 cells/6 WT mice and 14 cells/5 KO
mice. **** p < 0.0001.
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Figure 4.5: Elevated phosphorylation of KCC2 S940 in P24 Fmr1 KO mice. (A) Representative
western blots of whole-cell lysates of auditory cortex probed for pS940, total KCC2 and NKCC1,
with b-actin used as loading controls. (B) A significant increase in pS940, normalized to b-actin,
was found P24 KO mice relative to WT littermate controls (n = 6 WT, 7 KO). No differences were
found in the levels of NKCC1:KCC2, total KCC2 or NKCC1 (not shown), consistent with the lack of
differences in the membrane preparation lysates in Figure 2.4. * p < 0.05
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Figure 4.6 Altered presynaptic regulation of inhibitory transmission in L2/3 pyramidal
neurons of P12 Fmr1 KO mice in the auditory cortex. (A-D) mIPSC analysis of L2/3 pyramidal
neurons in the auditory cortex. (A) Representative mIPSC traces. (B-D) mIPSC amplitude,
frequency, and weighted decay t are unaltered in P12-13 Fmr1 KO mice. N = 17 cells/5 WT mice
and 17 cells/5 KO mice. (E-F) Paired pulse ratio analysis of eIPSC at P12-13. (E) Representative
traces from interstimulus intervals of 20 and 50 ms. (F) Fmr1 KO mice have significantly different
eIPSC paired pulse ratios compared to WT mice, with more depressed PPR values. N = 16 cells/3
WT mice and 19 cells/3 KO mice. * p < 0.05
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Amplitude (pA)

Frequency (Hz)

Weighted Decay t
(ms)

WT (22/9)

24.01± 2.18

0.56 ± 0.10

25.42 ± 2.12

KO (24/7)

23.07 ± 1.46

0.47 ± 0.07

23.19 ± 1.57

p = 0.7192

p = 0.4478

p = 0.3976

WT (22/9)

20.20 ± 0.98

1.63 ± 0.12

16.86 ± 1.06

KO (21/8)

20.68 ± 1.52

1.97 ± 0.16

16.75 ± 0.87

p = 0.7881

p = 0.0634

p = 0.9381

WT (25/10)

21.36 ± 0.96

4.49 ± 0.32

11.55 ± 0.37

KO (21/7)

21.16 ± 0.78

4.33 ± 0.28

11.41 ± 0.32

p = 0.8778

p = 0.7214

p = 0.7894

WT (20/10)

24.70 ± 1.44

6.65 ± 0.34

10.08 ± 0.43

KO (21/10)

23.33 ± 1.36

7.50 ± 0.39

9.77 ± 0.23

p = 0.4919

p = 0.1086

p = 0.5206

Genotype
(n = cells/mice)

P9-10

P12-13

P15-16

P21-25

Table 4.1: Summary of sIPSC median amplitudes, frequency and weighted decay t. All values
are mean ± SEM. Student’s t test or Mann-Whitney was performed for each age, with p values
listed.
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Weighted Decay t (ms)

Amplitude
Genotype

ACSF

ZOLP

p-value

ACSF

ZOLP

p-value

WT (12/6)

25.61 ±
3.43

22.87 ±
1.85

0.4866

22.79 ±
2.92

31.6 ±
2.77

0.0041

KO (14/5)

23.40 ±
2.28

23.85 ±
2.25

0.856

22.12 ±
2.14

31.39 ±
2.43

0.0085

WT (9/5)

21.33 ±
1.55

23.08 ±
1.81

0.114

16.54 ±
0.95

22.58 ±
2.16

0.0133

KO (11/6)

23.18 ±
2.49

28.03 ±
2.38

0.0046

18.47 ±
1.33

22.39 ±
1.63

0.0074

WT (10/5)

24.61 ±
1.07

29.96 ±
1.58

0.0018

12.13 ±
0.62

15.5 ±
0.59

< 0.0001

KO (13/6)

21.88 ±
0.80

25.61 ±
0.83

0.0015

11.42 ±
0.40

15.54 ±
0.37

< 0.0001

WT (10/6)

29.11 ±
1.72

31.77 ±
2.14

0.0068

9.47 ±
0.33

12.31 ±
0.42

< 0.0001

KO (10/6)

25.54 ±
1.67

27.76 ±
1.54

0.1934

9.38 ±
0.25

12.69 ±
0.53

< 0.0001

(n = cells/mice)

P9-10

P12-13

P15-16

P21-25

Table 4.2: Summary of sIPSC pharmacological sensitivity to zolpidem in the auditory cortex.
Group mean ± SEM reported for median amplitude and weighted decay t for ACSF and ZOLP for
each age. The p values are listed from paired t test or Wilcoxon matched-pairs signed rank.
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ABSTRACT
The identification of excitatory-inhibitory (E-I) imbalance in a circuit necessitates a careful
assessment of potential alterations in both excitatory and inhibitory synaptic transmission.
In the Fmr1 KO mouse, we identified alterations in the developmental patterns of
excitability and synaptic plasticity in the L4 to L2/3 circuit of the auditory cortex, and further
characterized dysregulation of inhibitory GABA maturational patterns in L2/3 pyramidal
neurons. Given that the proper maturation of excitatory glutamatergic signaling is crucial
for the regulation of developmental excitability and plasticity, we sought to evaluate
AMPAR maturation in L2/3 pyramidal neurons during the postnatal development of the
auditory cortex in WT and Fmr1 KO mice. To date, studies of functional glutamatergic
synaptic development in the Fmr1 KO auditory cortex are limited. Therefore, we
specifically examined the postnatal maturation of 1) NMDAR-only “silent” synapses that
postnatally convert to “functional” AMPAR-containing synapses, which is an underlying
factor in the capacity for developmental plasticity, and 2) AMPAR GluA2 subunits that
render AMPARs impermeable to calcium, which modulate neuronal excitability and
plasticity in early development. The data presented in this chapter is preliminary, with
further experimentation needed. Here, we demonstrate feasibility and the consideration
for a more complete evaluation of E-I circuit analysis in the Fmr1 KO auditory cortex.

111

INTRODUCTION
The functional maturation of GABAergic inhibitory signaling is necessary for the regulation
of cortical critical periods and the development and maintenance of proper auditory
processing (Wehr and Zador, 2003; Hensch, 2005; Blackwell and Geffen, 2017). In
Chapter 4, we detailed the postnatal maturational patterns of GABAAR-mediated signaling
in the developing auditory cortex, focusing on the inhibitory regulation of L2/3 pyramidal
neurons. Fmr1 KO mice exhibit alterations in these developmental patterns, with
dysregulation of both postsynaptic and presynaptic GABAergic function. However,
another crucial regulator of developmental excitability and plasticity is the postnatal
activity-dependent maturation of excitatory glutamatergic signaling (Rakhade and Jensen,
2009).

Changes and refinements in AMPAR and NMDAR excitatory circuits also modulate critical
periods (Hensch, 2005; Oswald and Reyes, 2008). The neonatal brain has a high
proportion of NMDAR-only silent synapses that are functionally “silent” at due to the
magnesium block at resting membrane potential. Their activity-dependent conversion to
functional synapses via AMPAR insertion is correlated with the capacity for synaptic
plasticity and the refinement of relevant connections, particularly for thalamocortical
synapses of sensory cortices (Crair and Malenka, 1995; Isaac et al., 1997; Harlow et al.,
2010; Hanse et al., 2013). Alterations in silent synapse maturation are known to disrupt
synaptic plasticity and manifest in functional deficits, as we previously reported that
hyperexcitability from early-life seizures can disrupt auditory tonotopic critical period
plasticity and hippocampal synaptic plasticity by prematurely unsilencing glutamatergic
synapses (Zhou et al., 2011; Sun et al., 2018). Conversely, a persistence of silent
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synapses in the barrel cortex of Fmr1 KO mice results in a temporal delay of its critical
period (Harlow et al., 2010).

Additionally, the postnatal and activity-dependent regulation of AMPAR subunits further
influence developmental excitability and plasticity (Liu et al., 2004; Isaac et al., 2007). In
particular, the GluA2 subunit is expressed at relatively low levels early in postnatal
development, thereby causing many AMPARs to lack GluA2 and be calcium-permeable.
However, the prevalence of GluA2-lacking AMPARs in early development are necessary
for permitting enhanced excitability and activation of calcium-dependent pathways to
facilitate synaptogenesis and synaptic plasticity (Isaac et al., 2007; Rakhade and Jensen,
2009). Alterations in GluA2 subunit expression have been identified across
neurodevelopmental disorders (Salpietro et al., 2019; Yennawar et al., 2019), and
AMPARs are also dynamically regulated in the auditory cortex based on environmental
exposure, with associated with alterations in auditory processing in cortical neurons (Cai
et al., 2010; Guo et al., 2012a; Hackett et al., 2015).

In Chapter 2, we identified altered expression of membrane-bound AMPARs in the
auditory cortex of Fmr1 KO mice. Specifically, GluA2 levels were increased in P9 KO mice
relative to WT, before ear canal opening, as well as increased GluA2:GluA1 at both P9
and P12. Additionally, in Chapter 3, we identified alterations in the developmental
progression of synaptic plasticity and excitability within the L4-L2/3 circuit in Fmr1 KO
mice. Given the importance of AMPAR regulation to developmental excitability and
plasticity, we sought to investigate whether Fmr1 KO mice exhibit functional deficits in
AMPARs in the developing auditory cortex to complement our functional studies that
examined inhibitory maturation. We specifically evaluated AMPAR maturational properties
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by examining sEPSCs, silent synapses, and AMPAR I-V plots for GluA2 analysis in L2/3
pyramidal neurons. The data presented in this chapter is preliminary and ongoing;
therefore, they are presented without any statistical analyses. Here, we demonstrate
feasibility and our consideration for a more complete evaluation of E-I circuit analysis in
the Fmr1 KO auditory cortex.
METHODS
Animals
Fmr1 WT and Fmr1 KO mice of the congenic FVB background were obtained from The
Jackson Laboratory (stock # 004828; 004624). Heterozygous females were generated
from the original breeders, whereby heterozygous female mice were crossed with WT or
hemizygous male mice to obtain Fmr1 WT and KO male littermates. Age-matched WT
and KO male littermate mice were used for all experiments to avoid the confounding
effects of X-inactivation that would be present in heterozygous females. All procedures
were performed in accordance with the guidelines of the NIH and with the approval of the
Institution of Animal Care and Use Committee with the University of Pennsylvania. All
efforts were made to minimize animal suffering and numbers.

Brain slice preparation
Acute coronal brain slices for whole-cell electrophysiology were prepared from Fmr1 WT
and KO littermate mice at the following ages: P9-10, P12-13, P15-16, and P21-25.
Animals were rapidly decapitated and brains were quickly removed and placed in chilled
cutting solution containing the following (in mM): 220 sucrose, 3 KCl, 1.25 NaH2PO4, 0.5
CaCl2, 1 MgCl2, 26 NaHCO3, and 10 D-glucose, ~300 mOsm, pH 7.4, bubbled with 95%
O2/5% CO2 at 4°C. Coronal slices (350 µm) containing the auditory cortex, identified by
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anatomical landmarks, were cut using a vibratome (Leica VT1000S) in cutting solution.
Slices were incubated in oxygenated ACSF containing the following (in mM): 124 NaCl, 5
KCl, 2 CaCl2, 1.2 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose, ~295 mOsm,
and transferred to 32°C for 30 min. Then, slices were kept at room temperature for at least
1 hour before recordings.

Whole-cell electrophysiology
Whole-cell patch-clamp recordings were made in the auditory cortex, visualized with an
upright Zeiss Axioscop 2 FsPlus IR-DIC microscope. All recordings were made at room
temperature with ACSF perfused at a rate of ~2 ml/min. Glass electrodes were pulled (P87, Sutter Instruments) with a resistance of 2-5 MW and filled within internal solution
containing (in mM): 110 Cs methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl2, 0.5 EGTA, 10
HEPES, 4 ATP-Mg, 0.3 GTP, 7 phosphocreatine, creatine phosphokinase (17 units/ml), 1
QX-314, pH 7.3, 270-280 mOsm.

For sEPSC recordings, cells were voltage-clamped at a holding potential of -60 mV and
recorded for 10 min in the presence of 60 µM picrotoxin to block GABAA receptors. Access
resistance was monitored throughout each experiment, with applied series resistance
compensation of up to 75%, and recordings discarded if access resistance was >25 MW
or changed >20%. Data was collected using Axopatch 200B amplifier and pClamp 10
software (Molecular Devices), filtered at 2 kHz and digitized at 20 kHz using a Digidata
1440A analog to digital converter. Each trace was first low-pass filtered at 1 kHz
(Gaussian). Events were detected automatically with a threshold of 5-6 pA (2 times the
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root mean square of the noise), depending on the noise level (Rakhade et al., 2008; Zhou
et al., 2011; Sun et al., 2013), and were visually confirmed.

To examine postsynaptic silent synapses, synaptic responses in the L2/3 pyramidal
neurons were evoked by stimulating L4 in the presence of 60µM picrotoxin. Cells were
first held at -60 mV and stimulated using a threshold stimulation intensity that elicited
detectable synaptic responses with about a 40-60% failure rate from 50 consecutive trials
(Zhou et al., 2011; Sun et al., 2018). Cells were then stimulated with the same intensity at
+40 mV for another 50 trials. The fraction of silent synapses was calculated by using the
corresponding eEPSC failure rates at -60 and +40 mV in the following formula: (1 – ln(F60)/ln(F+40)),

as per published methods (Liao et al., 1995; Sun et al., 2018).

For evoked AMPAR I-V plot recordings, 0.1 mM spermine was added to the internal
recording solution, with 60 µM picrotoxin and 50 µM D-AP5 added to the bath to isolate
AMPAR-mediated currents. L2/3 pyramidal neurons were held from -80 to +40 mV,
increasing in 20 mV, with evoked stimulations at the L3/4 border. Data were obtained from
the average 4-8 recordings per cells, with amplitudes of AMPA-mediated EPSC responses
normalized to -80 mV holding voltage.

Experimental design and statistical analysis
For all experiments, the sample size and power were determined based on previously
published work in our laboratory and using StatMate software. Statistical analysis was
completed using Prism 8 (GraphPad). Data were tested for normality using the Shapiro-
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Wilk test. Data are reported as mean ± SEM with p values reported in Results. All n’s are
reported in the figure legends or tables, or within figures themselves.

RESULTS
Maturation of cortical excitatory synapses in L2/3 pyramidal neurons in the
developing auditory cortex
Given the significantly elevated levels of membrane-bound GluA2 in the auditory cortex of
P9 Fmr1 KO mice compared to age-matched WT littermates, we wanted to examine
whether there were changes in synaptic AMPAR in L2/3 pyramidal neurons. We
performed whole-cell patch-clamp recordings from ex vivo slice preparations of WT and
KO mice across development, measuring sEPSCs while cells were voltage-clamped at 60mV (Figure 5.1), which isolate for AMPAR-mediated events given that NMDARmediated currents require depolarized holding potentials. Consistent with the overall
progression of sEPSC properties across development in the rodent cortex (Kroon et al.,
2019), WT mice exhibit a clear age-dependent increase in the frequency of sEPSCs
(Figure 5.1C; Table 5.1). There is also a subtle developmental increase in the median
amplitude of sEPSCs, perhaps between P9-10 and P12-13 (Figure 5.1B). Fmr1 KO mice
also appear to follow a similar age-dependent regulation in sEPSC frequency and
amplitude, with more elevated sEPSC frequencies at the older developmental ages of
P15-16 and P21-25; however, no conclusions can be drawn given the preliminary nature
of these experiments.

Measuring the fraction of silent synapses in auditory cortex L2/3 pyramidal neurons
The auditory thalamocortical synapses of L4 pyramidal neurons exhibit a maturation of
NMDAR-only silent synapses that correspond to the auditory cortex critical period. We
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sought to evaluate their maturation in auditory cortex L2/3 pyramidal neurons, which
crucially integrate input from L4 tonotopy and other brain regions (Guo et al., 2012b; Meng
et al., 2020). The maturation of silent synapses can be monitored by measuring the
proportion of silent synapses across development, which can be calculated by using a
protocol of minimally evoked EPSCs. Specifically, cells are first held at -60 mV and
stimulated using a minimal stimulus intensity that results in evoked synaptic responses
with ~50% failure rate. The holding potential is then raised to +40 mV and again stimulated
with the same stimulus intensity (Figure 5.2A-D), whereby we use the difference in failure
rates to calculate the proportion of silent synapses (Liao et al., 1995; Sun et al., 2018).

Silent synapse recordings were performed at P12-13 and P15-16 (Figure 5.2), though it
is our intention to also evaluate the P9-10 and P21-25 ages for a more comprehensive
evaluation. In most of the L2/3 pyramidal neurons recorded, we found a decrease in failure
rates when we raised the holding potential from -60 to +40 mV (Figure 5.2E-F). The
preliminary recordings from WT neurons exhibit an age-dependent decrease in the
fraction of silent synapses present (P12-13 WT: 44.55 ± 7.99%; P15-16 WT: 23.16 ±
14.63%) (Figure 5.2G). The preliminary recordings from Fmr1 KO did not this change
(P12-13 KO: 29.43 ± 11.71%; P15-16 KO: 37.84 ± 7.41%).

The calculation of silent synapses is dependent on the failure rates at the -60 and +40 mV
holding potentials. However, these initial recordings presented some technical challenges,
where it was often difficult to find a stimulus intensity that elicited ~50% failure rate at -60
mV. Minimal changes in stimulation quickly transitioned from >90% to <20% failure rate.
These challenges may be related to the differences in synaptic organization within the
cortex, where L2/3 pyramidal neurons do not have a unidirectional dendritic fiber input
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compared to thalamocortical synapses of L4 or the Schaffer collateral pathway from CA3
to CA1 of the hippocampus (Zhou et al., 2011; Sun et al., 2018). For our preliminary
calculations in Figure 5.2, we included cells with <20% failure rate at -60 mV. However,
future analyses will be kept to cells that are able to achieve the initial ~50% failure rate at
-60 mV, given that a low initial failure rate could result in a skewed calculation that does
not capture a true physiological difference in failure rates between the two holding
potentials.

AMPAR GluA2 subunit maturation in L2/3 pyramidal neurons in the auditory cortex
To more directly examine whether there were functional differences in the maturation of
the GluA2 subunit in Fmr1 KO mice, related to the elevated GluA2:GluA1 membranebound levels, we examined AMPAR I-V relationships in L2/3 pyramidal neurons across
development in the auditory cortex (Figure 5.3). GluA2-containing or GluA2-lacking
AMPARs can be distinguished based on the rectification of their I-V curves. Spermine,
included in the intracellular solution, causes a voltage-dependent channel block in GluA2lacking AMPARs that results in an inward rectification, whereas GluA2-containing
AMPARs will have a more linear I-V relationship (Pellegrini-Giampietro, 2003; Isaac et al.,
2007). The degree of rectification can be compared quantitatively by calculating the
rectification index, which is the ratio of the peak absolute amplitude of AMPAR-eEPSC at
-60 to +40 mV.

Given that the GluA2 subunit postnatally increases in expression, we would expect to
observe a developmental progression in AMPAR I-V plots, transitioning from inwardly
rectifying to more linear I-V curves. Unexpectedly, we did not identify a dramatic
developmental pattern in L2/3 pyramidal neurons in WT mice from our preliminary
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recordings (Figure 5.3). There was a minor decrease in the rectification index between
WT mice at P9-10 (3.498 ± 0.636) and P12-13 (3.072 ± 0.312), but the subsequent ages
were similar (P15-16: 2.908 ± 0.529; P21-25: 2.946 ± 0.588) (Figure 5.3F). Interestingly,
Fmr1 KO mice appear to exhibit more of a developmental decrease in their AMPAR
rectification index (P9-10 KO: 3.073 ± 0.423; P12-13: 4.209 ± 0.858; P15-16: 1.842 ±
0.187; P21-25: 1.993 ± 1.630); however, any conclusions related to genotypes cannot be
made as this data is very preliminary.

DISCUSSION
The developmental maturation of glutamatergic and GABAergic signaling is critical in
mediating the regulation of developmental excitability and plasticity for optimal circuit
formation. In a subset of our preliminary data, we can identify broad developmental
patterns related to glutamatergic maturation in L2/3 pyramidal neurons of the auditory
cortex. Continued functional analysis of AMPAR maturation is warranted to 1) better
characterize cell-type and layer-specific developmental patterns during the postnatal
maturation of the mouse auditory cortex in its intracortical formation, and 2) to
comprehensively understand whether there are alterations in excitatory synaptic
maturation in the Fmr1 KO mouse that could contribute to the deficits related to E-I circuit
development and the auditory phenotypes in these mice.

Our initial assessment of glutamatergic maturation includes analysis of spontaneous
AMPAR-mediated postsynaptic currents, silent synapses, and GluA2 subunits. Across
these measures, sEPSCs exhibited the strongest developmental regulation of AMPARs
with a clear age-dependent increase in frequency, consistent with the maturational
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properties of L2/3 pyramidal neurons of other cortical regions (Tatti et al., 2017; Kroon et
al., 2019). sEPSC amplitudes also exhibit a developmental increase, mainly between P910 and P12-13 mice, albeit a relatively subtle increase in comparison to the changes in
frequency. Nevertheless, these increases in synaptic AMPAR-mediated currents are
related to both synaptogenesis of excitatory glutamatergic synapses, and the
strengthening of individual synapses with increasing number of synaptic AMPARs
(Huttenlocher et al., 1982; Garner et al., 2002; Rakhade and Jensen, 2009).

Given the low frequency in AMPAR-sEPSCs we measured during early development, we
hypothesize that there will be a high proportion of NMDAR-only silent synapses at P9 and
P12 in the auditory cortex L2/3 pyramidal neurons. As sEPSC frequency increases, we
expect the number of silent synapses to concordantly decrease. Indeed, the initial
calculations show a decrease in the number of silent synapses between P12 and P15 in
WT mice, but we lack measures in P9-10 mice, which could more interestingly reveal the
magnitude of silent synapse loss during the transition to an open ear canal compared to
the progression during the auditory cortex tonotopic critical period. Such evaluations of
WT development would be even more interesting when compared to the Fmr1 KO auditory
cortex, given that L4 of the barrel cortex of KO mice is characterized by a delayed
persistence of silent synapses and thus a delayed barrel cortex critical period window
(Harlow et al., 2010). Neither our LTP experiments of L4-L2/3 synaptic plasticity in ex vivo
brain slices (Chapter 3), nor the in vivo tone-rearing experiments by Kim et al. (2013)
indicated a delayed plasticity window in the auditory cortex of Fmr1 KO mice. Thus, the
patterning of silent synapse maturation could reveal the basis of the aberrant
developmental synaptic plasticity in Fmr1 KO mice.
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Alterations in the GluA2 AMPAR subunit are also another mechanism by which synaptic
excitability and plasticity are impacted (Chater and Goda, 2014). Interestingly, in our WT
mice, we did not observe a strong developmental decrease in the rectification index at the
ages we tested, representative of more linear AMPAR I-V plots and thus GluA2-containing
calcium-impermeable AMPARs. This was unexpected as pyramidal neurons are
described to rapidly lose calcium-permeable AMPARs after P14 in rodents (Diering and
Huganir, 2018), and we specifically evaluate earlier and older postnatal ages. In addition,
despite the elevated membrane-bound expression of GluA2 we found between the 1st and
2nd postnatal weeks in Fmr1 KO mice, our preliminary data did not indicate functional
differences of GluA2-containing AMPARs in the KO L2/3 pyramidal neurons. Such
discrepancies could be related possible cell-type specific alterations, as GABAergic
interneurons and glial cells, including both astrocytes and oligodendrocytes, are known
express have a high fraction of GluA2-lacking AMPARs (Isaac et al., 2007; Diering and
Huganir, 2018; Ceprian and Fulton, 2019), which could be where the differences manifest.
Given that neural progenitors derived from induced pluripotent stem cells of FXS-patients
exhibited a higher proportion of GluA2-lacking AMPARs (Achuta et al., 2018), it would be
curious as to whether we observe cell-type or region-specific alterations in the Fmr1 KO
mice.

A continued, thorough evaluation of AMPAR maturation in the auditory cortex is necessary
to identify alterations in the development of auditory circuitry in the developing Fmr1 KO
mice. Synaptic evaluations in the auditory brainstem of Fmr1 KO mice revealed enhanced
excitatory connectivity in neurons of the lateral superior olive (Garcia-Pino et al., 2017).
Notably, significantly increased sEPSC frequency was observed in P14 and P21 mice with
increased immunostaining of vesicular glutamate transporters, which could suggest that if
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glutamatergic alterations are indeed present in the Fmr1 KO auditory cortex, they may
follow the disrupted auditory brainstem circuit and instead have differences in the auditory
cortex at these later ages. Nevertheless, a continued evaluation of functional AMPAR
maturation is necessary to understand E-I deficits in the Fmr1 KO auditory cortex.
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FIGURES

Figure 5.1: Postnatal maturation of sEPSCs in L2/3 pyramidal neurons of the auditory cortex
in WT and Fmr1 KO mice. (A) Representative traces of sEPSCs recorded across development.
(B-C) Summary of median amplitudes and average frequencies across animals. (C) sEPSC
frequencies have a developmental increase. All values and n’s are summarized in Table 5.1.
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Figure 5.2: NMDAR-only silent synapses in L2/3 pyramidal neurons in WT and KO mice in
the auditory cortex. (A-D) Representative minimal L4-evoked eEPSCs in L2/3 pyramidal neurons
at P12. (A, C) eEPSC traces at +40 mV and -60 mV (only showing 20 out of 50 sweeps). (B, D)
Summary of eEPSC responses across all stimulation trials. (E-F) Summary of failure rates at -60
mV and +40 mV holding potentials at P12-13 and P15-16 in WT and Fmr1 KO mice. (G) Fraction
of calculated silent synapses. N = P12-13: 6 cells/2 WT mice & 2 cells/1 KO mouse; P15-16: 3
cells/1 WT mouse & 3 cells/1 KO mouse
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Figure 5.3: AMPAR-isolated I-V plots in L2/3 pyramidal neurons of the developing auditory
cortex. (A-D) I-V plot relationships of peak responses of AMPAR-eEPSCs across membrane
holding potentials of -80 to +40 mV, with currents normalized to -80 mV. (E) Representative AMPAR
eEPSC traces at -60 and +40 mV in WT and Fmr1 KO mice at P9 and P15. (F) The rectification
index (the ratio of current evoked at -60 and +40 mV) across ages. P9-10: n = 6 cells/2 WT mice &
10 cells/3 KO mice; P12-13: n = 10 cells/3 WT mice & 4 cells/2 KO mice; P15-16: n = 3 cells/1 WT
mouse & 5 cells/2 KO mice; P21-25: n = 5 cells/2 WT mice & 2 cells/1 KO mouse
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Genotype

Amplitude (pA)

Frequency (Hz)

WT (4/2)

7.77 ± 0.19

0.16 ± 0.05

KO (3/1)

8.32 ± 0.26

0.27 ± 0.08

WT (13/5)

9.30 ± 0.26

1.26 ± 0.22

KO (4/2)

8.90 ± 0.26

1.85 ± 0.40

WT (5/2)

8.35 ± 0.37

1.67 ± 0.39

KO (5/2)

9.07 ± 0.40

4.26 ± 0.61

WT (6/2)

9.05 ± 0.37

4.33 ± 0.64

KO (2/1)

8.89 ± 0.13

9.61 ± 4.34

(n = cells/mice)

P9-10

P12-13

P15-16

P21-25

Table 5.1: Summary of sEPSC median amplitudes and frequency from L2/3 pyramidal
neurons in the auditory cortex. All values are mean ± SEM.
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CHAPTER 6:
GENERAL DISCUSSION

Impairments in language development, communication, and auditory processing are
pervasive in Fragile X syndrome (FXS) and many autism spectrum disorders. However,
there are currently no treatments capable of profoundly improving or mitigating such
deficits despite the perturbations that have been broadly characterized in the FXS brain.
Therefore, a more comprehensive evaluation of region-specific circuit development is
necessary to 1) understand how brain circuits uniquely alter across brain areas; 2) identify
when alterations first manifest and if such changes are lasting or dynamic; 3) correlate or
causally link neuronal circuit changes to the broader phenotypes; and 4) uncover new
therapeutic targets and windows for targeted treatment. The data presented in this
dissertation carefully examined these criteria, and provide evidence of altered excitatoryinhibitory (E-I) circuit maturation in the auditory cortex of Fmr1 KO mice during early
postnatal maturation, which ultimately provide valuable insight when considering the
development of therapies for FXS.

Our results present an in-depth analysis of the regulation of ionotropic receptor protein
expression, and physiological maturation patterns in the naturally developing auditory
cortex of wild-type mice. While there exist reports that have examined auditory cortex
maturation, such studies have differed in their use of animal models (Bi et al., 2006; Xu et
al., 2007; Takesian et al., 2010, 2012), and the cell types, cortical layers, or age windows
evaluated (Hackett et al., 2015; Blundon et al., 2017; Deng et al., 2017; Cisneros-Franco
et al., 2018; Sun et al., 2018; Takesian et al., 2018). In particular, we utilized more granular
age windows to enable neuronal circuit characterization related to the dynamics of ear
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canal opening, and both the start and end of the auditory cortex critical period for tonotopy.
We presented developmental protein expression of membrane-bound glutamate and
GABAA receptors, which are more reflective of physiologic function compared to prior
expression studies that examined total protein expression from whole-cell lysates (Xu et
al., 2007) or developmental mRNA transcript expression (Hackett et al., 2015). We further
detailed L4 to L2/3 synaptic circuit maturation, while thoroughly characterizing the
maturation of inhibitory regulation of L2/3 pyramidal neurons in the mouse auditory cortex.

This extensive characterization of natural auditory cortex development in WT mice
revealed maturational patterns in E-I circuit maturation that were clearly dysregulated and
improperly coordinated in Fmr1 KO mice, particularly in relation to GABAergic maturation.
Alterations were found in the molecular and cellular expression of GABAAR a-subunits in
Fmr1 KO mice, along with various GABAAR-mediated postsynaptic and presynaptic
modifications that collectively manifest in impairments of L4-L2/3 circuit excitability and
plasticity. Our continued evaluation of glutamatergic circuit maturation in Fmr1 KO mice
will enable us to further complement our findings to comprehensively identify how both
excitatory and inhibitory signaling are dysregulated across auditory circuit maturation.

FMRP is necessary for the postnatal maturation of auditory cortical circuits
One of the overarching features related to the impairments we characterized in the Fmr1
KO mice is that deficits in the auditory cortex first manifest during early postnatal
development. This is largely consistent with other alterations in the Fmr1 KO auditory
cortex, such as the impaired tonotopic critical period plasticity (Kim et al., 2013), and
altered developmental EEG and auditory event-related potential phenotypes (Wen et al.,
2019). Additionally, Fmr1 KO mice have delayed parvalbumin cell maturation in the
129

auditory cortex, where reduced parvalbumin cell numbers at P14 were thought to impact
the regulation of network excitation (Wen et al., 2018). We complement this finding and
confirm functional deficits related to GABAergic regulation in the developing auditory
cortex, where at approximately the same age window (P12-13), our studies revealed
decreased expression of GABAAR a3-subunit, altered presynaptic deficits in GABAmediated

inhibition,

and

altered

postsynaptic

regulation

including

enhanced

pharmacological sensitivity to GABAAR modulators. Furthermore, we find that these
alterations are not persistent, and rather are dynamic across postnatal maturation,
consistent with the developmental evaluations of inhibitory synaptic transmission in the
auditory brainstem and amygdala of Fmr1 KO mice (Vislay et al., 2013; Garcia-Pino et al.,
2017).

The combination of these GABAergic impairments ultimately underlies circuit defects in
L4 to L2/3 within the developing auditory cortex. Such defects included differences in
excitability of L4-L2/3 basal synaptic transmission, and an altered developmental
progression of L4-L2/3 LTP (Chapter 3). Specifically, P12-13 pyramidal neurons had high
variability in their synaptic eEPSC response at baseline. Additionally, LTP, though capable
of being induced, was visibly less stable compared to P12-13 WT mice. Alterations in
GABAAR signaling are well-characterized to regulate both network excitability and
plasticity (Hensch, 2005; Brooks-Kayal, 2011), suggesting that our alterations also
underlie some of the auditory-related phenotypes in FXS. GABA-mediated disruptions of
critical periods are described in neurodevelopment, where enhanced GAD67 expression
in Mecp2-null mice causes a precocious visual critical period (Krishnan et al., 2015), and
Gad65-null mice are incapable of inducing auditory critical periods unless inhibitory GABA
signaling is pharmacologically induced (Kalish et al., 2020). Furthermore, disruptions in
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inhibitory GABA signaling elicit auditory processing deficits, consistent with the FXS
auditory phenotypes (Wehr and Zador, 2003; Caspary et al., 2013; Kim et al., 2013;
Rotschafer and Razak, 2013; Blackwell and Geffen, 2017; Cisneros-Franco et al., 2018).

For a more comprehensive evaluation of GABAergic dysregulation in the auditory circuit
of FXS, the functional maturation of inhibitory neurons themselves must also be evaluated.
Our work thus far has largely focused on the regulation of E-I synaptic input onto L2/3
pyramidal neurons. By also examining GABAergic neurons, including their intrinsic
properties, and the direct excitatory and inhibitory synaptic input onto inhibitory
interneurons, we can further elucidate the altered E-I circuit dynamics in FXS that impact
the regulation of auditory plasticity and processing. Additionally, examination of
connectivity across the different cortical layers is also necessary to fully capture
intracortical dysregulation. This can lead to a better understanding of the underlying
mechanisms related to the differences that manifest with more global measures, like EEGs
or event-related potentials, which are more feasible in use for patients.

Secondary phenotypes resulting from loss of FMRP expression
While hyperexcitability is generalizable across the Fmr1 KO brain, the global loss of FMRP
yields region-specific alterations. For example, the critical periods of the various sensory
cortices are altered in differing manners. In the somatosensory cortex of Fmr1 KO mice,
the critical period is characterized by a delay, where the temporal window for
thalamocortical LTP is shifted approximately 3 days later than in WT mice (Harlow et al.,
2010). Such alterations are linked to a persistence of NMDAR-only silent synapses and a
delayed GABA polarity switch (Harlow et al., 2010; He et al., 2014). In the auditory cortex,
there is a general impairment of tonotopic plasticity, with no temporal delay (Kim et al.,
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2013). Notably, in the visual cortex, Fmr1 KO mice showed faster ocular dominance
plasticity responses, where monocular deprivation caused substantial open-eye
potentiation in a shorter period compared to WT mice (Dolen et al., 2007). In both the
auditory and visual cortex, deficits in critical periods were corrected by either
pharmacological or genetic reductions of mGluR-mediated signaling. However, no
additional evaluations related to underlying synaptic mechanisms were performed.
Interestingly, the sensory critical periods occur at different ages in development, with the
barrel cortex from P3-7 (Harlow et al., 2010), auditory tonotopy from P12-15 (Barkat et al.,
2011), and binocular plasticity from P19-32 (Gordon and Stryker, 1996). Thus, the
distinctions of the types of critical period abnormalities in Fmr1 KO mice may be a result
of adaptive synaptic and circuit maturation occurring across brain development as a result
of the more direct alterations caused by the loss of FMRP expression.

The alterations we have characterized in our studies of the developing auditory cortex of
Fmr1 KO mice are also likely secondary to the genetic mutation rather than a direct cause
of FMRP loss, given that neither the AMPAR or GABAAR a-subunits are not direct FMRP
targets (Darnell et al., 2011). The aberrant regulation of GABAAR-mediated signaling could
instead be from the hyperexcitability in the developing FXS brains, as occurs following
early-life seizures that increase a1-subunit expression, accelerate GABA polarity
switches, and occlude plasticity (Ben-Ari, 2002; Galanopoulou, 2008b; Brooks-Kayal,
2011; Sun et al., 2018). Prior to hearing onset, Fmr1 KO mice have enhanced excitatory
connectivity in the auditory brainstem (Garcia-Pino et al., 2017; Rotschafer and Cramer,
2017) that could drive enhanced excitability in higher auditory regions and disrupt synaptic
maturation. The barrel cortex in KO mice is also hyperexcitable (Contractor et a., 2015),
potentially influencing excitability given the integration of somatosensory and auditory
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cortex circuitry (Fu et al., 2003). Such hypotheses could be tested by broadly modulating
hyperexcitability strictly during the first postnatal week of Fmr1 KO mice, particularly using
known treatment paradigms that have corrected barrel cortex defects (He et al., 2019).
Subsequent analysis can be performed to test whether it this restricted early treatment is
sufficient to correct the phenotypes we have characterized in the L4-L2/3 auditory circuit.

Implications for the development of new FXS therapies
The past several decades have been plagued by failures in once promising clinical trials
in Fragile X syndrome. Given this broad lack of success, our findings underscore the need
to 1) develop age-specific therapies, particularly focusing on targeting patients early in
development; 2) consider combinatorial treatments that are dynamic with age; and 3)
utilize more rigorous biomarkers and redefine clinical endpoints that are reflective of what
is truly malleable at certain developmental ages.

Both our work and those of others highlight that molecular, cellular and physiological
alterations in the brain manifest early in Fmr1 KO development, with the critical periods
themselves altered in their normal function. Correcting the course of FXS disease
pathophysiology early during brain development could be more efficacious given that
circuits are more malleable during these age windows, and that this early correction could
subsequently attenuate the secondary effects of the core pathology. However, the cohorts
of patients in many of the past clinical trials have often included adults or older adolescent
ages, who would be well beyond their windows for the various critical periods. While there
is an overall consensus that future trials must include younger patients with more tailored
age groups, such animal model studies reaffirm this as a strong priority in future clinical
trial designs.
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Circuit hyperexcitability is a broad, persistent phenotype characterized across ages in the
Fmr1 KO brain (Contractor et al., 2015). However, the synaptic and neuronal alterations
underlying the circuit deficits are both multifactorial and dynamic across ages. We
observed in our work and those of others that many changes in the Fmr1 KO brain are
neither persistent nor permanent across multiple ages, and they often have disruptions to
numerous regulators of circuits (Harlow et al., 2010; Vislay et al., 2013; He et al., 2014;
Contractor et al., 2015; Garcia-Pino et al., 2017; Wen et al., 2018; Wen et al., 2019). While
this increases the overall complexity of a single-target approach, this does raise the
question as to whether a more combinatorial “cocktail” approach that adapts with age is
ultimately more appropriate. Perhaps modulating the function of chloride transporters,
whether with the NKCC1 inhibitor bumetanide or with regulators of KCC2 activity, could
be beneficial early in development when deficits were first identified in the somatosensory
cortex (He et al., 2019). However, later in development, a direct targeting of the GABAmediated system could be more efficacious, as altered presynaptic and postsynaptic
regulation have been characterized to occur across FXS (Braat and Kooy, 2015b, a).
Interestingly, a clinical trial has recently been completed in 2018 that actually targeted two
different pathways that are well-characterized to be aberrant in FXS (Protic et al., 2019).
However, the results of the combined treatment using lovastatin and minocycline
(LovaMix, NCT02680379) have not been published.

Earlier we alluded to the notion of identifying and correcting core versus secondary
disease pathology in FXS. There are increasing discussions that have centered on
whether some of the physiological phenomena that are being characterized in the animal
model, particularly at later ages, are adaptive or homeostatic mechanisms to
counterbalance the core hyperexcitability caused by loss of FMRP (Mullins et al., 2016;
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Cea-Del Rio et al., 2020). Such evaluations and interpretations are critical for therapy
design and drug targeting, where a drug’s mechanism of action in relation to disease
pathology and the relevant time windows must be considered. Given FMRP’s main
function as a mRNA translational regulator, whose transcripts span from synaptic proteins
to epigenetic regulators thus enabling extensive dysregulation (Bagni and Greenough,
2005; Darnell et al., 2011; Alpatov et al., 2014; Korb et al., 2017), it is unlikely that the
deep, core underlying pathology can be addressed without gene therapy early in life where
the expression of FMRP is increased (Hampson et al., 2019; Shitik et al., 2020).

However, this does not exclude the potential beneficial effects derived from downstream
targeting in FXS. Many proteins for which FMRP exerts direct translational control are
altered in their expression and activity in FXS. For example, matrix metalloproteinase-9
(MMP-9), a secreted endopeptidase, is directly regulated by FMRP and is found to have
elevated levels and activity in both patients and the Fmr1 KO model. Genetic reductions
of MMP-9 levels and pharmacological attenuation of its activity have demonstrated
beneficial effects in rescuing several auditory-related phenotypes in the FXS mouse
model, and were positively associated with improvements of some clinical measures in
early clinical trials (Dziembowska et al., 2013; Wen et al., 2018; Lovelace et al., 2020).
Other downstream targets that are also altered via indirect mechanisms of FMRP loss of
expression could still aid in the attenuation of E-I imbalance in the brain. Interestingly,
there is currently a clinical trial recruiting for volunteers to examine AZD7325, a positive
modulator of GABAAR a2 and a3, in adults with Fragile X syndrome (NCT03140813). The
targeting of the GABAAR a3 subunit is highly consistent with our findings where we
observed its reduced expression during early development in the auditory cortex.
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Nevertheless, with these various approaches for the treatment of FXS, it is also highly
critical to reconsider the clinical endpoints that are used to evaluate the relative success
of investigational therapies. Our work, in conjunction with the established literature,
continues to prove the prevalence of region-specific alterations that manifest in the rodent
brain caused by loss of expression of FMRP. While disruptions to global brain function
certainly contribute to the neuropsychiatric symptoms, it may be necessary to decouple
the alterations and identify more explicit biomarkers linked to specific symptoms or brain
regions. More specific biomarkers or symptoms may actually be positively modulated by
the drug under investigation, but are not captured with the broader endpoints, such as
improvements of behavioral symptoms. Lastly, the identification of region-specific
biomarkers could enable the understanding of age-dependent cascades in FXS
pathophysiology that reveal what symptoms are possibly more malleable given the
patient’s age, and ultimately, what therapies might yield greater success. These
developmental characterizations are comprehensively being performed in the FXS rodent
model. However, for improved translational applications that more precisely elucidate the
pathophysiology in humans, it is likely necessary to move towards FXS models in nonhuman primates where the complexities of brain development can be more robustly
captured.
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